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Cows are susceptible to new Escherichia coli intramammary infections (IMI) in the non-
lactating period of late gestation (known as the ‘dry period’). These IMI often persist up until 
parturition without inducing highly inflammatory responses and increase the risk of postpartum 
mastitis in the subsequent lactation. The bovine maternal immune system is hypothesized to be 
regulated during late gestation to prevent highly inflammatory, cell-mediated responses however 
the mechanisms in generating such tolerance have not been fully elucidated. In other mammalian 
species mononuclear phagocytes play a primary role in generating maternal immune tolerance, 
and although beneficial for the fetus, often negatively impacts immune responses to invading 
pathogens. The work presented here investigated changes in maternal immunity and its 
relationship to dry period E. coli IMI dynamics through the use of experimental and 
mathematical approaches. The objectives were to 1) characterize changes in blood monocyte 
composition and monocyte-derived dendritic cell (moDC) function over pregnancy to identify 
unique changes in late gestation, 2) investigate pregnancy-associated factors that regulate these 
cells, 3) investigate the relationship between maternal immune regulation and dry period E. coli 
IMI dynamics and risk of postpartum mastitis through mathematical models, and 4) investigate 
the effect of intramammary immunization with UV-killed E. coli on IMI dynamics and host 
response. Pregnancy was accompanied with a decrease in inflammatory monocytes and impaired 
moDC maturation following E. coli stimulation. Aspects of hindered moDC maturation could be 
induced by in vitro treatment of late gestation levels of progesterone and estradiol. Deviations in 
  
 
prepartum monocyte composition related to risk of postpartum disease. Mathematical model 
results indicated these shifts in cytokine production alone were not able to recapitulate IMI 
dynamics in the dry period, but rather it involved an interaction between maternal immune 
regulation and physiological and immunological changes to the mammary gland that accompany 
the dry period. Intramammary immunization at dry-off generated protective responses against E. 
coli challenge later in the dry period. Overall, shifts in maternal immunity both in the periphery 
and in the mammary gland during the dry period relate to persistent E. coli IMI and postpartum 
mastitis, and local immunity can be manipulated to generate protection against IMI in the dry 
period.
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CHAPTER 1:  
INTRODUCTION 
  
1. Mastitis 
1.1. Definition, Epidemiology, Etiology,  and Risk Factors 
Mastitis is one of the most prevalent and costly diseases afflicting dairy farms worldwide 
(Seegers et al., 2003, Bannerman, 2009). Financial losses associated with mastitis are attributed 
to decreased milk production and quality, increased culling rates, discarded milk, treatment costs, 
and adverse effects on fertility and early pregnancy (Hortet and Seegers, 1998, Seegers et al., 
2003, Hertl et al., 2014a). The greatest incidence of mastitis occurs within the first weeks 
following parturition that overlaps with the transition period, a time of negative energy balance 
following the onset of lactation and immune dysfunction (Barkema et al., 1998, Green et al., 
2002). Clinical signs of mastitis include painful swelling of the afflicted mammary gland, 
increased somatic cell counts (SCC), decreased milk production and abnormal secretions, and, in 
extreme cases where bacteremia occurs, systemic signs such as rumen stasis, shock, or even 
death (Burvenich et al., 2003, Schukken et al., 2011). Bovine mastitis is most commonly caused 
by bacterial intramammary infections (IMI) (Bannerman, 2009). Escherichia coli is the most 
prevalent of the gram-negative pathogenic agents responsible for IMI and cases of clinical 
mastitis in dairy cattle and that are typically of greater severity and mortality than other mastitis-
causing pathogens (Barkema et al., 1998, Bannerman, 2009, Rinaldi et al., 2010, Quesnell et al., 
2012, Oliveira et al., 2013). Common environmental sources of E. coli include contaminated 
bedding, manure solids and unhygienic housing conditions. E. coli IMI are often self-limiting 
and short in duration with high bacterial counts, although some strains are known to cause mild, 
chronic forms of mastitis and have the ability to form intracellular reservoirs in mammary 
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epithelial cells (MEC) (Dopfer et al., 2000, Dogan et al., 2006, White et al., 2010, Schukken et 
al., 2011, Dogan et al., 2012).  
1.2. Immune Response Associated with  E. coli IMI 
E. coli express an array of virulence factors, most notability the endotoxin 
lipopolysaccharide (LPS) which is central to pathogenesis in IMI (Wenz et al., 2006, Lippolis et 
al., 2014). Factors other than LPS also contribute to the pathogenesis of E. coli; some strains 
express adhesins, invasins, and secreted factors related to serum resistance that enable them to 
persist in the gland (Wenz et al., 2006, Suojala et al., 2011, Dogan et al., 2012, Lippolis et al., 
2014). The clinical severity of E. coli mastitis is thought to be dependent largely on cow-specific 
factors and host response to these virulence factors (Burvenich et al., 2003, Schukken et al., 
2011). Specifically, stage of lactation, parity, metabolic status, and immune function are 
associated with clinical severity of mastitis (Burvenich et al., 2003, Burvenich et al., 2007). In 
addition, initial sensing and strength of the innate immune response to invading E. coli is thought 
to be dependent on bacterial load (Vangroenweghe et al., 2004, Mehrzad et al., 2008, 
Bannerman, 2009, Schukken et al., 2011). Both Vangroenweghe et al. (2004) and Mehrzad et al. 
(2008) found that increasing the E. coli inoculum in primiparous cows induced a more rapid 
inflammatory cytokine response and increased CD8+ T cell trafficking to the gland, but this 
immune response did not correspond to a more rapid clearance of the bacteria. These findings 
suggest that the ability to clear E. coli IMI efficiently involves more complex elements than 
strong, early initiation of the inflammatory cascade (Vangroenweghe et al., 2004, Mehrzad et al., 
2008). 
The mammary gland innate immune defense is comprised of physical barriers such as the 
teat sphincter and keratin, soluble factors in mammary gland secretions including lactoferrin, 
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complement, and defensins, and cellular defenses at the mucosa including tissue-resident cells 
and recruited leukocytes i.e.  MEC, monocytes (Mo), dendritic cells (DC), macrophages (Mφ), 
lymphocytes, neutrophils (PMN), mast cells, natural killer (NK) cells, etc. (Riollet et al., 2000, 
Burvenich et al., 2003, Hodgkinson et al., 2009, Maxymiv et al., 2012). Inflammation induced by 
E. coli IMI is initiated by toll-like receptor (TLR) signaling, primarily through TLR2 and TLR4 
expressed on the surface of MEC, mast cells, and myeloid cells (Mo, DC, Mφ) which recognize 
pathogen-associated molecular patterns (PAMP) such as LPS. Lipopolysaccharide-induced 
signal transduction via TLR2/4 with co-receptors CD14 and MD-2 leads to recruitment of 
adaptor proteins (MyD88, TRIF, TIRAP/MAL, TRAM, SARM) and ultimately results in 
translocation of transcription factor NF-κB into the nucleus to induce pro-inflammatory cytokine 
production (IL-1β, IL-6, IL-8, TNFα) (Akira et al., 2006, Schukken et al., 2011, Piras and 
Selvarajoo, 2014). The inflammatory cascade leads to the recruitment of leukocytes from the 
blood to the infected mammary gland and eventual clearance of E. coli, however, changes in 
immune function i.e. PMN diapedesis, ROS production, phagocytosis, cytokine production at 
different stages of lactation, parity, age, etc. influence severity of clinical mastitis and outcome 
of IMI (Vangroenweghe et al., 2005, Burvenich et al., 2007, Bannerman et al., 2008, Detilleux, 
2009, Wenz et al., 2010, Quesnell et al., 2012). Antigen presenting cells, including Mo, Mφ, and 
DC are present in the mammary gland; these tissue-resident cells orchestrate innate and adaptive 
immunity imperative to efficient bacterial clearance and mucosal vaccine efficacy (Sordillo and 
Streicher, 2002, Bharathan and Mullarky, 2011, Maxymiv et al., 2012). Following parturition 
cows experience a state of immune dysfunction leading to uncontrolled inflammation and 
increased incidence and severity of infectious diseases. Increased nutritional demands of 
lactation in addition to dramatic changes in hormone profiles following calving are thought to 
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regulate aspects of the immune response (Burvenich et al., 2007, Sordillo, 2016). Periparturient 
cows have reduced circulating levels of T cells, decreased IFN-γ secretion, and impaired PMN 
oxidative function, all of which are likely to contribute to heightened risk of clinical mastitis 
(Hoeben et al., 2000, Vangroenweghe et al., 2005, Rinaldi et al., 2008). However, the specific 
factors and mechanisms that regulate immune cell function and ultimately lead to changes in IMI 
dynamics in dairy cattle are not fully elucidated (Vangroenweghe et al., 2005). 
1.3. Vaccination against E. coli mastitis 
In efforts to prevent this highly prevalent and costly disease, farms employ management 
practices to improve milking protocols and milking hygiene, housing conditions and cow 
hygiene and nutrition. Some farms may also choose implement vaccination programs against E. 
coli mastitis. The commercially available systemic E. coli J5 bacterin mastitis vaccine is 
commonly administered in the non-lactating period of late gestation known as the ‘dry period’; 
J5 vaccination is meant to aid in the reduction of clinical severity in postpartum E. coli mastitis 
through enhanced J5-specific IgM, IgG1, and IgG2 serum levels (Dosogne et al., 2002, Wilson et 
al., 2009). However, these commercially available J5 vaccines are not labeled for the prevention 
of E. coli IMI rather they labeled to aid in clinical signs associated with E. coli mastitis. There 
are numerous challenges associated with generating mucosal immunity and eliciting strong, 
appropriate immune response to vaccination; the route of vaccination and immune status of the 
animal may impact vaccine efficacy (Bharathan and Mullarky, 2011). Preventing  new infections 
in the dry period prior to the transition period, a period of known immune dysfunction, would 
greatly reduce the incidence of postpartum mastitis. Parameters related to immune status of the 
cow influence both susceptibility to disease, and infection dynamics, and response to vaccination 
is not fully elucidated. Identifying the key parameters that substantially impact the outcome of 
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IMI and vaccination are necessary to optimize management strategies and aid in efforts of 
generating effective and appropriate bio-therapeutics, vaccines, and schedule for prophylaxis 
administration to prevent cases of clinical mastitis postpartum.  
2. Dry period and late gestation 
2.1. Definition of dry period 
The non-lactating period prior to calving in primiparous and multiparous cows, known as 
the ‘dry period’, is a time for turnover of MEC meant to maximize milk production in the 
coming lactation, and coincides with a time of considerable fetal growth (Esposito et al., 2014). 
Typically the dry period ranges between 40-60 days prior to calving, a period in which the 
mammary gland goes through involution characterized by apoptosis and subsequent cell 
regeneration (De Vries et al., 2010). Concurrent to changes in mammary gland physiology, there 
are also numerous alterations to immunity within the mammary gland. 
2.2. Intramammary infections in the dry period 
The dry period is a known time of heightened susceptibility to new IMI, specifically 
around dry-off and colostrogenesis when milk leakage is likely to occur due to the increased 
pressure within the mammary gland; conjointly, the risk of IMI increases with possible delays in 
keratin plug formation following milk cessation in high producing cows (Smith et al., 1985a, 
Burvenich et al., 2007). In addition to milk leakage, there is a delay in leukocyte recruitment to 
the mammary gland by approximately a week following the onset of dry-off until protective 
levels of leukocytes are reached; additionally, upon reaching the gland these cells have decreased 
phagocytic function from ingestion of milk fat and cell debris in the early dry period (Burvenich 
et al., 2007). The lowest incidence of new IMI occurs in the mid-dry period when the gland 
remains in steady-state involution, the teat ends are sealed, conditions are unfavorable for 
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bacterial growth, and there is a high concentration of phagocytes, lactoferrin, acute phase 
proteins, and other soluble mediators in the gland and secretions (Ziv and Gordin, 1973, Jensen 
and Eberhart, 1981, Todhunter et al., 1990). The majority of cases of clinical mastitis occurring 
in the first 60 days post-calving are caused by IMI acquired in the dry period (Fig. 1); among the 
mastitis-causing pathogens, E. coli is the most common isolate from the dry period associated 
with clinical mastitis in the subsequent lactation (Smith et al., 1985a, Smith et al., 1985b, 
Barkema et al., 1998, Green et al., 2002). Interestingly, signs of inflammation typically observed 
with E. coli mastitis in lactation do not accompany IMI acquired in the dry period; often these 
IMI persist in the dry period without signs of inflammation up until parturition (Quesnell et al., 
2012).  
 
Figure 1. Distribution of incidence rate of clinical mastitis of weeks following calving. 
Adapted from Barkema et al. (1998). 
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in the dry period the infection persisted until parturition without clinical signs or upregulation of 
pro-inflammatory cytokines (TNFα, IL-1β, IFNγ); following calving cows developed clinical 
mastitis and upregulated these pro-inflammatory cytokines hallmark of E. coli mastitis in 
challenged quarters. Sipka et al. (2013) found when mid-lactation multiparous cows were given 
similar intramammary challenges with E. coli ECC-Z, animals developed clinical mastitis and 
upregulated pro-inflammatory cytokines within 24hr following challenge. As mentioned 
previously, the severity of E. coli mastitis and response to infection are thought to be largely 
dependent on cow factors. The specific factors associated with late gestation and dry period 
which impact IMI dynamics and allow for persistence of infection without clinical signs in the 
dry period are poorly understood.  
3. Maternal Immune Regulation in Pregnancy 
3.1. Maternal Immune Tolerance  
During pregnancy the maternal immune system is presented with the challenge of 
needing to concurrently tolerate the growth of a semi-allogenic fetus and respond to invading 
pathogens. Highly inflammatory, cell-mediated T helper 1 (Th1) and T helper 17 (Th17)-type 
responses in pregnancy can be detrimental to the health of the fetus, thus, the maternal immune 
system must be carefully regulated (Rosbottom et al., 2008, Betz, 2012, Krishnan et al., 2013, 
Lash and Ernerudh, 2015, Regal et al., 2015). Though highly inflammatory responses appear to 
negatively impact pregnancy success, the original dogma that the maternal immune system is 
suppressed and biased towards Th2/Treg-type responses throughout pregnancy in order to 
tolerate the conceptus is an oversimplification of maternal immune tolerance. The manner in 
which the maternal immune system is regulated varies depending on the needs of particular 
stages of pregnancy, i.e. fertilization, implantation, maintenance, preparation for labor and 
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parturition (Oliveira et al., 2012, Bauersachs and Wolf, 2013, Gomez-Lopez et al., 2014, Sandra 
et al., 2015, Nair et al., 2016). These changes to the maternal immune system occur locally at the 
tissues apart of the fetal-maternal interface and also systemically in peripheral blood and other 
mucosal sites in the body (Bauersachs and Wolf, 2013, Schumacher et al., 2014). However, as 
observed in human and murine pregnancy, the dam’s immune system still maintains aspects of 
immune competency, and it is also possible for maternal immune tolerance to be disrupted; the 
immune response elicited to invading pathogens is differentially regulated by the stage of 
pregnancy (Entrican, 2002, Innes, 2007, Krishnan et al., 2013). Maternal immune regulation in 
pregnancy is extensively studied in both human and mice, but less is known about changes made 
to the maternal immune system in dairy cows. However, given the wide biological differences 
and energy demands of a production animal, the findings in humans and mice may not be 
directly transferable to a bovine model. 
3.2. Cell Types Involved in Generating Maternal Immune Tolerance 
Myeloid and lymphoid cell populations such as Mo, Mφ, DC, NK cells, T cells, and B 
cells, are directly and indirectly regulated by various pregnancy-associated factors including 
hCG (in the case of humans), progesterone (PG), estradiol (E2), pregnancy-associated 
glycoproteins, etc. to promote tolerance of the fetus (Schumacher et al., 2014). Myeloid cells 
(Mo, Mφ, DC), in particular DC, are known to play a critical role in the generation and 
maintenance of maternal immune tolerance and are regulated both locally at the feto-maternal 
interphase and in the periphery (Bachy et al., 2008, Negishi et al., 2012, Leno-Duran et al., 2014, 
Schumacher et al., 2014). Dendritic cells are potent antigen presenting cells that both initiate 
immune responses and induce peripheral tolerance; the type of response elicited depends heavily 
on DC maturation status and cytokine production (Hivroz et al., 2012). In human and murine 
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pregnancy, the composition of DC subsets changes and regulatory subsets such as plasmacytoid 
and regulatory myeloid DC increase, which promote Treg expansion and are pertinent to fetal 
survival (Miyazaki et al., 2003, Ban et al., 2008, Fang et al., 2016). The regulation of 
conventional DC and monocyte derived DC (moDC) maturation in humans and rodents is a key 
mechanism in the generation of immune tolerance through the inhibition of antigen presentation 
(MHC II), dampened expression of co-stimulatory molecules (CD80, CD86, CD40), and 
generation of antigen-specific, cell-mediated responses; maternal DC regulation varies by 
species, stage of pregnancy, and subset of DC (Lutz and Schuler, 2002, Bachy et al., 2008). 
Tolerance is often generated by immature and semi-mature DC due to the weak and insufficient 
receptor and cytokine signaling provided to naïve T cells thereby hindering antigen-specific 
immunity and other innate immune cell populations including neutrophils and NK cells (Lutz 
and Schuler, 2002, Doz et al., 2013). Previous work in humans and mice indicates DC 
maturation is impaired during mammalian pregnancy due tothe influence of circulating 
pregnancy-associated factors in order to debilitate strong cellular, inflammatory responses 
detrimental to the fetus and favor Th2/regulatory immunity (Uemura et al., 2008, Segerer et al., 
2009, Della Bella et al., 2011, Xu et al., 2011, Cordeau et al., 2012, Schumacher et al., 2013, 
Schumacher et al., 2014). 
Monocyte and Mφ populations are also modulated in pregnancy. Monocytes are 
classified by CD14 and CD16 expression into classical (cM), intermediate (intM), and 
nonclassical (ncM) monocytes with unique functions, however these subsets have only recently 
been defined in cattle and subset functional characteristics appear to deviate from other species 
(Hussen et al. 2013). In humans and rats, high levels of intM relative to cM during pregnancy is 
associated with the inflammatory disease pre-eclampsia (Faas et al., 2014). Monocytes may also 
  
10 
differentiate into Mφ and DC following tissue infiltration. Macrophages are thought to play 
essential roles in spiral artery formation during placentation in humans and predominantly 
maintain an anti-inflammatory, M2 phenotype over M1 (Faas et al., 2014).   
In bovine pregnancy very little is known about the mechanisms involved in maternal 
immune regulation including which cell types are subject to regulation and which factors 
regulate them. Manjari et al. (2016) observed dampening of pro-inflammatory responses through 
changes in gene expression profiles in PMN and plasma cytokine levels as early as implantation. 
Changes in T cell populations are observed throughout stages of bovine pregnancy (Asai et al., 
1998, Oliveira and Hansen, 2008, Maeda et al., 2013). Cattle experience an increase in peripheral 
CD4+CD25+ T cells in response to pregnancy, and aspects of T cell function are regulated in 
pregnancy; PG inhibits the mRNA expression of Th1 and Th17 cytokines IFN-γ and IL-17 and 
transcription factors T-bet and RORC, and enhanced the mRNA expression of IL-4 in cells from 
pregnant cows (Oliveira and Hansen, 2008, Maeda et al., 2013). Asai et al. (1998) found an 
increase in CD4+/CD8+ T cell ratio and IL-2 and IL-4 production from cells in mammary gland 
secretions in the dry period relative to lactating stages of non-pregnancy and pregnancy. Work 
on early pregnancy in cattle suggests the important role of myeloid cells at the feto-maternal 
interphase Specifically Mansouri-Attia et al. (2012) found there was a substantial increase in the 
number of CD14+ cells and CD172a+CD11c+ cells (Mo, Mφ, DC) in the endometrium during 
very early stages of pregnancy. Kamat et al. (2016) observed comparable changes in pregnant 
heifers with increases in numbers of CD14+CD11c+ cells and tolerance-inducing indoleamine 
2,3-dioxygenase (IDO) expression in both blood and endometrium in early pregnancy. Other 
studies from later stages of pregnancy showed accumulation of Mφ in the mammary gland 
during involution within the early dry period and in the endometrium approaching calving 
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(Sordillo and Streicher, 2002, Oliveira and Hansen, 2008, Oliveira and Hansen, 2009). Despite 
their central role in human and murine pregnancy little is known about functional changes to 
various myeloid cell populations during bovine pregnancy, mechanisms that regulate these cells, 
and their specific roles in maternal immune tolerance across pregnancy.  
3.3. Endocrine factors involved in maternal immune tolerance 
Multiple factors in pregnancy regulate various maternal immune cell populations; these 
cells may be regulated differently depending on the stage of pregnancy in order to meet the 
specific demands for successful implantation, maintenance of pregnancy, and preparation for 
parturition (Bauersachs and Wolf, 2013, Gomez-Lopez et al., 2014, Robertson and Moldenhauer, 
2014). Immune-endocrine crosstalk is essential for pregnancy maintenance. In human and 
murine pregnancies gonadotropin and steroid hormones suppress detrimental maternal responses 
to fetal antigens by generating and maintaining maternal immune tolerance. Specifically, 
pregnancy associated hormones may reduce the antigen-presenting capacity of DC, Mo, and Mφ 
as well as regulate NK cells, T and B cells i.e. support the proliferation of uterine NK cells and 
induction of regulatory T and B (B1) cells (Laskarin et al., 2007, De Vries et al., 2010, Muzzio et 
al., 2014, Schumacher et al., 2014, Nair et al., 2016). In humans, pregnancy recognition 
following fertilization relies heavily on conceptus produced luteotropic hormone human 
chorionic gonadotropin (hCG) that directly acts upon the corpus luteum (CL) to sustain 
progesterone (PG) production. In bovine pregnancy the initial cross-talk between the conceptus 
and the dam is from locally produced, conceptus-derived, antiluteolytic IFNτ which blocks 
luteolysis through paracrine actions on the uterine endometrium (Bazer et al., 2010). These 
pregnancy-recognition, conceptus-derived molecules also act on the maternal immune system to 
generate tolerance in the early pregnancy. For example, in regards to human pregnancy, hCG 
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modulates multiple cell populations to initiate maternal immune tolerance towards the conceptus. 
Specifically, hCG induces Treg cell formation and recruitment to the fetal maternal interface, 
inhibits IL-2 production by peripheral mononuclear cells (PBMC) leading to a reduction in T cell 
activation, and generates tolerogenic DC (Bansal et al., 2012, Polese et al., 2014). In ruminants, 
IFNτ primarily acts locally within the uterine tissue, but also has systemic effects analogous to 
the effects of hCG in humans that promote PG secretion from luteal cells through systemic 
activation and recruitment of neutrophils by IFNτ (Shirasuna et al., 2015).  
Estradiol (E2) and PG are known to regulate aspects of maternal immune tolerance and 
are related to the maintenance of pregnancy (Schumacher et al., 2014). Estradiol and PG are 
relatively high in bovine gestation, and in the case of E2, this hormone drastically increases as 
cows approach calving in the third trimester of pregnancy (Hunter et al., 1970, Echternkamp and 
Hansel, 1973, Smith et al., 1973). Maeda et al. (2013) showed that in vitro treatments with PG 
influenced the expression of T cell transcription factors to promote T regulatory cell formation in 
bovine PMBC.  Lamote et al. (2004), (2006) found E2 and PG regulated the function and 
phenotype of bovine neutrophils. Previous work on human and murine pregnancy found E2 and 
PG to have immunosuppressive effects on DC differentiation and maturation i.e. reduction in 
CD80 and MHC II, enhanced anti-inflammatory cytokine production with concurrent suppressed 
pro-inflammatory cytokine responses, and T cell stimulatory capacity (Hughes et al., 2008, 
Segerer et al., 2009, Jones et al., 2010, Xu et al., 2011, Lasarte et al., 2013). Estradiol and PG in 
conjunction with other pregnancy-associated hormones such as cortisol, relaxin, and 
prostaglandin play a role in preparation for labor both directly on the tissues, and indirectly 
through influence of local immune cell populations (Shynlova et al., 2013). For example, in non-
bovine species, IL-1β and IL-10 are key cytokines involved in priming the uterus for labor and 
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preventing preterm labor in late gestation, respectively, and E2 and P4 are known to influence 
the expression of these cytokines and related receptors (Sato et al., 2001, Schaefer et al., 2005, 
Pioli et al., 2006, Robertson et al., 2006, Robertson et al., 2007, Boro et al., 2014). Despite the 
importance of both immune endocrine crosstalk and myeloid cells in maternal immune 
regulation across other species, we lack an understanding on the impact of hormones on myeloid 
cell populations.  
3.4. Immunity to Infection in Late Gestation 
Pregnancy poses the unique challenge for the maternal immune system; it must be 
capable of simultaneously promoting maternal immune tolerance to the semi-allogenic fetus and 
responding to invading pathogens. Maternal immune regulation in mammalian pregnancy is 
dynamic, and dairy cattle show varying responses to infectious agents a different stages of 
pregnancy (Innes, 2007, Rosbottom et al., 2008, Quesnell et al., 2012, Sipka et al., 2013). In 
human and murine pregnancy, women and mice are more susceptible to intracellular pathogens 
like L. monocytogenes, Salmonella enterica Typhimurium, influenza, etc. which rely on 
Th1/Th17, cell-mediated responses for effective clearance (Krishnan et al., 2013). Previous work 
investigating the interplay between maternal immune regulation and infectious disease within 
pregnancy has primarily focused on abortion-causing pathogens. However, as mentioned 
previously both Quesnell et al. (2012) and Gurjar et al. (2013) have shown there are alterations to 
bovine IMI immune response in the dry period which coincides with late gestation. Namely, 
there are hindered pro-inflammatory responses and clearance of E. coli in the mammary gland 
throughout the dry period (Quesnell et al., 2012, Gurjar et al., 2013).  
Similar to IMI dynamics in the dry period, previous work on Neospora caninum 
pathogenesis has shown gestational stage-dependent changes in infection dynamics with notable 
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differences in late gestation relative to earlier stages of pregnancy (Innes, 2007, Rosbottom et al., 
2008). N. caninum is a major abortion-causing parasite in cattle which is transmitted via 
ingestion of oocyst-contaminated feed or water and leads to transplacental transmission to the 
fetus resulting in abortion or full-term congenitally infected fetuses (Innes, 2007).  Previous 
work has shown that when cattle are experimentally infected with N. caninum in early pregnancy 
during the first trimester (less than 100 days carrying calf) fetal death is most likely to occur, 
whereas the risk of transmission from dam to fetus is highest in the last trimester (Williams et al., 
2000, Maley et al., 2003, Macaldowie et al., 2004, Maley et al., 2006, Gibney et al., 2008, 
Rosbottom et al., 2008). These differences in N. caninum infection outcome are largely thought 
to be due to the changes in maternal immune system which vary by stage of pregnancy. Early 
induction of cell-mediated responses including early production of Th1-type cytokines IFN-γ and 
IL-12, NK cell lysis of infected cells, and antigen-specific T cell responses are necessary to 
eliminate this obligate intracellular pathogen; these responses are most severe in early pregnancy 
when fetal death is greatest and mildest in late pregnancy when infections are most likely to 
persist (Gazzinelli et al., 1996, Marks et al., 1998, Staska et al., 2003, Boysen et al., 2006, Maley 
et al., 2006, Innes, 2007, Rosbottom et al., 2008, Canton et al., 2014). These studies indicate is 
the greatest regulation of cell-mediated immune responses occurs in late gestation and hinders 
effective responses to infection; the specific role maternal immune regulation plays in IMI 
dynamics in late gestation and the dry period is not fully known. Our limited understanding of 
maternal immune regulation hinder our ability to elucidate complexities of host-pathogen 
interactions at periods of heightened susceptibility and thus, hinder the development of optimal 
preventative interventions in the dry period to eliminate IMI. 
4. Objectives and hypotheses 
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The overall objective of the work presented in this dissertation was to evaluate differences in 
late gestation immune response as it relates to the outcome of E. coli IMI in the dry period 
compared to other stages of lactation. The known roles of myeloid cells in other mammalian 
species indicate that they are key drivers in the immune response to infection, the antigen-specific 
responses to immunization, and in the maternal immune tolerance. Thus, we chose to investigate 
changes to Mo and moDC in bovine late gestation as a parameter related to E. coli IMI dynamics 
in the dry period and subsequent postpartum disease. The studies presented here investigated the 
specific hypothesis that bovine myeloid cells, including Mo and DC populations, have reduced 
capacity to promote cell-mediated, inflammatory and antigen-specific responses in late gestation 
which contribute to a suboptimal defense against E. coli IMI and pathogen clearance. The 
following experiments used E. coli ECC-Z strain which is an isolate from a case of clinical 
bovine mastitis (Dogan et al., 2006) and has been used in a number of intramammary challenge 
studies (Quesnell et al., 2012; Gurjar et al., 2013; Sipka et al., 2013). The first objective of this 
dissertation was to compare the ability of moDC from late gestation dairy cows to mature in 
response to UV irradiated E. coli ECC-Z stimulation to those from non-pregnant dairy cows in a 
cross-sectional study. The second objective captured the dynamics of monocyte subsets, and the 
phenotypic maturation and cytokine production induced by E. coli ECC-Z of respective moDC 
populations through a prospective longitudinal study in cows from mid-gestation through calving 
into the subsequent lactation to elucidate stage-specific changes. The third objective was to 
characterize influence of steroid hormones on moDC using an in vitro model of moDC co-
cultured with pregnancy-associated steroid hormones, in order to further understand what factors 
may regulate changes observed in late gestation.  
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To investigate the role of maternal immune regulation in intramammary infection dynamics 
in the dry period of late gestation and subsequent postpartum disease, the remaining objectives of 
this dissertation investigate the relationship between prepartum immune function and postpartum 
disease. The fourth objective investigated maternal immune function and postpartum disease by 
elucidating relationship between prepartum monocyte composition and postpartum disease using 
logistic regression models to analyze prospective data. The fifth objective was an expansion of a 
pre-existing mathematical model on dynamics of E. coli IMI to account for the altered immunity 
in late gestation using data from other objectives. The sixth and final objective investigated the 
impact of intramammary immunization with UV irradiated E. coli ECC-Z in the dry period on 
intramammary challenge with the same strain on IMI and postpartum mastitis.  
The long term goal of the studies proposed here is to characterize the influence of gestation 
on bovine immune function to permit the development of optimal dry cow management, 
vaccination schemes, and potential immune-modulators to prevent IMI in the dry period thereby 
reducing risk of clinical mastitis in early lactation.  
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ABSTRACT 
During late gestation the bovine immune system is less capable of eliciting inflammatory 
responses and eliminating invading pathogens. The maternal immune system is directed towards 
tolerance in order to prevent fetal rejection due to recognition of paternal antigens. In humans 
and mice, dendritic cell (DC) populations maintain a tolerogenic phenotype essential in the 
generation and preservation of maternal immune tolerance throughout pregnancy. However, the 
primary mechanisms which facilitate maternal immune tolerance involved in bovine gestation 
remain poorly understood. In order to determine if DC phenotype and function were regulated 
towards tolerance during bovine gestation, we compared in vitro generated monocyte-derived 
DC (moDC) from monocytes isolated from cows in late gestation (LG) to those from non-
pregnant (NP) cows in their ability to mature following stimulation with UV irradiated E. coli. 
Our results show moDC from LG cows have an impaired ability to mature in response to E. coli 
stimulation in a receptor and cytokine-mediated fashion in comparison to those from NP cows. 
Specifically, moDC from LG cows were unable to upregulate MHC II and maintained high 
expression of CD14, both indicative of an immature phenotype following E. coli-stimulation. 
Only moDC from LG showed significant increase in IL-10 production and had a significantly 
lower ratio of production of the Th1-polarizing cytokine IL-12 to regulatory cytokine IL-10 
following E. coli stimulation compared to moDC from NP cows. Our findings demonstrate 
moDC from LG cows have a stifled capacity to develop a mature phenotype and drive pro-
inflammatory Th1-type responses to E. coli stimulation. Results from this study provide insight 
into DC immune modulation in bovine pregnancy and elucidate host factors which may 
contribute to the heightened susceptibility to infection in late gestation. 
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1. Introduction 
Successful maintenance of a pregnancy requires careful regulation of the maternal 
immune system in order to tolerate the growth of a semi-allogeneic fetus (Betz, 2012, 
Zenclussen, 2013). Highly inflammatory, Th1-type responses must be mitigated during 
pregnancy to prevent fetal rejection. However, this may result in deleterious effects on 
appropriate responses required for pathogen elimination (Krishnan et al., 2013). The ability to 
mount Th1-type responses is compromised in late gestating dairy cattle, and the susceptibility to 
new intramammary infections greatly increases during this stage of pregnancy (Sordillo and 
Streicher, 2002, Green et al., 2005). Intramammary infections acquired during the non-lactating 
period of late gestation (also known as the ‘dry period’) greatly increase the risk of early 
lactation clinical mastitis (Barkema et al., 1998, Green et al., 2002). Quesnell et al. (2012) and 
Gurjar et al. (2013) demonstrated that dairy cattle in the dry period failed to elicit pro-
inflammatory, Th1-type immunity in response to experimental E. coli intramammary infections, 
and were unable to clear the infecting pathogen throughout the remainder of gestation leading to 
subsequent mastitis post-calving. However, Sipka et al. (2013) found mid-lactation dairy cows 
challenged with the same dose of the same E. coli strain developed clinical mastitis and were 
fully capable of eliciting an inflammatory response.  
Previous work on leukocyte populations in periparturient cows suggests that the bovine 
immune system experiences an anti-inflammatory, Th2/regulatory bias in late gestation 
analogous to maternal immune regulation that has been described in other mammals. Previous 
studies observed a decrease in the proportion of circulating CD4, CD8, and IL-2 expressing 
lymphocytes in late gestation dairy cattle which gradually increased following parturition 
(Kimura et al., 1999, Meglia et al., 2005). More recent work found circulating lymphocytes in 
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late gestation cattle had suppressed Th17 and Th1-related gene expression and were regulated by 
epigenetic changes at the IL-4 and IFNγ promoters to sustain a Th2/regulatory bias by hindering 
IFNγ production and promoting IL-4 production (Maeda et al., 2013, Paibomesai et al., 2013). 
Other immune cell populations responsible for maintaining maternal immune tolerance and 
providing signals to regulate circulating lymphocytes remain poorly characterized in dairy cattle.  
Dendritic cells (DC) are known to play a critical role in the generation and maintenance 
of maternal immune tolerance in murine and human pregnancy (Bachy et al., 2008, Negishi et 
al., 2012, Leno-Duran et al., 2014). Dendritic cells are potent antigen presenting cells which both 
initiate immune responses and induce peripheral tolerance depending heavily on DC maturation 
status and cytokine production (Hivroz et al., 2012). The suppression of DC maturation is a key 
mechanism in the generation of immune tolerance (Lutz and Schuler, 2002). Immature DC have 
low expression of co-stimulatory molecules (CD40, CD86,  CD80) and MHC molecules, and are 
not capable of producing high levels of pro-inflammatory cytokines (IL-12, TNFα, IL-1β, IL-6). 
Tolerance is often generated by immature and semi-mature DC due to the weak and insufficient 
receptor and cytokine signaling provided to naïve T cells and other innate immune cell 
populations including neutrophils and NK cells (Lutz and Schuler, 2002, Doz et al., 2013). 
Dendritic cell maturation is impaired during pregnancy by the influence of circulating 
pregnancy-associated factors in order to debilitate strong cellular, inflammatory responses 
detrimental to the fetus and favor Th2/regulatory immunity (Uemura et al., 2008, Segerer et al., 
2009, Della Bella et al., 2011, Xu et al., 2011, Cordeau et al., 2012, Schumacher et al., 2013, 
Schumacher et al., 2014). 
  Dendritic cells present in the bovine mammary gland are hypothesized to play an 
important role in defense against invading pathogens (Maxymiv et al., 2012). Impaired DC 
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maturation in late gestation could negatively impact appropriate inflammatory responses 
necessary for clearance of intramammary infections caused by E. coli. Bovine DC function has 
not been characterized in late gestation despite their important role in both orchestrating innate 
and adaptive immune activation and inducing tolerance.  
The objective of this study was to compare the ability of monocyte-derived DC (moDC) 
from late gestation (LG) dairy cows to mature in response to UV irradiated E. coli ECC-Z 
stimulation to those from non-pregnant (NP) dairy cows. For this study we selected non-pregnant 
dairy cows earlier in lactation as opposed to mid-gestation because highest incidence of clinical 
mastitis caused by natural infection occurs early in lactation following calving, and this also 
excluded other pregnancy factors present in mid-gestation (Barkema et al., 1998, Green et al., 
2002). The E. coli ECC-Z strain is an isolate from a case of clinical bovine mastitis (Dogan et al., 
2006) and has been used in a number of intramammary challenge studies (Quesnell et al., 2012, 
Gurjar et al., 2013, Sipka et al., 2013). This study characterized moDC maturation by measuring 
changes in surface marker expression (CD14, CD80, MHC II) and cytokine production (IL-10, 
IL-12) 24 hours following E. coli ECC-Z stimulation. The selection of parameters was based on 
findings in current literature in rodent and human models which indicated both CD80 and HLA-
DR/MHC II expression and IL-10 and IL-12 production were altered during pregnancy and/or 
affected by pregnancy-associated hormones (Bachy et al. 2008, Della Bella et al. 2011, Xu et al. 
2011). This study provides evidence for maternal immune regulation of bovine moDC 
populations in late gestation. 
2. Materials and methods 
2.1. Animals  
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Fourteen Holstein-Friesian cows, 7 non-lactating cows in the third trimester of pregnancy 
within 45-60 days prior to expected calving date, to be called ‘late gestation’ (LG) and 7 non-
pregnant, lactating cows past the periparturient period to be called ‘non-pregnant cows’ (NP) 
were selected from the Cornell University Veterinary College Teaching Dairy Barn. All animals 
enrolled were matched by lactation, and the same number of cows in 2nd and 3rd lactation was 
sampled for each group. The mean age of cows in the pregnant group at time of sampling was 
3.81 years old with a standard deviation of 0.80 years and the mean age of cows in the non-
pregnant group at time of sampling was 3.62 years old with a standard deviation of 0.42 years. 
No disease (i.e. metabolic, reproductive, mastitis) was recorded within 30 days prior to the time 
of sampling for all enrolled animals.  Peripheral blood and serum were collected by jugular 
venipuncture from enrolled animals into bottles with vacuum containing EDTA and 10ml 
vacutainer glass serum tubes with no additive (Becton Dickinson, Franklin Lakes, NJ). Blood 
samples were put on ice and transported immediately to the laboratory for further processing. All 
procedures were approved by the Cornell Institutional Animal Care and Use Committee (project 
number: 2007-0110).  
2.2. Generation of peripheral blood monocyte-derived dendritic cells (moDC) 
Peripheral blood mononuclear cells (PBMC) were isolated from whole blood diluted 1:1 
in PBS by density gradient centrifugation with Histopaque®-1077 (Sigma-Aldrich, St. Louis, 
MO). Mononuclear cells were isolated from the interphase and pooled. Isolated PBMC were 
washed twice with PBS. Any remaining red blood cells were lysed with hyposmotic NaCl 
solution and washed once more in PBS following erythrolysis. Cells were resuspended in MACS 
buffer (PBS, pH 7.2, 0.5% bovine serum albumin, 2mM EDTA) and passed over a 0.44µm2 filter 
to remove any clumps. Mononuclear cells were counted, pelleted by centrifugation, and 
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resuspended in 80µl of cold MACS buffer per 107 cells. Monocytes were isolated using 
magnetic-activated cell sorting (MACS): PBMC were incubated with anti-human CD14 
antibodies conjugated with paramagnetic microbeads (Miltenyi Biotech, Inc., Auburn, CA) at 
50µl bead solution per 108 cells for 20 minutes, washed twice in MACS buffer, pelleted, 
resuspended in MACS buffer, and transferred to MACS LS magnetic separation column 
(Miltenyi Biotech, Inc., Auburn, CA). After the column was washed repeatedly with MACS 
buffer, magnetically labeled cells were collected. Purity was determined by flow cytometry, 
using mouse anti-bovine CD14 (Kingfisher Biotech, Inc., Saint Paul, MN) and Alexafluor488-
conjugated goat anti-mouse IgG1 secondary antibody to detect CD14+ cells, and purity was 
shown to be >90%. Monocytes were resuspended in differentiation media (phenol-free complete 
RPMI with L-glutamine, supplement with 10% autologous serum, 20ng/ml recombinant bovine 
IL-4and , 20ng/ml recombinant bovine GM-CSF, both Kingfisher Biotech, Inc., Saint Paul, MN) 
then plated in 6-well tissue culture plates at 1.3-1.8x106 cells in 3ml differentiation media per 
well. Cells were cultured for 5 days (37○C, 5% CO2) in presence of recombinant cytokines to 
generate immature moDC. One third of the media was replaced after three days in culture. 
2.3. Inactivation of E. coli ECC-Z 
Frozen stock (-80○C) of the previously characterized E. coli ECC-Z strain known to 
cause mild persistent clinical mastitis (Dogan et al., 2006, Lippolis et al., 2014) was inoculated 
into LB liquid broth, and grown to log phase (37○C, agitation). Bacteria were pelleted and 
diluted in cold PBS. Bacterial suspension was plated on agar plates prior to inactivation to 
determine concentration of stock solution. The bacterial suspension was inactivated using UV 
irradiation in the laboratory of Dr. Randy W. Worobo (Department of Food Science and 
Technology, Cornell University).  E. coli were inactivated using UV irradiation in order to 
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preserve the bacterial structure while preventing bacterial growth during the experiment. 
Bacterial suspension inactivated using the described UV irradiation failed to produce colonies on 
LB agar plates (37○C). Aliquots of UV irradiated E. coli were resuspended in sterile 10% 
glycerol/PBS were stored at -80○C. 
2.4. Maturation of bovine moDC with UV irradiated E. coli 
Maturation of moDC was induced by bacterial stimulation through the addition of UV 
irradiated E. coli to immature moDC cultures in an MOI (multiplicity of infection) of 10 
(Cavatorta et al., 2009). Cultures of moDC without bacterial stimulation served as media 
controls. Following 24 hours of culture with UV irradiated E. coli- stimulated moDC were 
considered mature moDC. At 24 hours in culture with UV irradiated E. coli, moDC were 
harvested from all cultures for phenotypic analysis by flow cytometry. Cell culture supernatants 
were collected and stored at -80○C until further cytokine analysis by ELISA. 
2.5. Flow cytometry 
Expression of surface markers on moDC was measured with flow cytometry. Cells were 
washed in FACS buffer (PBS containing 0.5% BSA and 0.05% sodium azide), spun at 400xg for 
3 minutes to pellet cells, and resuspended and blocked with 10% normal goat serum (Life 
Technologies, Grand Island, NY) for 15 minutes at 4○C. Blocked cells were incubated with 
primary, unlabeled mouse mAb: anti-bovine MHC II DR orthologue (TH4B; Kingfisher 
Biotech), CD14 (MM61A; Kingfisher Biotech), and CD80 (ILA159; Kingfisher Biotech) diluted 
in FACS buffer at 1:50 for anti-bovine MHC II DR and CD14 mAb and 1:100  for anti-bovine 
CD80 for 30 minutes at 4○C. Following incubation with primary mAb, cells were washed twice 
in FACS buffer and incubated with Alexa Fluor® 488 conjugated goat anti-mouse IgG1 or IgG2α 
mAb (Life Technologies, Grand Island, NY) diluted at 1:100 for 20 minutes at 4○C in the dark. 
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Secondary Alexa Fluor® 488 conjugated mAb controls were incubated with the same 
concentration as used for cells labeled with primary mAb. No differences were found in baseline 
autofluoresence as determined by consistent MFI of secondary controls between cows (data not 
shown). Labeled cells were washed in FACS buffer and then stained with LIVE/DEAD® 
Fixable Red (Life Technologies, Grand Island, NY) according to manufacturer instructions to 
exclude dead cells during analysis. Labeled cells were then fixed with 4% paraformaldehyde for 
15 minutes at 4○C in the dark. Following fixation, cells were washed twice in FACS buffer and 
measured with a FACSCalibur (Becton Dickinson). A minimum of 10,000 events gated by 
morphology of viable cells were recorded for each sample. Flow cytometry data were analyzed 
using FlowJo (TreeStar Inc., Ashland, OR). 
2.6. Measurement of IL-10 and IL-12 by ELISA 
Supernatant levels of bovine IL-10 and IL-12 were measured using ELISA. Thermo 
Cliniplate EB flat-bottom 96-well plates (ThermoFisher, Vantaa, Finland) were coated with 
100µl of capture antibody diluted in 0.05M of carbonate buffer with a pH of 9.6: mouse anti-
bovine IL-10 (clone CC320; AbDSerotec, Raleigh, NC) at 1µg/ml for 1.5 hours at room 
temperature, and IL-12 (clone CC301; AbDSerotec) at 2µg/ml overnight at 4○C. Plates were 
washed three times with wash buffer (PBS containing 0.05% Tween-20) then blocked with 2% 
fish skin gelatin (Sea Block buffer, ThermoFisher) in PBS for 1 hour at room temperature. 
Blocked plates were washed four times with wash buffer and 100µl of supernatant diluted in 
PBS at 1:5 for IL-10 and 1:20 for IL-12 was added to each well. Known concentrations of 
recombinant bovine IL-10 (Kingfisher Biotech Inc., St. Paul, MN) and IL-12 (Kingfisher Biotech 
Inc., St. Paul, MN) were assayed simultaneously with the respective ELISA to generate a 
standard curve from which sample concentrations were determined. Plates were incubated for 1.5 
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hours at room temperature. Following sample and standard incubation, plates were washed four 
times with wash buffer, and 100µl of respective biotinylated detection antibodies: mouse anti-
bovine IL-10 (clone CC320; AbD Serotec) at 1µg/ml and IL-12 (clone CC301; AbD Serotec) at 
5µg/ml were added to each well. All samples and standard dilutions of known recombinant 
protein concentration were assayed in triplicate. Samples were corrected for their respective 
dilution factor to determine the actual concentrations of the cytokine. 
2.7. Statistical Analysis 
Data were analyzed with a paired, two-tailed, non-parametric Wilcoxon signed rank test 
and unpaired, two-tailed, Mann Whitney test. Data were analyzed using a SAS statistical analysis 
program, version 9.2 (SAS Institute Inc., Cary, NC). 
3. Results 
3.1. Increased CD14 expression in moDC from LG cows 
After 5 days of culturing CD14+ monocytes with recombinant GM-CSF and IL-4, LG 
and NP cultures had non-adherent and loosely adherent cells with typical DC morphology of 
cells with dendrite-like projections. Following the 5 day differentiation period, maturation was 
induced by 24 hour stimulation with UV irradiated E. coli ECC-Z. Monocyte-derived DC from 
NP and LG cows decreased in relative levels of CD14 expression following UV E. coli ECC-Z 
maturation (p=0.047 and p=0.026, respectively; Fig. 2 A-C). However, E. coli ECC-Z-stimulated 
moDC from LG cows had higher levels of expression of CD14 compared to moDC from NP 
cows (p= 0.007; Fig. 2 C). Though numerically different, difference in levels of CD14 
expression between immature moDC of NP and LG cows were not statistically significant 
(p=0.064; Fig. 2 C). Only moDC from NP cows had a significant decrease in the percentage of 
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CD14+ moDC from a median of 95.1% CD14+ to 75.6% CD14+ following E. coli ECC-Z 
stimulation (p=0.026; Fig. 2 D). 
Figure 2. CD14 expression in moDC from late gestation cows (LG) and non-pregnant cows 
(NP) following 24hr stimulation with UV irradiated E. coli ECC-Z. Representative 
histograms of CD14 expression measured by flow cytometry from LG (A) and NP (B) moDC 
cultures. Solid black lines represent media control cultures, dotted black lines represent E. coli 
ECC-Z stimulated cultures, and solid grey lines represent secondary antibody staining control. 
Relative level of CD14 expression as determined by geometric mean fluorescence intensity 
(MFI) (C), and proportion of moDC expressing surface marker CD14 (D) following E. coli ECC-
Z stimulation. White bars represent moDC media controls, and black bars represent E. coli ECC-
Z-stimulated moDC. Bars represent median (n=7) with error bars representing interquartile 
range. Significant differences determined by Wilcoxon signed rank test when comparing media 
controls to E. coli ECC-Z-stimulated moDC, and Mann Whitney-U test when comparing 
between LG and NP of same treatment group.*p<0.05, **p<0.01 
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3.2. Impaired upregulation of MHC II expression in E. coli-activated moDC from LG 
cows 
Activation of naïve T cells requires expression of co-stimulatory signals and antigen 
presentation in DC. Stimulation with UV irradiated E. coli ECC-Z induced a significant up-
regulation in the level of expression and percentage of cells expressing co-stimulatory molecule 
CD80 in moDC from both LG and NP cows (p=0.016, p=0.016, p=0.031, and p=0.016, 
respectively Fig. 3 A-D). No differences were found in CD80 expression levels or percentage of 
cells expressing CD80 between E. coli-stimulated moDC from LG cows and NP cows (p=0.908 
and p=0.749, respectively, Fig. 3 C&D).  
Figure 3. CD80 expression in moDC from late gestation cows (LG) and non-pregnant cows 
(NP) following 24hr stimulation with UV irradiated E. coli ECC-Z. Representative 
histograms of CD80 expression measured by flow cytometry from LG (a) and NP (b) moDC 
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cultures. Solid black lines represent media control cultures, dotted black lines represent E. coli 
ECC-Z stimulated cultures, and solid grey lines represent secondary antibody staining control.  
Proportion of moDC expressing surface marker CD80 (c), and relative level of CD80 expression 
as determined by geometric mean fluorescence intensity (MFI) (d) following E. coli ECC-Z 
stimulation. White bars represent moDC media controls, and black bars represent E. coli ECC-Z-
stimulated moDC. Bars represent median (n=7) with error bars representing interquartile range. 
Significant differences determined by Wilcoxon signed rank test when comparing media controls 
to E. coli ECC-Z-stimulated moDC, and Mann Whitney-U test when comparing between LG and 
NP of same treatment group. *p<0.05, **p<0.01 
 
 
Both, un-stimulated media controls and E. coli-stimulated moDC from LG and NP cows 
did not differ in the percentage of MHC II-expressing moDC, and all cultures had a median 
expression of ~98% MHC II+ (p=0.701 and p=0.5645, respectively; Fig. 4 A). Expression levels 
of MHC II were comparable between moDC un-stimulated, media controls in both LG and NP 
cows. However, only moDC from NP cows were able to significantly upregulate their level of 
MHC II expression following E. coli stimulation (p=0.031; Fig. 4 C), while MHC II expression 
in stimulated moDC from LG cows remained unchanged (p=0.578; Fig. 4 C). Overall NP cows 
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showed significantly higher MHC II expression with less variation compared to those from LG 
cows (p=0.001; Fig 4 C).  
Figure 4. MHC II expression in moDC from late gestation cows (LG) and non-pregnant 
cows (NP) following 24hr stimulation with UV irradiated E. coli ECC-Z. Representative 
histograms of MHC II expression measured by flow cytometry from LG (A) and NP (B) moDC 
cultures. Solid black lines represent media control cultures, dotted black lines represent E. coli 
ECC-Z stimulated cultures, and solid grey lines represent secondary antibody staining control.  
Relative level of MHC II expression as determined by geometric mean fluorescence intensity 
(MFI) (C) following E. coli ECC-Z stimulation. White bars represent moDC media controls, and 
black bars represent E. coli ECC-Z-stimulated moDC. Bars represent median (n=7) with error 
bars representing interquartile range. Significant differences determined by Wilcoxon signed 
rank test when comparing media controls to E. coli ECC-Z -stimulated moDC, and Mann 
Whitney-U test when comparing between LG and NP of same treatment group. *p<0.05, 
**p<0.01 
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3.3. Suppressed IL-12 production and elevated IL-10 production by E. coli-stimulated 
moDC from LG cows 
Culture supernatants from un-stimulated media controls and E. coli-stimulated moDC 
cultures were harvested after 24 hours to measure levels of the pro-inflammatory Th1 cytokine, 
IL-12 and the anti-inflammatory cytokine IL-10. Only moDC from LG cows showed a 
significant increase in IL-10 production following E. coli-stimulation (p=0.031; Fig. 5 A). Both, 
moDC cultures from NP cows and LG cows significantly upregulated level of IL-12 production 
following E. coli-stimulation (p=0.031 and p=0.031, respectively; Fig. 5 B). Upregulation of IL-
12 was numerically higher in moDC from NP relative to moDC from LG. Ratios of pro-
inflammatory IL-12 to anti-inflammatory IL-10 cytokine production were used to compare 
cytokine profiles of E. coli-stimulated moDC from LG cows to NP cows. Though both groups 
were able to produce IL-12 in response to E. coli stimulation, the ratio of IL-12 to IL-10 
produced by E. coli-stimulated moDC was significantly lower in cultures from LG cows 
compared to NP cows (p=0.015; Fig. 5 C).  
Figure 5. IL-10 and IL-12 production by moDC from late gestation cows (LG) and non-
pregnant cows (NP) following 24hr stimulation with UV irradiated E. coli ECC-Z. IL-10 
concentration (ng/ml) in cell-free supernatant harvested 24hr following UV irradiated E. coli 
ECC-Z stimulation as determined by sandwich ELISA (A). IL-12 concentration (ng/ml) in cell-
free supernatant harvested 24hr following UV irradiated E. coli ECC-Z stimulation as 
determined by sandwich ELISA (B). Ratio of IL-12 to IL-10 levels in cell-free supernatant from 
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E. coli ECC-Z-stimulated moDC cultures from LG and NP cows (C). White bars represent 
moDC media controls, and black bars represent E. coli ECC-Z-stimulated moDC (A, B). Bars 
represent median (n=6) with error bars representing interquartile range. Significant differences 
determined by Wilcoxon signed rank test when comparing media controls to E. coli-C1-
stimulated moDC, and Mann Whitney-U test when comparing between LG and NP. *p<0.05, 
**p<0.01 
 
4. Discussion 
During gestation the maternal immune system is hypothesized to be directed towards 
tolerance in order to prevent rejection of the fetus (Dietert and Piepenbrink, 2008). Little is 
known about the underlying mechanisms involved in generation and maintenance of maternal 
immune tolerance in dairy cattle. Dendritic cells are known to play a crucial role in the 
generation of maternal immune tolerance in other mammalian species (Lutz and Schuler, 2002). 
Our study showed that moDC from LG dairy cows had a biased and impaired ability to fully 
mature in response to stimulation with UV irradiated E. coli both phenotypically and functionally 
when compared NP cows.  
Upon antigen uptake and appropriate microenvironment, DC become activated and 
subsequently express surface markers that distinguish them from immature DC. Fully 
differentiated, mature DC are characterized by low levels of CD14 expression (Lei and Hostetter, 
2007, Merant et al., 2009). We found E. coli-stimulated moDC from LG cows expressed higher 
levels of CD14 compared to moDC from NP cows (Fig. 2). Only moDC from NP cows showed a 
decrease in percent of CD14+ moDC. High levels of CD14 expression following E. coli 
stimulation indicate LG cows have impaired moDC maturation relative to NP cows. Zanoni et al. 
(2009) demonstrated a novel role of CD14-dependent signaling following LPS-stimulation 
within the DC life cycle as a mechanism of inducing apoptosis of terminally differentiated DC 
through CD14-mediated CA2+ influx and NFAT (nuclear factor of activated T cells) activation. 
Dendritic cell apoptosis is another mechanism of generating and maintaining immune tolerance 
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by reducing prolonged T cell priming. However, the importance of CD14-dependent DC 
regulation during gestation has not yet been described in bovine DC and needs further 
investigation.  
Co-stimulatory molecules including CD80 and MHC-antigen complexes are upregulated 
during DC activation, and provide necessary signals to activate naïve lymphocytes and generate 
antigen-specific responses (Cools et al., 2007). Both moDC from LG and NP cows were able to 
upregulate CD80 in response to E. coli stimulation, and CD80 expression between groups were 
at comparable levels (Fig 3). However, only moDC from NP animals were able to upregulate 
MHC II following E. coli-stimulation (Fig. 4). Della Bella et al. (2011) found a similar semi-
mature DC phenotype in the context of human pregnancy in which human moDC conditioned in 
plasma from healthy pregnant women were able to upregulate co-stimulatory molecule CD80 but 
were unable to upregulate MHC II. Up-regulation of MHC II-antigen complexes is necessary to 
generate antigen-specific T cell responses. Impaired MHC II-antigen presentation results in weak 
T cell receptor signaling and subsequent bias for Th2 differentiation due to reduced activation of 
ERK (Extracellular Signal-regulated Kinase) (Yamane and Paul, 2013). The inability of moDC 
from LG cows to upregulate MHC II molecules in response to E. coli-stimulation indicates DC 
in late gestation are unable to undergo complete activation, which may elucidate one mechanism 
utilized to maintain maternal immune tolerance.  
E. coli-stimulated moDC from LG cows had reduced pro-inflammatory cytokine IL-12 
production and increased regulatory cytokine IL-10 production, which resulted in a significantly 
lower IL-12/IL-10 ratio compared to those from NP cows (Fig. 5). The balance of these two 
cytokines greatly influences the production of IFN-γ and polarization of the immune response; 
Collins et al. (1999) found IL-12-induced IFN-γ production in bovine PBMC was greatly 
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impaired in presence of IL-10. Interleukin 12 induces IFN-γ production in NK cells, T cells, and 
macrophages, and provides the necessary signal to direct Th1 differentiation following T cell 
activation (Schroder et al., 2004, O'Garra and Murphy, 2009). Interleukin 10 is a potent 
regulatory cytokine which inhibits Th1-type and other pro-inflammatory responses. High levels 
of Th1 cytokines often in conjunction with danger signals such as LPS are associated with 
pregnancy loss in mammalian species (Nahum et al., 2004, Hadfield et al., 2011). The 
suppression of Th1-type cytokine production appears to be specific to late gestation in dairy 
cows; Rosbottom et al. (2008) found cattle infected with Neospora caninum in the early 
pregnancy had a strong increase in Th1 cytokine mRNA expression and subsequent fetal loss, 
but cattle infected during late gestation had minimal increase in Th1 cytokine mRNA expression 
and experienced no fetal loss. Negishi et al. (2012) demonstrated substantial pregnancy loss 
either by the depletion of tolerogenic DC populations or addition of exogenous IL-12 in pregnant 
mice. This demonstrates the crucial role of DC and DC cytokines in maintaining tolerance 
through Th2/Th1 balance. Our study indicates that bovine DC in late gestation have reduced 
Th1-promoting cytokine production relative to regulatory cytokine production coinciding with 
previous work (Bachy et al., 2008, Della Bella et al., 2011, Negishi et al., 2012). The low IL-
12/IL-10 ratio produced by E. coli-stimulated moDC from LG cows would contribute to the 
hampered pro-inflammatory responses to E. coli infections characteristic of the dry period by 
self-impaired Th1 cytokine production and inability to stimulate Th1-type responses in other 
leukocyte populations. Though dampened Th1 cytokine production is favorable to fetal survival, 
this could enable pathogens to persist in the dry period due to ineffective immune responses. 
Similar to bovine dendritic cells in mammary gland and afferent lymph, and conventional DC in 
the blood, bovine moDC express high levels of MHC II, low levels of CD14, and are CD11c+ 
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(Maxymiv et al., 2012). However, Maxymiv et al. (2012) observed different subpopulations of 
DC in tissue based on CD11a expression, but bovine moDC generated in vitro using recombinant 
GM-CSF and IL-4 have been described as singularly CD11alo (Werling et al., 1999, Denis and 
Buddle, 2008). Thus, moDC represent only one of multiple DC subsets found in the tissue, and 
we must take precaution when making inferences about DC populations found in vivo. 
 Maternal immune tolerance and tolerogenic DC may be generated and maintained by interfering 
with DC maturation. Dendritic cell function has been shown to be influenced by endocrine 
factors including estradiol, progesterone, human chorionic gonadotropin, and glycoprotein 
hormone activin-A to generate a tolerogenic DC phenotype comparable to that observed during 
pregnancy (Uemura et al., 2008, Della Bella et al., 2011, Schumacher et al., 2014). Our findings 
indicate moDC generated from LG dairy cows have impaired ability to mature and a biased pro-
inflammatory cytokine production in response to E. coli stimulation. Although impaired DC 
maturation is potentially beneficial for maintenance of pregnancy and maternal immune 
tolerance in dairy cattle, this may impede optimal immune responses to invading pathogens. This 
is the first study providing evidence for the potential role of DC in the maintenance of maternal 
immune regulation in dairy cattle through the impairment and bias in DC activation. Precise 
mechanisms involved in the regulation of DC activation in bovine late gestation still require 
further investigation.  
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ABSTRACT 
Changes in monocyte and dendritic cell populations during bovine pregnancy and 
lactation remain poorly described despite the key roles these cells play in immune tolerance and 
activation. Using a prospective longitudinal study, we characterized CD14+ monocyte-derived 
dendritic cell (moDC) differentiation and maturation and captured monocyte composition 
dynamics from mid-gestation through calving and into the subsequent lactation in dairy cows 
(n=7). First, we measured absolute counts of classical (CD14+CD16-, cM), intermediate 
(CD14+CD16+, intM), and nonclassical (CD14-CD16+, ncM) monocytes in the blood and 
determined proportions of individual subsets within the total monocyte population. We found the 
proportion of cM decreased and intM increased significantly by early lactation, whereas there 
was a nadir in the proportion of ncM in late gestation, two weeks prepartum. Monocyte 
composition appears to be regulated in pregnancy, possibly to limit the proportion of highly 
inflammatory monocytes i.e. intM. Ultimately, we found that moDC differentiated from CD14+ 
monocytes isolated in the early dry period of late gestation had impaired E. coli-induced 
maturation, with nadirs in upregulation of CD80 and MHC II, and downregulation of CD14. The 
moDC from late gestation also had altered cytokine profiles with greatest production of pro-
inflammatory IL-1β and anti-inflammatory IL-10. These data suggest monocytes in late 
gestation, in contrast to other stages of pregnancy and lactation, differentiate and maturate into 
moDC less capable of eliciting strong T cell activation, and have macrophage-like cytokine 
profiles. These results provide insight into maternal immune modulation and elucidate potential 
immune changes necessary to facilitate bovine pregnancy.  
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1. Introduction 
During pregnancy the maternal immune system is presented with the challenge of 
needing to concurrently tolerate the growth of a semi-allogenic fetus and respond to invading 
pathogens. Highly inflammatory, T helper 1 (Th1) and T helper 17 (Th17)-type responses in 
pregnancy have been shown to be detrimental to the health of the fetus, thus, the maternal 
immune system must be carefully regulated (Rosbottom et al., 2008, Betz, 2012, Krishnan et al., 
2013). Maternal immune regulation is dynamic; dairy cattle show varying responses to infectious 
agents depending upon their stage of pregnancy and lactation (Innes, 2007, Rosbottom et al., 
2008, Quesnell et al., 2012, Sipka et al., 2013). Previous work found cows in the third trimester 
of pregnancy, particularly during the non-lactating period of late gestation (known as the ‘dry 
period’), had a heightened susceptibility to persistent infections caused by mastitis- and abortion-
causing pathogens including E. coli and N. caninum with hindered pro-inflammatory, Th1-type 
responses relative to the postpartum period and earlier stages of gestation (Williams et al., 2000, 
Green et al., 2002, Anderson, 2007, Rosbottom et al., 2008, Quesnell et al., 2012). Monocytes 
and monocyte derived cells play a major role in maternal immune regulation throughout 
pregnancy across multiple species; these cells are involved at all stages of pregnancy including 
implantation, maintenance of pregnancy, and parturition and show dynamic regulation by stage 
of gestation (Oliveira et al., 2012, Gomez-Lopez et al., 2014, Leno-Duran et al., 2014, 
Schumacher et al., 2014). Though previous work on dairy cattle indicated that certain immune 
cell populations have altered function in pregnancy, this area of research remains largely 
underdeveloped (Lamote et al., 2004, Lamote et al., 2006, Maeda et al., 2013, Pomeroy et al., 
2015). We lack an understanding of underlying mechanisms in immune tolerance, gestational 
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stage-dependent changes in maternal immune function, and how this relates to overall health of 
the dam and fetus.  
Bovine monocytes have only recently been classified into three major subsets, classical 
(cM), intermediate (intM), and nonclassical (ncM), based on CD14 and CD16 expression 
analogous to their human counterparts (Hussen et al., 2013, Hussen et al., 2014, Corripio-Miyar 
et al., 2015, Hussen et al., 2016). Unlike CD14- ncM, both CD14+ subsets, cM and intM, have 
been shown to be highly responsive to LPS stimulation (Hussen et al., 2013, Hussen et al., 2014). 
Changes in monocyte subset composition have been shown to influence disease susceptibility 
and pregnancy outcome in species such as mouse and human, but these changes have not been 
characterized in cattle (Al-ofi et al., 2012, Melgert et al., 2012, Devevre et al., 2015, Tang et al., 
2015b). These monocyte populations circulating in the periphery migrate into tissues either 
during inflammation or steady-state conditions where they may differentiate into macrophages 
(Mφ) or dendritic cells (DC).  
Across multiple species, DC are shown to be regulated in pregnancy and play a crucial 
role in generating maternal immune tolerance toward fetal antigens (Bachy et al., 2008, Della 
Bella et al., 2011, Negishi et al., 2012, Leno-Duran et al., 2014, Pomeroy et al., 2015). Recently 
we found key differences in monocyte derived DC (moDC) phenotype and cytokine production 
in a cross-sectional study comparing moDC from late gestation cows to moDC from non-
pregnant cows in early lactation. We found moDC had limited Th1-type responses and were 
likely to have a poor ability to activate T cells during late gestation (Pomeroy et al., 2015).  
Here we aim to expand upon our previous work and capture the dynamics of monocyte 
subsets, and the function and phenotype of respective moDC populations through a prospective 
longitudinal study in cows from mid-gestation through calving into the subsequent lactation. The 
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objective of this study was to analyze differentiation and maturation with UV-killed E. coli-
stimulation of moDC, derived from blood CD14+ across pregnancy and into early lactation. We 
investigated phenotype and function analyzing surface marker expression (CD14, CD40, CD80, 
MHC II) and cytokine production (IL-1β, TNFα, IL-10) following E. coli stimulation. 
Furthermore we measured monocyte subset composition (cM, intM, ncM) in blood at the 
designated time points to describe the composition of monocyte subsets in blood as a baseline 
and further understand the implications of starting monocyte population on moDC differentiation 
and maturation.    
2. Materials and methods 
2.1. Animals 
Seven Holstein–Friesian cows, in the second trimester of pregnancy between 90-110 days 
carrying calf (‘mid-gestation’, MG, 90-110dcc/P-190-170d) as determined from insemination 
date were selected from the Cornell University Veterinary College Teaching Dairy Barn. No 
disease (i.e. metabolic, reproductive, mastitis) was recorded within 30 days prior to the time of 
first sampling for all enrolled animals. Peripheral blood was collected by jugular venipuncture 
from enrolled animals into 250ml vacuum bottles containing EDTA and 10 ml vacutainer glass 
serum tubes with no additive (Becton Dickinson, Franklin Lakes, NJ). Each enrolled animal was 
sampled repeatedly throughout the remainder of pregnancy and into the subsequent lactation as 
depicted in figure 6. Blood was collected at MG, early dry period within the first week since dry-
off ~60-53 days prior to expected calving date (‘early dry’, ED, 1-7d dry/P-60-53d), late dry 
period ~2 weeks prior to expected calving date (‘late dry’, LD, 43d dry/P-14d), 4-6 days 
following parturition ( ‘post-calving’, PC, P+4-6d), and the final collection ~45-55 days 
following parturition before breeding (‘early lactation’, EL, P+45-55d) (Fig. 6).  Disease was 
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monitored daily and recorded in DairyComp® by farm management; metritis cases were 
diagnosed within the first two weeks postpartum by abnormal vaginal discharge and foul odor of 
the discharge. All animal procedures were approved by the Cornell Institutional Animal Care and 
Use Committee (project number: 2007-0110). 
 
Figure 6. Blood sampling timeframe over pregnancy and lactation. Sample time points 
starting in mid-gestation (MG) at 90-110d carrying calf (dcc)/approximately 190-170 d prior to 
parturition (P) estimated by insemination date and final blood samples taken in subsequent 
lactation in early lactation (EL) at 45-55d after parturition. The dry period begins at 
approximately 60d prior to the expected calving date. The ‘-’ signifies prior to, and ‘+’ signifies 
after parturition. Abbreviations: parturition (P), days carrying calf (dcc), days dry (d dry), mid-
gestation (MG), early dry (ED), late dry (LD), post-calving (PC), early lactation (EL). 
 
2.2. Generation of peripheral blood CD14+ moDC  
Monocyte derived DC were generated from CD14+ monocytes as described previously 
by Pomeroy et al. (2015); CD14+ positive selection was preformed based on the use of UV 
irradiated E. coli ECC-Z stimulation to induce moDC maturation in conjunction with previous 
work from Hussen et al. (2013) and (2014) indicating CD14+ cM and intM are the monocyte 
subsets responsive to LPS stimulation. In brief, peripheral blood mononuclear cells (PBMC) 
were isolated from whole blood by density gradient centrifugation. The PBMC were incubated 
with anti-human CD14 antibodies conjugated with paramagnetic microbeads (Miltenyi Biotech, 
Inc., Auburn, CA) in MACS buffer (PBS, pH 7.2, 0.5% bovine serum albumin, 2 mM EDTA), 
transferred to MACS LS magnetic separation column, and after repeatedly washing the column 
with MACS buffer the magnetically labeled cells were collected (Miltenyi Biotech, Inc.). Purity 
was determined by flow cytometry and was shown to be >90%. Monocytes were re-suspended in 
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differentiation media (phenol-free complete RPMI with l-glutamine, supplemented with 10% 
autologous serum, 20 ng/ml recombinant bovine IL-4 and, 20 ng/ml recombinant bovine GM-
CSF both from Kingfisher Biotech), plated in 6-well tissue culture plates at 1.5 × 106 cells in 
3 ml differentiation media per well, and cultured for 5 days (37 °C, 5% CO2) in presence of 
recombinant cytokines to generate immature moDC; at 2-3 d cultures were given 1ml/well of 
fresh differentiation media. 
2.3. Inactivation of E. coli ECC-Z 
E. coli ECC-Z was inactivated as described by Pomeroy et al. (2015). In brief, frozen 
stock of the previously characterized E. coli ECC-Z strain known to cause mild persistent 
clinical mastitis (Dogan et al., 2006, Lippolis et al., 2014) was grown to log phase in LB liquid. 
Bacteria were pelleted and diluted in PBS. Bacterial suspension was plated on agar plates prior to 
inactivation to determine concentration of stock solution. The bacterial suspension was 
inactivated using UV irradiation in the laboratory of Dr. Randy W. Worobo (Department of Food 
Science and Technology, Cornell University). The UV irradiated E. coli suspension failed to 
produce colonies on LB agar plates. Aliquots of UV irradiated E. coli were resuspended in sterile 
10% glycerol/PBS and stored at −80 °C. 
2.4. Maturation of moDC with UV irradiated E. coli 
Maturation of moDC was induced by bacterial stimulation through the addition of UV 
irradiated E. coli to immature moDC cultures in an MOI (multiplicity of infection) of 10 for 24 h 
based on previous work (Cavatorta et al., 2009, Pomeroy et al., 2015). Cultures of moDC 
without bacterial stimulation served as media controls. Cells were harvested after 24 h E. coli 
stimulation for phenotypic analysis by flow cytometry. Cell culture supernatants were collected 
at this time and stored at −80 °C until further cytokine analysis by ELISA. 
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2.5. Flow cytometry 
2.5.1. Monocyte subset staining 
Composition of monocyte subsets in PBMC was determined using a similar staining 
protocol as described by Hussen et al. (2013). To identify monocyte subsets isolated PBMC were 
analyzed using directly labeled mouse monoclonal antibodies against human CD16:FITC 
(MCA5665F, AbD Serotec, Raleigh, NC), mouse anti-human CD14:RPE (MCA1568PE, AbD 
Serotec), and CD172a (Kingfisher Biotech) conjugated with Alexa Fluor® 647 dye using 
monoclonal antibody labeling kit (Life Technologies). Discrimination between live and dead 
cells was done by adding propidium iodide (PI, 1 µg/ml, Sigma Aldrich). A minimum of 75,000 
events gated on viable cells were recorded for each sample. Due to issues with reagent 
availability, PBMC from MG were isolated and stored in freezing media (8mM HEPES, 9% 
DMSO, 45% HI FBS, antibiotic-antimitotic in phenol-free RPMI, +L-glut), slowly frozen at -80 
oC, and transferred to liquid nitrogen until monocyte subset staining could be conducted. No 
differences were found in monocyte populations between frozen and fresh samples (data not 
shown). Absolute counts of monocyte subsets were estimated based on PBMC counts isolated 
per volume of blood.  
2.5.2.  Monocyte-derived dendritic cell staining 
Expression of surface markers on moDC was measured with flow cytometry as described 
previously by Pomeroy et al. (2015). In brief, moDC were blocked with 10% normal goat serum 
(Life Technologies), subsequently incubated with primary unlabeled monoclonal mouse 
antibodies against bovine MHC II DR orthologue (TH4B), CD14 (MM61A), CD40 (ILA158A), 
and CD80 (ILA159) (Kingfisher Biotech), and then indirectly labeled with secondary Alexa 
Fluor® 488 conjugated monoclonal goat antibodies against mouse IgG1 or IgG2α (Life 
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Technologies). Secondary controls were of moDC stained only with Alexa Fluor® 488 
conjugated secondary antibodies. No differences were found in baseline autofluoresence as 
determined by consistent MFI of secondary controls across samples (data not shown). Labeled 
cells were stained with LIVE/DEAD® Fixable Red (Life Technologies) to exclude dead cells 
during analyses, and then fixed with 4% paraformaldehyde. A minimum of 10,000 events gated 
on viable cells were recorded for each sample. All measurements were taken with a 
FACSCalibur (Becton Dickinson). All flow cytometry data were analyzed using FlowJo software 
(TreeStar Inc., Ashland, OR). 
2.6. Measurement of IL-10, TNFα, and IL-1β by ELISA 
Supernatant levels of bovine IL-10 were measured using ELISA as described in Pomeroy 
et al. (2015). In brief, Thermo Cliniplate EB flat-bottom 96-well plates (ThermoFisher, Vantaa, 
Finland) were coated with capture monoclonal mouse antibody against bovine IL-10 (1 μg/ml; 
CC320; AbDSerotec) in 0.05 M carbonate buffer (pH 9.6). Plates were washed then blocked 
with 2% fish skin gelatin (Sea Block buffer, ThermoFisher) in PBS. Following blocking 
supernatant samples were added. Known concentrations of recombinant bovine IL-10 
(Kingfisher Biotech) were assayed simultaneously to generate a standard curve from which 
sample concentrations were determined. Following sample and standard incubation, plates were 
washed, and biotinylated detection monoclonal mouse antibody against bovine IL-10 (1 μg/ml, 
CC320, AbD Serotec) was added. All samples and standards were assayed in duplicate. 
Supernatant levels of TNFα and IL-1β were measured according to using commercially 
available kits according to the manufacturer (bovine TNFα DuoSet® ELISA, DY2279, R&D 
Systems, Minneapolis, MN; bovine IL-1β ELISA, Thermo Scientific, Rockford IL).  
2.7. Statistical analysis 
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All data were analyzed using the SAS v 9.4 statistical analysis program (SAS Institute 
Inc., Cary, NC). Initially, data were graphed and evaluated for outliers. Outliers were inspected 
and reanalyzed where necessary. Significant changes in monocyte subset composition in blood, 
moDC surface marker expression, and moDC cytokine production over time were determined 
using polynomial regression (SAS, PROC MIXED); linear models adjusted for repeated 
measures within cow and accounted for between subject factors. Regression coefficients were 
evaluated for statistical significance. If data did not fit a linear polynomial model, data were 
analyzed using multiple comparison tests with repeated measures ANOVA; a Tukey for post hoc 
tests was used. For all analyses a type I error of <0.05 was used. 
3. Results 
All cows completed all samplings and carried their pregnancies to full term without any 
recorded or observed clinical disease or other complications during pregnancy. After calving, 2 
cows developed metritis. 
3.1. Monocyte population dynamics show increasing intM and ncM, and decreasing cM 
composition postpartum relative to late gestation 
Greatest proportion (mean=31.7%, SD=13.1%) and absolute count (mean=7.591x105 
cells/ml, SD=2.671x105 cells/ml) of total monocyte population occurred PC (Fig. 7 A, Table 1). 
Monocyte subset composition is shown in figure 7 B. The proportion of cM had a significant 
time-dependent quadratic relationship in which lowest values occurred in EL, with a plateau 
occurring in late gestation; cM proportions over pregnancy (MG, ED, LD) and PC were 
relatively consistent (Fig. 7 C). There was no significant difference detected in absolute counts of 
cM across pregnancy or subsequent lactation (Table 1). The proportion of intM had a significant 
time-dependent linear relationship in which lowest values occurred in MG, slightly increasing as 
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pregnancy progressed into the subsequent lactation and reached highest proportions at EL (Fig. 7 
D). There was a significant increase in absolute counts of intM from LD to PC (p=0.05); cows 
which acquired metritis (n=2) were outliers with low intM counts at PC (0.44591x105 cells/ml, 
0.44639x105 cells/ml) (Table 1). The absolute counts of cM and intM used in moDC culture 
were estimated based on proportions measured in PBMC; cultures from EL had highest intM 
counts and lowest cM counts compared to all time points (Fig. 8). The proportion of ncM had a 
significant time-dependent quadratic relationship in which it decreased from MG until a nadir 
occurred in LD and then subsequently increased into EL (Fig. 7 E). In conjunction, there was a 
significant increase in absolute counts of ncM at PC (ED v. PC (p=0.05) LD v. PC (p=0.008), EL 
v PC (p=0.03); cows which acquired metritis (n=2) were outliers with low ncM counts at PC 
(0.29045x105 cells/ml, 0.19966x105 cells/ml) (Table 1).  
Figure 7. Changes in monocyte subset proportions from peripheral blood over pregnancy 
and lactation. The mean of the proportion (A) of CD172a+ cells in peripheral blood 
mononuclear cells (PBMC). Gating strategy on CD172a+ population used to determine relative 
proportion and absolute counts of individual subsets (B). The mean of the proportion of classical 
monocytes (cM) (C), intermediate monocytes (intM) (D), and nonclassical monocytes (ncM) (E) 
  
57 
 
within total monocyte population (cM+intM+ncM). (n=7, missing data at MG (n=5) and ED 
(n=6)). Error bars represent SEM. Significant changes (minimum and maximums) were 
determined using polynomial regression; only significant fits as indicated with triangles and solid 
black lines were are depicted. Terms of the regression models were considered significant if 
p<0.05 when tested against the null hypothesis that the coefficients of the terms were zero. All 
regression models correct for repeated measures. 
 
Table 1. Changes in absolute counts of monocyte subsets from peripheral blood over 
pregnancy and lactation. Mean with standard deviation of all enrolled animals (n=7, missing 
data at MG (n=5) and ED (n=6)). Bold indicates time points that had one or more significant 
differences from other time points (p<0.05). 
 
Mid- 
gestation 
Early dry Late dry Post-calving 
Early 
lactation 
Total monocyte 
population (CD127a+) 
10
5
 cells/ml 
4.97534 
(±1.06231) 
5.15939 
(±1.34377) 
4.76751 
(±1.33409) 
7.5881 
(±2.67147) 
4.99155 
(±1.79158) 
Classical monocytes 
(CD172a+CD14+CD16-) 
10
5
 cells/ml 
2.79034 
(±0.99817) 
3.63731 
(±0.90306) 
3.646 
(±0.68536) 
3.6753 
(±3.22558) 
3.09059 
(±1.08718) 
Intermediate monocytes 
(CD172a+CD14+CD16+) 
10
5
 cells/ml 
1.04582 
(±1.62374) 
0.57665 
(±0.26718) 
0.74694 
(±0.59223) 
2.58210 
(±2.24307) 
1.06926 
(±0.51890) 
Nonclassical monocytes 
(CD172a+CD14-CD16+) 
10
5 
cells/ml 
0.83274 
(±1.14193) 
0.61384 
(±0.68549) 
0.17373 
(±0.13838) 
2.8976 
(±2.71907) 
0.60789 
(±0.58731) 
 
Figure 8. Changes in CD14+ monocyte subset composition in culture isolated from 
peripheral blood over pregnancy and lactation. Black bars represent the means of cM counts 
estimated in culture and white bars represent the means of the intM counts estimated in culture. 
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Error bases represent SEM. Counts of individual subsets were estimated by using proportion of 
intM and cM in blood and total number of monocytes plated. Significant differences indicated by 
*p<0.05, **p<0.01 
 
3.2. E. coli-stimulated moDC have hindered MHC II and CD80 upregulation, and high 
CD14 expression in early dry period of late gestation 
As shown in figure 9, moDC had greater phenotypic maturation following calving (PC, 
EL) compared to stages of late gestation (ED, LD). The expression of CD14 as determined by 
MFI had a significant time-dependent cubic relationship in which maximum expression occurred 
in ED, and minimum expression at PC, with higher levels of CD14 expression across pregnancy 
(MG, ED, LD) relative to non-pregnant stages (PC, EL) (Fig. 9 A&B). The MFI of CD14 
expression in E. coli-stimulated moDC shows least variation during PC and EL (Fig. 9 A&B). 
All moDC upregulated co-stimulatory molecules CD40 and CD80 following E. coli stimulation, 
however, percent CD80+ E. coli-stimulated moDC had a significant time-dependent cubic 
relationship over the sampling period which indicated a nadir in CD80+ cells at ED and a plateau 
with maximum CD80+ cells at PC into EL (Fig. 9 A&C, Table 1S). There were no significant 
changes in CD40 expression; this marker was constituently expressed throughout pregnancy into 
the subsequent lactation at comparable levels (Fig. 9 A, data not shown). We found upregulation 
of MHC II expression as determined by delta MFI (MFI E. coli-stimulated moDC– MFI 
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unstimulated moDC) had a significant time-dependent quadratic relationship indicating a nadir at 
ED, maximum in EL (Fig. 9 A&D). 
Figure 9. Phenotypic maturation induced by 24hr stimulation with UV irradiated E. coli 
ECC-Z stimulation in moDC generated from CD14+ monocytes over pregnancy into 
lactation. Representative histograms of moDC expression of CD14, CD40, CD80, and MHC II 
from one cow from MG to EL; dashed line represents secondary, negative staining control, 
dotted line represents stained, unstimulated moDC, and solid line represents stained, E. coli-
stimulated moDC (A) . Dynamics of relative expression as determined by geometric mean 
fluorescence intensity (MFI) of CD14 (B) in E. coli-stimulated, moDC. Dynamics of E. coli-
stimulated moDC population positive for CD80 (C). Delta MFI of MHC II (D) in moDC to 
investigate MHC II upregulation in response to E. coli stimulation Circles represent the mean 
(n=7) at each time point (B-D). Error bars represent SEM. Significant changes (minimum and 
maximums) were determined using polynomial regression; only significant fits as indicated with 
triangles and solid black lines were are depicted. Terms of the regression models were 
considered significant if p<0.05 when tested against the null hypothesis that the coefficients of 
these terms were zero. All regression models correct for repeated measures. 
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3.3. moDC have greatest production of IL-1β and IL-10 in late gestation  
Concentrations of IL-1β following E. coli stimulation had a significant time-dependent 
cubic relationship over the sampling period which indicated a transient peak in production at ED 
and higher levels at LD relative to MG, PC, and EL (Fig. 10 A&D). We found moDC from all 
stages were capable of upregulating TNFα production in response to E. coli,-induced maturation; 
there was no significant time-dependent relationship (Fig. 10 B&E). No significant production of 
IL-1β or TNFα was detected in the supernatant from unstimulated moDC. Concentrations of IL-
10 following E. coli stimulation had a significant time-dependent quadratic relationship which 
indicated maximum concentrations at LD (Fig. 10 C&F). Interleukin 10 was detected a varying 
levels in supernatant from unstimulated moDC across the sampling period so delta IL-10 (E. 
coli-stimulated moDC–unstimulated moDC) was used to compare IL-10 upregulation following 
E. coli stimulation (Fig. 10 C&G). Upregulation of IL-10 had a significant time-dependent cubic 
relationship which indicated maximum upregulation at ED and a nadir at PC (Fig. 10 C&G). 
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Figure 10. Cytokine production following 24hr stimulation with UV irradiated E. coli 
ECC-Z in moDC generated from CD14+ monocytes over pregnancy into lactation. IL-1β 
(A,D), TNFα (B,E), and IL-10 (C,F,G) concentration (pg/ml/106 unstimulated, iDC) in cell-free 
supernatant harvested 24hr following UV irradiated E. coli ECC-Z stimulation as determined by 
sandwich ELISA. Upregulation of cytokines determined by comparing unstimulated, iDC to E. 
coli ECC-Z, mDC (A, B, C). White bars represent unstimulated, immature moDC (media 
control), and black bars represent E. coli ECC-Z-stimulated moDC (A, B, C). Bars represent 
mean (n=7) with error bars representing SD. Significant differences were determined by repeated 
measures ANOVA and Tukey post-test and are indicated by *p<0.05, **p<0.01, ***p<0.001. 
Significant changes (minimum and maximums) were determined using polynomial regression for 
(D-G); only significant fits as indicated with triangles and solid black lines were are depicted. 
Terms of the regression models were considered significant if p<0.05 when tested against the 
null hypothesis that the coefficients of the terms were zero. All regression models correct for 
repeated measures. 
 
 
 
 
  
62 
 
 
4.  Discussion 
In non-bovine species, monocytes and DC are known to be key drivers of maternal 
immune tolerance and are differentially regulated to accommodate unique needs at each stage of 
pregnancy; similar dynamic changes have not been characterized in cattle (Blois et al., 2007, 
Della Bella et al., 2011, Negishi et al., 2012, Leno-Duran et al., 2014, Schumacher et al., 2014). 
In this longitudinal study, we identified unique profiles in monocyte composition and moDC 
maturation at specific stages of gestation and subsequent lactation that suggest greatest 
alterations to these cell populations occurs over the dry period in late gestation. 
Peripheral monocyte composition experienced dynamic changes dependent on the stage 
of pregnancy and lactation (Fig. 7&8). Within the total monocyte population we observed the 
greatest proportion of intM and lowest proportion of cM at early lactation 45-55 d following 
calving where all previous stages had relatively little change (Fig. 7 C&D, Fig. 8). Cows also 
experienced a nadir in the proportion of ncM 2 wk prior to calving, suggesting monocyte 
composition may relate to changes associated with preparation for labor in addition to pregnancy 
maintenance. Both intM and ncM have been associated with a pro-inflammatory response during 
various inflammatory conditions in humans, including preeclampsia in which affected pregnant 
women have significantly higher levels of both subsets indicating monocyte populations must be 
regulated to maintain a healthy pregnancy (Al-ofi et al., 2012, Melgert et al., 2012, Devevre et 
al., 2015, Tang et al., 2015b). Bovine intM and cM share functional homology to their human 
counterparts; intM are highly pro-inflammatory and more mature than cM (Hussen et al., 2013, 
Hussen et al., 2014, Corripio-Miyar et al., 2015, Hussen et al., 2016). Minimizing inflammatory 
and allogenic responses throughout pregnancy by limiting the available reservoir of intM may be 
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one possible mechanism in maternal immune tolerance, but without functional data we cannot 
confirm this.  
Like monocyte composition, moDC maturation had dynamic, stage dependent changes 
over pregnancy and lactation. In line with our previous work, we observed the lowest levels of 
CD14 expression and greatest upregulation of MHC II expression following E. coli stimulation 
in moDC from non-pregnant stages of lactation compared to the early dry period which had the 
highest and lowest, respectively (Fig. 3, Table 1S) (Pomeroy et al. 2015). Additionally, there was 
a significant nadir in the percentage of CD80+ moDC following maturation in the early dry 
period, with highest levels plateauing following calving carrying into early lactation  (Fig. 8 C, 
Table 1S). High CD14 expression indicates moDC from the early dry period are phenotypically 
less mature in contrast to those from the post-calving period and early lactation. The nadir in co-
stimulatory molecule CD80 and antigen-presentation molecule MHC II upregulation in the early 
dry period further indicates these moDC had hindered maturation which likely coincides with 
weaker T cell activation; the maximum upregulation of both these markers was observed in early 
lactation. Like in other species, bovine moDC differentiation and maturation may be influenced 
by the initial monocyte composition (Sanchez-Torres et al. 2001; Randolph et al. 2002). The 
increase in high MHC II expressing intM and decrease in cM at early lactation may relate to the 
peak in moDC MHC II upregulation observed at this time point (Fig. 8, Fig. 9 D) (Hussen et al 
2013). However, regression models of the dynamic, stage-dependent changes in markers of 
moDC maturation were not identical in shape to those of the starting monocyte composition 
suggesting other pregnancy factors also play a role in moDC maturation. 
In addition to phenotypic changes, moDC cytokine production following maturation was 
also dependent on stage of pregnancy and lactation. Dendritic cells may secrete and upregulate 
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of mRNA expression of IL-10 and IL-1β depending upon the stimulant, though typically to a 
lesser extent when compared to Mφ (Norimatsu et al., 2003, Langelaar et al., 2005, Heller et al., 
2012). The greatest upregulation of both pro- and anti-inflammatory cytokines, IL-1β and IL-10, 
by moDC was observed in the early dry period (Fig. 10). Our findings pertaining to IL-10 
production go in line with our previous cross sectional study in which moDC from late gestation 
dry cows had greater upregulation of IL-10 following E. coli-stimulation compared to those from 
early lactation cows (Pomeroy et al., 2015). As previously mentioned, moDC can be regulated by 
steroid hormones (Papenfuss et al., 2011, Xu et al., 2011, Lasarte et al., 2013). Poili et al. (2006) 
found estradiol enhanced production of IL-1β in both human uterine macrophages and blood 
monocytes. Dairy cattle increasing circulating levels of estradiol in late gestation which greatly 
surpass levels observed at estrus; autologous serum used to culture moDC containing these 
circulating factors in addition to the monocytes prior in vivo exposure may be related to the rise 
in IL-1β production we observed in the dry period (Echternkamp and Hansel, 1973, Smith et al., 
1973). In non-bovine species, IL-1β and IL-10 are key cytokines involved in priming the uterus 
for labor and preventing preterm labor in late gestation, respectively (Sato et al., 2001, Robertson 
et al., 2006, Boro et al., 2014). In conjunction with our previous work (Pomeroy et al., 2015) 
showing reduced moDC IL-12 production in late gestation cows, these increased levels of IL-1β 
and IL-10 with unsuppressed TNFα levels are more indicative of Mφ cytokine profile rather than 
that of DC (Werling et al., 2004, Denis and Buddle, 2008). This preferential in vitro 
differentiation of monocytes into Mφ-like cells in late gestation despite the addition of 
exogenous GM-CSF and IL-4 to promote DC differentiation may relate to previous work 
describing the accumulation of Mφ in the mammary gland during involution within the early dry 
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period and in the endometrium approaching calving (Sordillo and Streicher, 2002, Oliveira and 
Hansen, 2008, Oliveira and Hansen, 2009).  
5. Conclusion 
This study demonstrates there are distinct, dynamic changes in monocytes and respective 
monocyte derived cells by stage of gestation and lactation in dairy cattle. The data indicate that 
cows experience a reduction in intM and ncM during pregnancy, and a nadir in phenotypic 
moDC maturation concurrent with a Mφ-like cytokine profile in the early dry period of late 
gestation. The reduction in monocytes capable of generating stronger inflammatory responses in 
conjunction with hindered DC maturation likely promotes and maintains a viable, full term 
pregnancy by preventing the development of conceptus-derived antigen-specific responses. 
Future research should address specific roles and function of monocyte subsets and respective 
derived cells in pregnancy maintenance and preparation for labor as it relates to the dynamic 
changes we observed. 
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ABSTRACT 
The specific factors which regulate differentiation and maturation of dendritic cells in 
bovine pregnancy remain unclear. We evaluated the influence of physiologically relevant in vitro 
treatments of progesterone (PG) and estradiol (E2) observed in late pregnancy on the 
differentiation and maturation of CD14+ monocyte-derived dendritic cell (moDC)  from non-
pregnant, lactating dairy cows (n=7). We found that moDC differentiated in the presence of both 
E2 and PG had impaired E. coli-induced phenotypic maturation, specifically a significant 
reduction in CD80 and MHC II expression. Contrary to our previous work characterizing moDC 
from late gestating dairy cattle, we did not observe an increase in CD14 expression relative to the 
untreated control; this increase was only observed in the current data in the dexamethasone-
treated moDC. The moDC treated with a combination of both E2 and PG had significantly 
greater upregulation of anti-inflammatory cytokine IL-10 relative to the untreated control, but 
TNFα production was not suppressed; only dexamethasone-treated moDC showed abrogated 
TNFα production. These data suggest moDC may be regulated by E2 and PG to hinder 
phenotypic maturation and regulate inflammatory responses. Pregnancy-associated hormone 
profiles appear to be involved in the generation of maternal immune tolerance in pregnancy. 
These hormone-facilitated changes to moDC in pregnancy may also impede optimal immune 
responses to both invading pathogens and routine vaccinations administered in late gestation 
through limited antigen presentation and increased anti-inflammatory cytokine production. These 
results provide insight into maternal immune modulation and elucidate potential immune 
changes necessary to facilitate bovine pregnancy.  
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1. Introduction 
During pregnancy the maternal immune system is regulated by both maternal and fetal 
factors to generate tolerance toward the semi-allogenic fetus (Nahum et al., 2004, Schumacher et 
al., 2014, Fair, 2015). Across multiple species dendritic cells (DC) are known to play a crucial 
role in generating maternal immune tolerance toward fetal antigens by preventing the 
development of highly inflammatory, fetal antigen-specific responses (Zenclussen et al., 2005, 
Kahn and Baltimore, 2010, Petroff, 2011). Our previous work indicated that these cells are 
regulated in bovine late gestation (Bachy et al., 2008, Della Bella et al., 2011, Negishi et al., 
2012, Leno-Duran et al., 2014, Pomeroy et al., 2015). We found previously that relative to non-
pregnant cows, monocyte-derived DC (moDC) from cows in late gestation had hindered 
phenotypic maturation and altered cytokine secretion in response to E. coli stimulation and thus 
were likely to have a poor ability to activate T cells during late gestation. We also showed that 
these moDC from cows in late gestation showed heightened IL-10 production and hindered 
MHC II upregulation (Pomeroy et al., 2015). Hormone profiles unique to late gestation may 
affect the ability of DC to prime and activate T cells during this stage of pregnancy. 
Multiple factors in pregnancy have been shown to regulate various maternal immune cell 
populations; these cells may be regulated differently depending on the stage of pregnancy in 
order to meet the specific demands for successful implantation, maintenance of pregnancy, and 
preparation for parturition (Bauersachs and Wolf, 2013, Gomez-Lopez et al., 2014, Robertson 
and Moldenhauer, 2014). In murine and human models, the ability of DC to differentiate and 
mature can be altered by pregnancy-associated hormones, including estradiol (E2) and 
progesterone (PG), both of which are highly upregulated in pregnancy (Lamote et al., 2004, 
Segerer et al., 2009, Xu et al., 2011, Cordeau et al., 2012, Lasarte et al., 2013, Schumacher et al., 
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2014). The relationship of these two hormones, E2 and PG, appears to be complex and 
dependent on context and concentration. The majority of studies show immunosuppressive 
effects of both E2 and PG on DC differentiation and maturation i.e. reduction in CD80 and MHC 
II, enhanced anti-inflammatory cytokine production with concurrent suppressed pro-
inflammatory cytokine responses, and T cell stimulatory capacity (Hughes et al., 2008, Segerer 
et al., 2009, Jones et al., 2010, Xu et al., 2011, Lasarte et al., 2013). Both E2 and PG are 
relatively high in bovine late gestation relative to other stages of lactation, and in the case of E2, 
this hormone drastically increases as cows approach calving in the third trimester of pregnancy 
(Hunter et al., 1970, Echternkamp and Hansel, 1973, Smith et al., 1973). Previous work in dairy 
cattle showed that in vitro treatments of PG had an effect on lymphocyte transcription factors 
which may promote T regulatory cell formation, and E2 and PG influence the function of 
neutrophils. However despite the importance of DC in maternal immune regulation across other 
species, we lack an understanding of the impact of these hormones on DC (Lamote et al., 2004, 
Lamote et al., 2006, Maeda et al., 2013). 
Here we aim to expand upon our previous work and study the effects of two major 
pregnancy hormones on moDC differentiation and maturation to further understand what factors 
may regulate changes observed in late gestation. The objective of this study was to analyze 
differentiation and maturation of bovine moDC, derived from blood CD14+ monocytes with 
exogenous in vitro treatments of physiological levels of E2 and PG found in late gestation. We 
investigated phenotype and function analyzing surface marker expression (CD14, CD40, CD80, 
MHC II) and cytokine production (TNFα, IL-10) following E. coli stimulation.    
2. Materials and methods 
2.1. Animals 
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Seven Holstein–Friesian cows were included in the study. These cows were either in their 
second or third lactation, were greater than 30 days in milk (DIM) and had not been bred. Cows 
were selected from the Cornell University Veterinary College Teaching Dairy Barn. No disease 
(i.e. metabolic, reproductive, mastitis) was observed within 30 days prior to the time of first 
sampling for all enrolled animals. Peripheral blood was collected by jugular venipuncture from 
enrolled animals into 250ml vacuum bottles containing EDTA. All animal procedures were 
approved by the Cornell Institutional Animal Care and Use Committee (project number: 2007-
0110). 
2.2. Generation of peripheral blood CD14+ moDC  
Monocyte-derived DC were generated from CD14+ monocytes as described previously 
by Pomeroy et al. (2015). In brief, peripheral blood mononuclear cells (PBMC) were isolated 
from whole blood by density gradient centrifugation. The PBMC were incubated with anti-
human CD14 antibodies conjugated with paramagnetic microbeads (Miltenyi Biotech, Inc., 
Auburn, CA) in MACS buffer (PBS, pH 7.2, 0.5% bovine serum albumin, 2 mM EDTA), 
transferred to MACS LS magnetic separation column, and after repeatedly washing the column 
with MACS buffer the magnetically labeled cells were collected (Miltenyi Biotech, Inc.). Purity 
was determined by flow cytometry and was shown to be >90%. Monocytes were re-suspended in 
differentiation media (phenol-free complete RPMI with l-glutamine, supplemented with 10% 
heat-inactivated charcoal/dextran treated FBS (lot# J13137, Atlanta Biologicals), 20 ng/ml 
recombinant bovine IL-4 and, 20 ng/ml recombinant bovine GM-CSF both from Kingfisher 
Biotech), plated in 24-well tissue culture plates at 5-7 × 105 cells in 1 ml differentiation media 
per well containing hormone treatments, and cultured for 5 days (37 °C, 5% CO2) in presence of 
recombinant cytokines to generate immature moDC; at 2-3 d cultures were given 0.5ml/well of 
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fresh differentiation media containing the respective treatments. Monocytes were treated with 65 
pg/ml of E2 (E2758, Sigma Aldrich), 10 ng/ml of PG (P8783, Sigma Aldrich), a combination of 
both E2 and PG, or 50ng/ml of dexamethasone (DEX) (D4902, Sigma Aldrich); an untreated 
control was cultured in differentiation media with no addition of exogenous hormones. 
Dexamethasone was used as a positive control to show suppression of moDC differentiation and 
maturation (van Kooten and Gelderman, 2011). Estradiol and PG treatments were selected based 
on range of circulating levels measured in plasma and serum documented in the literature and 
measurements determined by radioimmunoassay (radioimmunoassay preformed by the 
Endocrinology Laboratory in the Animal Health Diagnostic Center/ New York State Veterinary 
Diagnostic Laboratory accredited by the American Association of Veterinary Laboratory 
Diagnosticians) from cows in 60-30 days prior to calving (data not shown) (Hunter et al., 1970, 
Smith et al., 1973).  
2.3. Inactivation of E. coli ECC-Z 
E. coli ECC-Z was inactivated as described by Pomeroy et al. (2015). In brief, frozen stock 
of the previously characterized E. coli ECC-Z strain known to cause mild persistent clinical 
mastitis (Dogan et al., 2006, Lippolis et al., 2014) was grown to log phase in LB broth (Merck 
Millipore, Billerica, MA, USA). Bacteria were pelleted and diluted in PBS. Bacterial suspension 
was plated on agar plates prior to inactivation to determine concentration of stock solution. The 
bacterial suspension was inactivated using UV irradiation in the laboratory of Dr. Randy W. 
Worobo (Department of Food Science and Technology, Cornell University). The UV irradiated 
E. coli suspension failed to produce colonies on LB agar plates. Aliquots of UV irradiated E. coli 
were re-suspended in sterile 10% glycerol/PBS and stored at −80 °C. 
2.4. Maturation of moDC with UV irradiated E. coli 
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Maturation of moDC was induced by bacterial stimulation through the addition of UV 
irradiated E. coli to immature moDC cultures in an MOI (multiplicity of infection) of 10 for 24 h 
(Pomeroy et al., 2015). Cultures of moDC without bacterial stimulation served as media controls. 
Cell culture supernatants were collected after 24 h E. coli stimulation and stored at −80 °C until 
further cytokine analysis by ELISA. Cells were also harvested at this time for phenotypic 
analysis by flow cytometry using Accutase™ Solution according to the manufacturer’s 
instructions (Merck Millipore).  
2.5. Flow cytometry 
Expression of surface markers on moDC was measured with flow cytometry as described 
previously by Pomeroy et al. (2015). In brief, moDC were blocked with 10% normal goat serum 
(Life Technologies), subsequently incubated with primary unlabeled monoclonal mouse 
antibodies against bovine MHC II DR orthologue (TH4B), CD14 (MM61A), CD40 (ILA158A), 
and CD80 (ILA159) (Kingfisher Biotech), and then indirectly labeled with secondary Alexa 
Fluor® 488 conjugated monoclonal goat antibodies against mouse IgG2α or Alexa Fluor
® 647 
conjugated monoclonal goat antibodies against mouse IgG1 (Life Technologies). Secondary 
controls were of moDC stained only with conjugated secondary antibodies. No differences were 
found in baseline autofluoresence as determined by consistent MFI of secondary controls across 
samples (data not shown). Discrimination between live and dead cells was done by adding 
propidium iodide (PI, 1 µg/ml, Sigma Aldrich). A minimum of 10,000 events gated on viable 
cells were recorded for each sample. All measurements were taken with a FACSCalibur (Becton 
Dickinson). All flow cytometry data were analyzed using FlowJo software (TreeStar Inc., 
Ashland, OR). 
2.6. Measurement of IL-10 and TNFα by ELISA 
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Supernatant levels of bovine IL-10 were measured using ELISA as described in Pomeroy 
et al. (2015). In brief, Thermo Cliniplate EB flat-bottom 96-well plates (ThermoFisher, Vantaa, 
Finland) were coated with capture monoclonal mouse antibody against bovine IL-10 (1 μg/ml; 
CC320; AbDSerotec) in 0.05 M carbonate buffer (pH 9.6). Plates were washed then blocked 
with 2% fish skin gelatin (Sea Block buffer, ThermoFisher) in PBS. Following blocking 
supernatant samples were added. Known concentrations of recombinant bovine IL-10 
(Kingfisher Biotech) were assayed simultaneously to generate a standard curve from which 
sample concentrations were determined. Following sample and standard incubation, plates were 
washed, and biotinylated detection monoclonal mouse antibody against bovine IL-10 (1 μg/ml; 
CC320; AbD Serotec) was added. All samples and standards were assayed in duplicate. 
Supernatant levels of TNFα were measured according to using a commercially available 
kit according to the manufacturer (bovine TNFα DuoSet® ELISA, DY2279, R&D Systems, 
Minneapolis, MN).  
2.7. Statistical analysis 
All data were analyzed using the GraphPad Prism 5 statistical analysis program 
(GraphPad Software, Inc., La Jolla, CA USA). Initially, data were graphed and evaluated for 
outliers. Outliers were inspected and reanalyzed where necessary. Significant changes in moDC 
surface marker expression, and moDC cytokine production between untreated control, was 
determined by testing whether the fold change over untreated control was significantly different 
from 1 i.e. no fold change from untreated control, using a non-parametric, Wilcoxon-ranked 
signed test. A type I error of ≤0.05 was used. 
3. Results 
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As determined by percent of cells negative for propidium iodide, cell viability was not 
impacted by hormone treatment; no differences were detected between treatment groups and 
untreated controls in either unstimulated, immature DC (iDC) or E. coli-stimulated mature DC 
(mDC) cultures (Supplementary data, Fig. 1S). 
3.1. In vitro E2 and PG treatments hinder MHC II and CD80 expression  
Few changes in surface marker expression were detected following differentiation in 
unstimulated iDC populations. The iDC treated with E2 showed a moderate decrease in CD40 
and CD80 following the differentiation period relative to untreated control iDC (median fold 
change=0.918, p=0.0313; 0.5526, p=0.0156 respectively), however, following maturation with 
UV-killed E. coli CD40 expression increased across treatments and E2 treated mDC reached 
comparable expression levels as untreated controls. Dexamethasone treatment significantly 
increased CD14 expression (3.77, p=0.156; 3.1, p=3.13), decreased CD40 expression (0.584, 
p=0.0156; 0.604, p=0.0156), and decreased MHC II expression (0.157, p=0.0156; 0.0864, 
p=0.0156) in both iDC and mDC. However, dexamethasone had no significant impact on CD80 
expression relative to the untreated control (Fig. 11 a-i). Treatments with E2, PG, and 
combination of E2 and PG hindered the increase in expression of MHC II following maturation 
(0.8702, p=0.0156; 0.793 p=0.0156; 0.825, p=0.0156). Similarly, hindered MHC II expression 
by PG could be observed prior to E. coli-stimulation in iDC (0.847, p=0.0313) (Fig. 11 a,e,i). In 
addition to MHC II expression, unlike dexamethasone, E2 and PG treatment significantly 
decreased expression of CD80 in mDC at comparative levels (0.8055, p=0.0156; 0.8076, 
p=0.0313) and the combination of E2 and PG had a similar trend which approached significance 
(0.8731, p=0.0938). Reduced CD80 expression by E2 treatment could be observed prior to 
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stimulation in iDC and the combination of E2 and PG had a similar trend that also approached 
statistical significance (0.5526, p=0.0156; 0.6667, p=0.0781) (Fig. 11 a,d,h). 
 
Figure 11. MoDC phenotypic differentiation and maturation induced by 24h stimulation 
with UV IR E. coli ECC-Z. Representative histograms of moDC expression of CD14, CD40, 
CD80, and MHC II; dashed line represents secondary, negative staining control, dotted line 
represents stained, unstimulated iDC, and solid line represents stained, E. coli-stimulated mDC 
(a). Fold changes over untreated, control in relative expression of CD14 (b,f), CD40 (c,g), CD80 
(d,h), and MHC II (e,i) as determined by geometric mean fluorescence intensity (MFI) in 
unstimulated, immature moDC (b-e) and UV IR E. coli-stimulated moDC (f-i). Solid black bars 
represent median (n=7). Error bars represent interquartile range. Significant differences were 
determined using a Wilcoxon-ranked signed test comparing medians to hypothetical value of 1. * 
indicates significant of p<0.05. 
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3.2. Combined treatment of E2 and PG enhances IL-10 upregulation following UV-
killed E. coli-stimulation  
Interleukin 10 was detected at varying levels in supernatant from unstimulated moDC. 
Therefore, delta IL-10 (E. coli-stimulated mDC–unstimulated iDC) was used to compare IL-10 
upregulation following E. coli stimulation (Fig. 12 a). Upregulation of IL-10 following UV-
killed E. coli-stimulation was enhanced in moDC treated with a combination of both E2 and PG 
relative to untreated controls (1.258, p=0.0156). However individual treatments of either E2 or 
PG alone did not enhance IL-10 upregulation (Fig. 12 a). Interestingly, dexamethasone treatment 
did not enhance IL-10 production (Fig. 12 a). 
No TNFα was detected in the supernatant from unstimulated iDC across treatments thus 
only concentrations of TNFα produced from E. coli-stimulated mDC were compared to untreated 
control mDC. We found mDC treated with E2 or PG or the combination of E2 and PG were 
capable of upregulating TNFα and there was no significant increase or decrease relative to the 
untreated control. There was a trend in moDC treated with both E2 and PG towards an increase 
in TNFα production (1.363, p=0.0781) (Fig. 12 b). Dexamethasone treated moDC had abrogated 
TNFα production, and the majority of samples were below limits of detection resulting in a 
drastic decrease relative to untreated control mDC (0, p=0.0147) (Fig. 12 b). 
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Figure 12. MoDC IL-10 and TNFα production following maturation induced by 24h 
stimulation with UV IR E. coli ECC-Z. Fold changes over untreated, control in upregulation of 
IL-10 (a); upregulation of IL-10 i.e. ΔIL-10 was defined as the difference in concentration of IL-
10 in cell-free, cell culture supernatant between UV IR E. coli-stimulated moDC and 
unstimulated, immature moDC. Fold change over untreated, control in TNFα production in cell 
culture supernatant from UV IR E. coli-stimulated moDC (b). Solid black bars represent median 
(n=7). Error bars represent interquartile range. Significant differences were determined using a 
Wilcoxon-ranked signed test comparing medians to hypothetical value of 1. * indicates 
significant of p<0.05.  
 
4. Discussion 
Dendritic cells are known to be key drivers of maternal immune tolerance and are 
regulated to accommodate unique needs at each stage of pregnancy by multiple pregnancy-
associated factors; factors which regulate these cells in bovine pregnancy have yet to be 
determined (Blois et al., 2007, Della Bella et al., 2011, Negishi et al., 2012, Leno-Duran et al., 
2014, Schumacher et al., 2014, Pomeroy et al., 2015). In this study, we analyzed the effect of in 
vitro exposure to physiological levels of E2 and PG found in late gestation on aspects of moDC 
phenotype and cytokine production from non-pregnant dairy cows. Our findings suggest levels 
of E2 and PG in late gestation regulate DC to promote tolerance through inhibition of phenotypic 
maturation and increase in the production of anti-inflammatory cytokine IL-10. 
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We were able to recapitulate some aspects of hindered phenotypic maturation observed in late 
gestation in moDC from non-pregnant lactating cows using in vitro treatments of E2 and PG at 
levels typically found in circulation during late gestation. We also observed some differences 
following the differentiation period, in unstimulated iDC in E2 or PG treated cultures relative to 
untreated controls where treated cells had a reduced expression of co-stimulatory markers 
(CD40, CD80) or MHC II, respectively (Fig. 11 a-e). Following maturation induced by UV-
killed E. coli stimulation, the moDC treated with these pregnancy-steroid hormones had reduced 
expression of CD80 and MHC II (Fig. 11 a, f-i). These results agree with our previous work 
characterizing moDC from cows in late gestation without addition of exogenous hormones; 
specifically we had observed hindered MHC II expression following E. coli stimulation in moDC 
from non-lactating cows in late gestation (Pomeroy et al. 2015). Though dexamethasone 
suppressed MHC II like E2 and PG it did so to a much greater extent. Interestingly, unlike 
treatments of E2 and PG, dexamethasone treatment did not suppress CD80 expression, but rather 
it suppressed CD40 expression and further greatly enhanced CD14 expression even following 
maturation. This difference in pregnancy steroid hormones and dexamethasone effect suggests 
that pathways which hinder maturation in moDC likely differ between these hormones (Fig. 11) 
(Yoshimura et al., 2001, Franchimont, 2004). The decrease in co-stimulatory molecule CD80 
and antigen-presentation molecule MHC II upregulation in E2 and PG treated moDC indicates 
that pregnancy steroid hormones may play a role in modulating the immune response specifically 
in DC and may relate to weaker T cell activation in late gestation. 
In addition to phenotypic changes, moDC cytokine production was influenced by in vitro 
hormone treatment. The upregulation of anti-inflammatory cytokine, IL-10 following maturation 
was relatively higher in moDC treated with both E2 and PG however numerically the data 
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suggest PG is likely the main driver in these changes (Fig. 12 a). Our findings pertaining to IL-
10 production go in line with our previous work in which moDC from late gestation dry cows 
had greater upregulation of IL-10 following E. coli-stimulation compared to those from early 
lactation cows (Pomeroy et al., 2015). In non-bovine species, IL-10 is a key cytokine involved in 
preventing preterm labor in late gestation, and maintaining tolerances (Sato et al., 2001, 
Robertson et al., 2006, Boro et al., 2014). Pro-inflammatory cytokine, TNFα, was not 
significantly altered with E2 or PG treatment, though there was a trend with treatments including 
PG suggesting it may elevate production of TNFα. In contrast to E2 and PG, dexamethasone 
treatment abrogated TNFα production (Fig. 12 b). These cytokine data suggests again that the 
pathway in which dexamethasone suppresses moDC maturation is likely different from E2 and 
PG because dexamethasone suppressed pro-inflammatory TNFα while no significant changes 
were found with regards to IL-10 production, but the combination of E2 and PG enhanced IL-10 
production but did not suppress TNFα production (Yoshimura et al., 2001, Franchimont, 2004). 
The observed upregulation of TNFα may be necessary at various stages of pregnancy, and 
argument that is similar for certain inflammatory cytokines and what is observed in other 
mammalian species, (Monzon-Bordonaba et al., 2002, Okuda and Sakumoto, 2003, Fair, 2015). 
It may also be possible that this pro-inflammatory cytokine is regulated by other factors in 
pregnancy and not by E2 or PG. Candidates for regulation of pro-inflammatory cytokines were 
suggested to be metabolic metabolites such as adiponectin (Kabara et al., 2014).  
This study demonstrates the effects of pregnancy-associated factors, E2 and PG present at 
elevated levels simulating bovine late gestation, on moDC and reveals that these steroid 
hormones may be modulators of maternal immune response in late pregnancy. Previous work in 
other species generally found these hormones to hinder maturation and alter cytokine profile of 
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DC generally minimizing T cell activation and highly inflammatory responses; for example, Xu 
et al. (2011) found in vitro treatments of PG diminishes the expression of maturation markers 
CD80 and MHC II, and elevated IL-10 while concurrently reducing IL-12 production, (Butts et 
al., 2008, Hughes et al., 2008, Jones et al., 2010, Xu et al., 2011). In non-bovine species, these 
hormones have been shown to inhibit the NF-κB pathway in multiple ways including, the 
suppression of translocation via Ikbkg or interfere with NF-κB transcriptional activity. 
Suppression of the NF-κB pathway negatively impacts effective antigen presentation by DC 
(Yoshimura et al., 2001, Davies et al., 2004, Lasarte et al., 2013). Diminished DC maturation 
generated by E2 and PG likely promotes and maintains a viable, full term pregnancy by 
preventing the development of conceptus-derived antigen-specific responses (Arck et al., 2007). 
In addition to the effects on DC, both E2 and PG have been shown to regulate other bovine 
immune cells including neutrophil phenotype and function and T cell transcription factors 
indicating these hormones play a larger role in maternal immune regulation and work in concert 
to generate tolerance (Lamote et al., 2004, Lamote et al., 2006, Maeda et al., 2013). Future 
research should investigate further functional aspects modulated by these hormones, determine if 
this relates to changes observed in vivo, and understand the pathways which are regulated by E2 
and PR signaling. In addition to a more in-depth analysis of the effects of E2 and PG on bovine 
moDC, other pregnancy-associated factors should also be addressed; unlike humans and rodents, 
dairy cattle experience drastic metabolic changes over the course of pregnancy and lactation that 
are likely to impact moDC phenotype and function (Sordillo et al., 2009, Rulle et al., 2012, Sim 
et al., 2016).  
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SUPPLEMENTAL DATA 
 
Figure 1S. MoDC viability following differentiation and maturation induced by 24hr 
stimulation with UV IR E. coli ECC-Z. Viability determined by percentage of cells negative 
for propidium iodide for unstimulated, iDC (a) and E. coli-stimulated mDC (b). Solid black bars 
represent median (n=7). Error bars represent interquartile range. Significant differences were 
determined using a Wilcoxon-ranked signed test comparing medians to hypothetical value of 1. * 
indicates significant of p<0.05. No significant differences were detected across hormone 
treatments. 
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ABSTRACT 
The heightened susceptibility to infectious diseases in postpartum dairy cows is often 
attributed to immune dysfunction associated with the transition period. However, the cell 
populations involved in this immune dysfunction and the dynamics between those populations 
are not well defined. Monocytes play a crucial role in governing initial immune response in 
bacterial infections. Bovine monocytes are subdivided in classical (CD14+/CD16-), intermediate 
(CD14+/CD16+) and non-classical monocytes (CD14-/CD16+) with distinct phenotypic and 
functional differences. This study investigated the relationship of monocyte subsets counts in 
blood at 42 and 14 days prior to expected calving date to occurrence of metritis and mastitis 
within 2 weeks postpartum. In the enrolled prospective cohort of 27 German Holstein cows, 
housed at the Institute of Animal Nutrition of the Friedrich-Loeffler-Institute Braunschweig, 
Germany, n=13 developed metritis and/or mastitis postpartum. A multivariable logistic 
regression was used to analyze the relationship between prepartum cell counts of monocyte 
subsets and neutrophils with postpartum disease. Our model revealed that higher counts of the 
two CD14+ monocyte subsets were predictive of disease. In contrast, higher numbers of the 
CD14- monocyte subset were negatively associated with disease. Interestingly, the neutrophil 
count, a common hallmark for inflammatory response, was not associated with the outcome 
variable at either time point. The results indicate that the number and composition of monocyte 
subsets before calving are related to the susceptibility to infectious disease within 2 weeks 
postpartum. Furthermore the oppositional effect of CD14+ and CD14- subsets strengthens the 
hypothesis that these subsets have different functional roles in the inflammatory response in 
dairy cows. 
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1. Introduction 
Dairy cows have an increased susceptibility to disease during the first 3 weeks 
postpartum (LeBlanc, 2010). Clinical mastitis and metritis are frequently observed in this period, 
and both of these diseases remain an animal welfare concern and a source of major costs for the 
dairy industry worldwide (Mallard et al., 1998, Bradford et al., 2015). The higher incidence of 
these diseases is commonly associated with an dysregulated inflammatory response in the 
animal, which often goes along with an overexpression of pro-inflammatory mediators like TNF-
α and IL-1β and increased disease severity (Sordillo and Raphael, 2013). The innate immune 
system represents the first line of defense against the initial stages of infection and is the key 
determinant in the outcome of mastitis and metritis (Aitken et al., 2011, Pinedo et al., 2013). 
Monocytes and monocyte-derived cells play an essential role in orchestrating the main features 
of the innate immune response (Hume et al., 2002, Auffray et al., 2007). Recently it has become 
evident that bovine monocytes are a heterogeneous population and can be divided based on the 
expression of CD14 and CD16 into classical (cM, CD14+/CD16-), intermediate (intM, 
CD14+/CD16+) and non-classical monocytes (ncM, CD14-/CD16+), with the majority of blood 
monocytes being CD14 positive (Hussen et al., 2013). Distinct functional features were reported 
for the different subsets in response to LPS and in the presence of chemokines. Hussen et al. 
(Hussen et al., 2013) found short term LPS stimulation (3h) induced stronger pro-inflammatory 
cytokine response and inflammasome activation in CD14+ subsets (cM and intM) compared to 
the CD14- ncM; however, Corripio-Miyar et al. (Corripio-Miyar et al., 2015) found that ncM 
showed an overall stronger pro-inflammatory response after long term LPS (18h) stimulation. In 
conjunction with inflammatory responses to LPS, cM also are able to produce relatively strong 
anti-inflammatory responses including high arginase I gene expression and IL-10 production. 
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Only the CD14+ subsets, cM and intM, are attracted by both the monocyte chemokine CCL5 and 
neutrophil degranulation products in vitro and to respond with significant Ca2+ influx (Hussen et 
al., 2014, Hussen et al., 2016). Though there remains some discrepancies in function in regards 
to CD14- monocytes it is evident these subsets have unique properties and CD14+ consistently 
show strong inflammatory responses. 
Although the role and dynamics of the different bovine monocyte subsets in vivo remain 
unclear, cows that develop infectious disease postpartum also have an altered monocyte 
response. Periparturient cows had an overall higher frequency of  monocytes in supra mammary 
lymphnodes and higher TNF-α production in tissue monocytes after stimulation with LPS but 
significantly lower response in blood monocytes (Sordillo et al., 1995). Monocytes from cows 
which developed metritis within the first week postpartum have elevated baseline expression of 
pro-inflammatory cytokines such as IL-6, TNF-α and IL-1β at 1 to 12 hours post calving, but 
showed a less pronounced increase of these mediators in response to bacterial challenge in vitro 
(Galvao et al., 2012). Despite an enhanced baseline pro-inflammatory cytokine production the 
immune response from those cows failed to prevent the establishment of infection with rapid 
clearance of the invading pathogen, and the increased inflammatory properties of these cells 
likely promoted disease. Another study showed that monocyte phagocytic capacity was 
significantly decreased in cows that developed endometritis within the first 20 days postpartum 
(Brodzki et al., 2014). It is unclear from these studies if susceptible cows also show changes in 
monocyte subset composition or an altered function of individual monocyte subsets. In humans 
however, there are associations between inflammatory conditions and monocyte subset 
composition. In tuberculosis patients an expansion of CD16+ subsets was reported while in vitro 
CD16- monocyte subsets were more prone to migrate in response to mycobacteria derived 
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gradients (Balboa et al., 2015). In an endotoxin tolerance model with human monocytes it was 
furthermore shown that prior exposure to LPS increased the frequency of CD14+ monocyte 
subsets after LPS restimulation (Dominguez-Nieto et al., 2015). Additional studies showed that 
human CD14- ncM were the most inflammatory of the subsets, and an increase in ncM was 
associated with autoimmune disorders and promotion of Th1-type responses, whereas CD14+ 
cM and intM attenuated T cell responses and were associated with certain diseases in humans 
such as sepsis and certain cancers (Wong et al., 2012, Mukherjee et al., 2015). Research 
pertaining to relationships between disease and monocyte subsets is underdeveloped in bovine 
immunology, yet the substantial evidence connecting disease and monocyte composition found 
in other species in conjunction with known species to species differences indicates this area 
should be further investigated within a bovine model.  
Therefore, the objective of this study was to investigate if there were a relationship 
between prepartum blood monocyte subset composition and postpartum infectious disease in 
dairy cows. Specifically, we investigated if disease susceptibility was correlated with changes in 
either CD14+ or CD14- subsets. We used logistic regression models with longitudinal 
prospective data to identify significant relationships between postpartum disease and counts of 
monocyte subsets. 
2. Materials and methods 
2.1. Animals and blood sampling  
The data was collected from cows enrolled in a previously published study (Eger et al., 
2016).  Briefly, 27 German Holstein cows housed at the experimental station of the Institute of 
Animal Nutrition, Friedrich-Loeffler-Institute in Braunschweig, Germany were enrolled in the 
study. Body condition score (BCS) was determined prior to the experiment and cows were 
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allotted to a BCS low (BCS 2.77 ± 0.10, mean ± SEM) and a BCS high group (BCS 3.73 ± 0.12) 
with consideration of milk yield, body weight and lactation number (Table 2).  Throughout the 
experiment the animals were housed in a free-stall barn with individual feeding stations. After 
calving cows were milked twice per day. Pre-partum, BCS low cows received a diet of 80% 
roughage, 50% grass silage and 50% corn silage based on dry matter content, and 20% 
concentrate according to the recommendations of the German Society of Nutrition Physiology 
(GfE, 2001). The BCS high group received 40% of the same roughage and 60% concentrate to 
induce energy oversupply. After calving the concentrate proportion in the diet was raised from 
30% to 50% in 2 or 3 weeks for the BCS low and the BCS high group, respectively, to promote 
negative energy balance in the BCS high group. Half of the enrolled animals were vaccinated 
against BVD (Bovilis BVD®-MD, MSD) at 42 and 14 days prior to expected calving date; half 
of the low BCS was vaccination and approximately half of the high BCS was vaccinated. The 
number of cows with a parity of 2 and cows with a parity of greater than 2 were approximately 
the same between the groups i.e. four groups based on BCS and vaccination status. Health status 
was monitored throughout the trial. Cows with purulent uterine discharge detected in the vagina 
were diagnosed with clinical metritis based on the definition provided by Sheldon et al. (2006).  
Mastitis cases were identified by clinical signs i.e. clots in milk, elevated somatic cell count, 
swelling/sensitivity of the mammary gland. Bacteriological cultures were not preformed to 
determine the etiology of clinical disease; metritis and mastitis were defined by clinical signs. 
For the purpose of this paper animals that developed metritis and/or mastitis within two weeks 
postpartum were combined into a single category of postpartum disease; therefore a binary 
outcome variable of postpartum disease yes or no was used in the subsequent data analyses 
(Table 2). Three cows developed clinical mastitis only, seven cows developed metritis only, and 
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three cows developed both mastitis and metritis in the first two weeks postpartum. Blood 
samples were collected by puncture of the jugular vein into heparinized vacutainer tubes at days 
42 and 14 prior to predicted calving date. Only two cows calved more than 2 weeks prior to 
predicted parturition, their prepartal sample was assigned to the nearest predicted day (one cow 
day -42, one cow day -14). This study was approved by the Lower Saxony State Office for 
Customer Protection and Food Safety (33.9–42502–04–11/0444). All procedures involving 
animals were carried out in accordance with the German legislation on animal welfare. 
2.2. Separation of blood leukocytes and characterization of monocyte subsets 
Blood was diluted with the same volume of PBS and centrifuged at 1000 x g for 10 min. 
Erythrocytes were lysed by adding 20 mL aqua dest. for 20 sec and subsequent addition of 20 
mL double concentrated PBS. This was repeated twice until complete erythrolysis. Cells were 
centrifuged and washed with PBS (500 x g, 250 x g and 100 x g for 10 min each) and finally 
adjusted to 1 x 107 cells/mL in PBS. Leukocytes were suspended in PBS containing 5 g/L bovine 
serum albumin and 0.1 g/L NaN3 (MIF buffer) and stained with a combination of three directly 
conjugated monoclonal antibodies: mouse anti-bovine CD172a-PECy5, mouse anti-human 
CD14-PE and mouse anti-human CD16-FITC (all from AbD Serotec, Oxford, UK) for 20 min at 
4 °C. Thereafter cells were washed with MIF buffer and analyzed by flow cytometry (Accuri C6 
Flow Cytometer®, Becton Dickinson GmbH, Heidelberg, Germany). Dead cells were excluded 
by adding propidium iodide (2 μg/mL, Calbiochem, Bad Soden, Germany). Mononuclear cells 
(MNC) and granulocytes (PMN) were gated according to their forward (FSC) and side scatter 
(SSC) properties (Gu et al., 2011). Among CD172a+ MNC, three bovine monocyte subsets were 
defined based on their CD14 and CD16 expression: cM were CD14+/CD16-, intM were 
CD14+/CD16+ and ncM CD14- /CD16+. Appropriate compensation was applied for 
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fluorochromes used in multi-color flow analysis of monocyte subsets in order to distinguish 
between PI and PE. Cell doublets were gated out in dot plots SSC-A vs SSC-H. Cell counts of 
monocyte subsets and  PMN were calculated by multiplying the absolute leukocyte count, 
determined in EDTA whole blood using an automatic analyzer (Celltac α MEK-6450, Nihon 
Kohden, Qinlab Diagnostik, Weichs, Germany), with percentages determined by flow cytometry. 
2.3. Data analysis and statistical methods 
All data were entered into a database and double checked for entry errors or outliers. Data 
were described using descriptive and graphical techniques. Descriptive analysis of raw data 
included the computation of median cell counts with interquartile range for individual cell 
populations measured at each sample time point and frequency tables of categorical study design 
variables (vaccination status, BCS, parity) and grouped by postpartum disease status. The small 
sample size precluded univariable statistical analyses of any associations between disease 
presence and BCS, parity, or vaccination status. Spearman’s correlation coefficients were 
calculated to identify correlations between counts of different myeloid cell populations to assess 
for possible collinearity. Further analysis was performed using multivariable regression analyses. 
The general logistic regression model was formulated as: Logit(Y) = α + βi Xi + e, where Y is the 
absence or presence of postpartum disease, α is the intercept, βi is the regression coefficient of 
predictor variable Xi. The term e is an independently, identically distributed binomial error term. 
Statistical significance was defined at P < 0.05. All Statistical analyses were preformed using 
SAS version 9.4 (SAS Institute). The dataset supporting the conclusions of this article is included 
within the article as an additional file (see Additional file 2). 
2.4. Multivariable analysis 
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Multiple multivariable logistic models were used to assess the relationship between 
absolute counts of different myeloid cell populations circulating in the peripheral blood during 
the third trimester of pregnancy (42 days and 14 days prior to calving) and development of 
disease within the first two weeks postpartum. Multivariable logistic models were constructed 
using generalized estimating equations and a binary distribution for the outcome variable 
(postpartum disease, yes vs. no).  Potential confounding variables included in the model were the 
original study design variables parity (parity=2, parity >2), body condition score (>3.0, <3.0), 
and vaccination schedule (vaccinated prepartum, yes=1 vs. no=0). These potential confounders 
were included in all multivariable logistic models as binary variables. Due to differences 
observed in counts of multiple myeloid cell populations between 42 days and 14 days prior to 
calving date, two logistic models were constructed based on time of data collection as a minimal 
model irrespective of individual contributions. The two models included data from either 42 days 
or 14 days prior to calving; any animals with missing data from either time point were excluded. 
Final models were generated using a forward stepwise selection of variables. Statistical 
significance was determined based on the likelihood ratio statistic of nested models, and model 
fit was described using Akaike’s Information Criterium (AIC). Likelihood ratios and odds ratio 
estimates with profile-likelihood confidence intervals were used to determine significance due 
the small sample size. With the data analyzed here, a Wald test is not preferable over the 
likelihood ratio test because the estimates for the coefficient and its standard error may have 
unreliable normal approximation of its distribution when the sample size is small; likelihood 
ratio test and profile-likelihood confidence intervals do not assume normality of the estimator 
(Dohoo et al., 2003). 
3. Results 
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3.1. Descriptive analysis 
Characteristics of the enrolled cows are summarized in table 2. The animals were 
grouped by parity, BCS and vaccine status, and the model controlled for these host 
characteristics though addition of forced variables. Out of the 27 enrolled cows 13 developed 
clinical disease postpartum. There were comparable numbers of cows within each category of 
BCS (either > or < 3), parity (=2, >2), and vaccinated between cows who did not develop clinical 
disease postpartum (“healthy”) and those cows who did develop clinical disease postpartum 
(“postpartum disease”) as determined by the chi-square test (Table 2). The gating strategy used 
to determine absolute count of CD14- monocytes (CD172a+CD14- mononuclear cells (MNC)), 
CD14+ monocytes (CD172a+CD14+ MNC), and granulocytes (PMN) in blood is presented in 
figure 13. The counts of CD14+ monocytes, CD14- monocytes, and PMN in blood at 42d and 
14d prior to the expected calving date within healthy cows and postpartum disease cows are 
presented in table 3 and figure 14. Cows that developed postpartum disease had a median CD14+ 
subset count at 14 days prior to expected calving date of 863 cells/µl blood whereas counts of 
CD14+ subsets in cows that did not develop disease postpartum had median count of only 289 
cells/µl blood (Fig. 14 A). The healthy and postpartum disease group had comparable median 
counts of CD14- subsets of the for both time points (Fig. 14 B). Descriptive analysis of monocyte 
subset counts based on parity revealed that cows in parity 2 that developed postpartum disease 
had median CD14+ and CD14- counts of 677 cells/μl and 44 cells/μl, respectively whereas cows 
in parity 3 or greater had median CD14+ and CD14- counts of 174 cells/μl and 9 cells/μl, 
respectively, validating the need to utilize a model to elucidate relationships between disease and 
monocyte populations so that these cofounders can be controlled for (see Additional file 2). The 
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counts of PMN showed similar dynamics in healthy and postpartum disease cows in blood at 42 
and 14 days prior to expected calving date (Table 3, Fig. 14 C) 
Table 2. Descriptive analysis & characteristics of enrolled population. Median cell counts 
with interquartile range (IQR) presented. 
Parameter Healthy (n=14) Postpartum disease (n=13) 
 Frequency Frequency 
Parity=2 5 7 
Parity >2 9 6 
BCS <3 7 6 
BCS >3 7 7 
Unvaccinated 8 8 
Vaccinated 6 5 
42 days prior to calving Median IQR Median IQR 
Neutrophil absolute count (cells/µl) 3075.5 2149 2851 1790 
CD172a+ absolute cell count (cells/µl) 517.90 171.16 552.15 616.21 
CD14+ monocyte absolute count (cells/µl) 469.95 170.13 510.12 557.28 
CD14- monocyte absolute count (cells/µl) 33.45 27.06 32.73 37.63 
14 days prior to calving     
Neutrophil absolute count (cells/µl) 3884.75 2303 4326.05 2202 
CD172a+ absolute cell count (cells/µl) 389.86 680.35 1003.21 399.70 
CD14+ monocyte absolute count (cells/µl) 341.98 602.29 915.14 358.69 
CD14- monocyte absolute count (cells/µl) 36.21 60.53 53.46 49.16 
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Figure 13. Flow cytometric Gating strategy for bovine peripheral blood leukocytes. 
Representative data are shown for cells of one animal. After gating on viable (propidium-iodide-
negative) cells (A), cell doublets were excluded in SSC-A /SSC-H dot plots (B). Bovine 
mononuclear cells (MNC) and granulocytes (PMN)  were identified  based on their characteristic 
forward and side scatter characteristics and their percentages were calculated (C). Three-color 
immunofluorescence of bovine MNC labelled with mAbs specific for CD172a, CD14 and CD16 
defines three monocyte subsets in peripheral blood: Among viable MNC, CD172a-positive cells 
were identified (D). Correlated dot plots (CD14 vs CD16) of CD172a-positive MNC display 
classical monocytes (CD14+CD16−, upper left), intermediate monocytes (CD14+CD16+, upper 
right) and nonclassical monocytes (CD14-CD16+, lower right) (E). 
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Figure 14. Monocyte and neutrophil counts in blood prepartum. Absolute counts of CD14+ 
monocytes (A) and CD14- monocytes (B) and PMN (C) per µl blood at 42 and 14 days prior to 
expected calving date in 27 multiparous cows. 13 cows developed mastitis and/or metritis within 
14 days postpartum (square symbols), 14 cows did not develop either disease (circular symbols). 
Individual values are shown with median and interquartile range.  
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Based on collinearity of cM and intM identified by Spearman’s correlation coefficients 
and similar biological function (Hussen et al. 2013) between these two CD14+ subsets, we chose 
to group CD14+ subsets into a single variable of absolute count of all CD14+ monocytes. Only 
ncM are CD14-, and thus absolute count of CD14- monocytes included only ncM.   
3.2. Multivariable regression models 
Based on these descriptive analyses two separate models were generated for data from 
42d prior to expected calving date and 14d prior to expected calving date and changes in cell 
counts over the days were also analyzed. At 42d prior to the expected calving date, the final 
model selected with a forward stepwise selection included the change in absolute counts of 
CD14+ monocytes from 42d to 14d prior to expected calving date (Δ14d-42d CD14+), and absolute 
count of CD14- monocytes at 42d prior to expected calving date (Table 3-5, Fig. 15). At 14d 
prior to the expected calving date, the final model selected with a forward stepwise selection 
included the absolute count of CD14+ monocytes and absolute count of CD14- monocytes at 14d 
prior to expected calving date (Table 6-8, Fig. 16). A flow chart summarizing the models 
findings on the statistically significant relationships between 42d and 14d prepartum absolute 
cell counts and postpartum disease are depicted in figures 15 and 16, respectively; parameters 
which decreased the risk of acquiring a postpartum disease are indicated with ‘-’ and those which 
increased the risk of acquiring postpartum disease are indicated with ‘+’.   
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Table 3. Multivariable analysis, Model 1 selection: only data collected at 42 days prior to 
calving date used to generate model. Model 1b is the best fitting model.  
 
Table 4. Parameter estimates for final model selected for 42d prior to expected calving 
date. Exact p-values calculated using a χ2 distribution; significance based on the likelihood 
ratio test. 
Parameter β 
Standard 
Error 
χ2 P-value 
Intercept -6.2125 2.953 - - 
Parity (>2) 5.9317 2.8295 8.91 0.0028 
Parity (=2, reference) 0 0 - - 
BCS (low, <3) -0.4746 1.9196 0.06 0.8 
BCS (high, >3, reference) 0 0 - - 
Vaccine (yes) 0.6141 1.5264 0.16 0.6879 
Vaccine (no, reference) 0 0 - - 
CD14- monocyte count (cells/µl) -0.1135 0.0615 8.83 0.003 
Δ14d-42d CD14+ 0.0059 0.0032 7.75 0.0054 
 
Table 5. Odds ratio estimates and profile-likelihood confidence intervals for significant 
explanatory variables from final model selected for 42d prior to expected calving date. Unit 
refers to the change in number of units the odds ratio estimate was based. 
Parameter Unit 
Odds Ratio 
Estimate 
95% Confidence Limits 
CD14- monocyte count (cells/µl) 5.0000 0.567 0.213 0.860 
Δ14d-42d CD14+ 200.0 3.270 1.304 18.950 
 
42d prior to calving model -2Loglikelihood AIC 
Likelihood 
ratio 
P-value 
Base Model: Parity + BCS  + 
Vaccination status 
28.89 36.89 - - 
Model 1a: Parity + BCS  + 
Vaccination Status + ΔCD14+ 
20.63 30.63 8.27 0.004 
Model 1b: Parity + BCS  + 
Vaccination Status + ΔCD14+ + CD14- 
11.80 23.80 8.83 0.003 
Model 1c: Parity + BCS  + 
Vaccination Status + CD14+/CD14- 
ratio 
22.54 32.54 6.36 0.012 
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Table 6. Multivariable analysis, Model 2: Only data collected at 14 days prior to calving 
date used to generate model. Model 2b was the best fitting model. 
14d prior to calving model -2Loglikelihood AIC 
Likelihood 
ratio 
P-value 
Base Model: Parity + BCS  + 
Vaccination status 
28.89 36.89 - - 
Model 2a: Parity + BCS  + 
Vaccination Status + CD14+ 
17.68 27.68 11.21 0.0008 
Model 2b: Parity + BCS  + 
Vaccination Status + CD14+ + CD14- 
8.45 20.45 9.23 0.0024 
Model 2c:Parity + BCS + Vaccination 
Status + CD14+/CD14- ratio 
20.82 30.82 8.087 0.0045 
 
Table 7. Parameter estimates for final model selected for 14d prior to expected calving 
date. Exact p-values calculated from likelihood ratio using a χ2 distribution; significance 
based on the likelihood ratio test. 
Parameter β 
Standard 
Error 
χ2 P-value 
Intercept -7.7997 5.2934 - - 
Parity (=2) 1.5204 2.1404 0.61 0.4346 
Parity (>2, reference) 0 0 - - 
BCS (low, <3) -11.753 7.5015 8.86 0.0029 
BCS (high, >3, reference) 0 0 - - 
Vaccine (yes) -9.9861 6.845 5.67 0.0173 
Vaccine (no, reference) 0 0 - - 
CD14- monocyte count (cells/µl) -0.2536 0.1658 9.23 0.0024 
CD14+ monocyte count (cells/µl) 0.044 0.0272 20.44 <.0001 
 
Table 8. Odds ratio estimates and profile-likelihood confidence intervals for significant 
explanatory variables from final model selected for 14d prior to expected calving date. Unit 
refers to the change in number of units the odds ratio estimate was based. 
Parameter Unit 
Odds Ratio 
Estimate 
95% Confidence Limits 
CD14- monocyte count (cells/µl) 5.0000 0.281 0.016 0.811 
CD14+ monocyte count (cells/µl) 50.0000 9.033 1.591 635.660 
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Figure 15. Results from final model selected for data from 42 days prior to calving date. 
Greater increase in peripheral CD14+ monocyte counts from 42 days prior to 14 days prior to 
expect calving date associated with increased risk of postpartum disease <14 days post-calving 
(increased risk indicated as ‘+’). Higher peripheral CD14- monocyte counts at 42 days prior to 
expected calving date associated with a decreased risk of postpartum disease <14 days post-
calving (decreased risk indicated as ‘-’). 
Figure 16. Results from final model selected for data from 14 days prior to calving. Higher 
peripheral CD14+ monocyte counts at 14 days prior to expect calving date associated with 
increased risk of postpartum disease <14 days post-calving (increased risk indicated as ‘+’). 
Higher peripheral CD14- monocyte counts at 14 days prior to expected calving date associated 
with a decreased risk of postpartum disease <14 days post-calving (decreased risk indicated as ‘-
’). 
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The absolute count of CD14- monocytes at 42d and 14d prior to expected calving date 
were significantly associated with a reduced risk of acquiring postpartum disease (Tables 3-8, 
Fig. 15&16). The odds ratio estimate for CD14- monocyte count was calculated based on if the 
count in blood were to increase by 5 cell/μl due to the relatively low numbers typically found in 
circulation; these odds ratio estimates were 0.567 and 0.281 at 42d and 14 d prior to expected 
calving dates, respectively (Tables 5&8). Models showed the increase in Δ14d-42d CD14+ 
monocyte count and the absolute counts of CD14+ monocytes at 14d prior to expected calving 
date were significantly associated with increased risk of postpartum disease (Tables 3-8). The 
odds ratio estimate for Δ14d-42d CD14+ monocyte count was calculated based on if the Δ14d-42d 
CD14+ monocyte count were to increase by 200 cell/μl due to the relatively high numbers of 
CD14+ monocytes typically found in circulation and changes observed between 42 and 14d prior 
to the expected calving date; the odds ratio estimate was 3.270 for Δ14d-42d CD14+ monocyte 
count at 42d prior to expected calving date (Table 5). The odds ratio estimate for CD14+ 
monocyte count was calculated based on if the count in blood were to increase by 50 cell/μl due 
to the relatively high numbers typically found in circulation; the odds ratio estimate was 9.033 
for CD14+ monocyte count at 14d prior to expected calving date (Table 8). Interestingly, 
absolute count of PMN circulating in the blood was not found to be a significant predictor of 
postpartum disease (metritis and mastitis) in either model selected using data from 42d or 14d 
prior to expected calving date given the data on monocyte subsets (Table 3&6). The original 
study design variables for parity, BCS, and vaccination status included as confounding variables 
in the model were found to have significant relationships with disease, although these 
relationships were not significant at all time points;  a parity of greater than 2 increased disease 
risk in the model for -42d samples, a BCS less than 3 decreased risk of disease in the model for -
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14d samples, and vaccination in the prepartum period decreased risk of disease in the model for -
14d samples (Tables 4&7). 
4. Discussion 
Based on the multivariable models described here, the composition of monocyte subsets 
in peripheral blood differs in cows that develop disease within 2 weeks postpartum compared to 
cows that remain healthy. Changes in the numbers of CD14- monocytes and CD14+ monocytes 
in the periphery predict the development of postpartum disease (mastitis, metritis). Higher counts 
of circulating CD14- monocytes at 42 and 14 days prior to calving reduced the probability of 
acquiring postpartum disease, whereas, an increase in CD14+ monocyte counts from 42 to 14 
days and the CD14+ monocyte counts at 14d prior to calving increased the probability of 
acquiring postpartum disease (Tables 5&8, Fig 15&16). The results of the regression analyses 
were presented in a pictorial way in figures 15 and 16. A ‘+’ in the figures represents a higher 
risk of disease whereas a ‘-’ represents a lower risk. These positive or negative indicators of 
disease risk correspond to positive or negative value of the regression coefficient, β, in tables 4 
and 7. The CD14+ subsets account for the majority of monocytes found in circulation with cM 
being the dominating cell population predicting an increased disease risk. As mentioned 
previously, the two bovine CD14+ subsets (cM, intM) have overlapping functions that differ 
from the CD14- monocyte subset (ncM). For example, both cM and intM respond to neutrophil 
degranulation products, migrate in presence of CCL5, and have high phagocytic capacity, 
whereas ncM do not (Hussen et al., 2013, Hussen et al., 2014, Hussen et al., 2016). Nonclassical 
monocytes are described as being the most mature of all monocytes subsets (Hussen et al., 2013). 
Bovine ncM have limited capacity to respond to LPS with inflammation or neutrophil 
degranulation products compared to the other subsets (Hussen et al., 2013, Hussen et al., 2014, 
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Hussen et al., 2016). In humans, ncM have a unique ability to patrol healthy tissue, and bovine 
ncM express adhesion molecules associated with similar behavior, suggesting that ncM are the 
first of the monocyte subsets to recognize and respond to infection (Geissmann et al., 2003, 
Hussen et al., 2016). Therefore changes in peripheral monocyte composition could lead to 
disturbances in primary recognition of invading pathogens within tissue as well as in the balance 
of specific inflammatory/anti-inflammatory responses to follow. In non-bovine species, diet 
composition, circadian rhythm, glucocordicoids, and vitamin D3 modulate blood monocyte 
subset composition, but there are currently no published studies addressing the regulation of 
blood monocyte composition in cattle, thus it cannot be speculated at this time what factors may 
cause the differences we observed (Nguyen et al., 2013, Devevre et al., 2015, Liu et al., 2015). 
Nonetheless, prepartum blood monocyte composition appears to be correlated with postpartum 
immune competency. 
Peripheral monocytes migrate into tissues either in steady state or during inflammation 
where they may differentiate into macrophages or dendritic cells. Similar to rodents and humans, 
in bovine pregnancy, macrophages accumulate in the endometrium and are present in large 
numbers in interplacentomal and placentomal endometrium; CD14+ cells in circulation share 
similar gene expression profiles to macrophages in the endometrium, indicating blood monocytes 
likely migrate to endometrium and differentiate into macrophages (Oliveira and Hansen, 2008, 
Oliveira and Hansen, 2009). Tissue-resident macrophages and recruited monocytes play an 
important role in tissue repair in the reproductive tract postpartum. The composition of tissue-
resident monocytes and monocyte derived cells in the reproductive tract and mammary gland 
during bovine late gestation is likely dependent on the available reservoir, migratory capacity, 
and functional differences of the monocyte composition in blood therefore, changes in monocyte 
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populations likely influence disease susceptibility (Sanchez-Torres et al., 2001, Randolph et al., 
2002, Hussen et al., 2014, Hussen et al., 2016). 
Though no concrete conclusions can be made on the exact role of these subsets in bovine 
postpartum disease at this time, this is the first piece of striking evidence which clearly shows a 
relationship between monocyte subset composition prepartum and postpartum disease and 
alludes to the different roles of CD14+ and CD14- subsets in disease susceptibility. 
In contrast to others who described relationships between neutrophil function in the 
periparturient period, negative energy balance and metritis postpartum, this model found no 
relationship between neutrophil counts in the peripheral blood at 42 and 14 days prior to calving 
and postpartum disease (Cai et al., 1994, Hammon et al., 2006). The data used generate the 
models presented here do not include data on functional properties of either neutrophils or 
monocyte subsets from these animals. Though prepartum numbers of neutrophils readily 
available to migrate into tissue was not associated with postpartum disease in these animals like 
monocyte subsets are, the risk of disease may still be impacted by neutrophil function like 
described in previous studies (Guidry et al., 1976, Heyneman et al., 1990, Hammon et al., 2006). 
The original study design variables for parity, BCS, and vaccination status had significant 
relationships with disease, although these relationships were not significant at all time points the 
relationships were biologically plausible based on peer-reviewed literature on trained immunity 
from vaccination, the role of metabolic factors in disease, and relationships between parity and 
immune function and disease; prepartum vaccination, lower BCS (<3), and animals of a parity of 
2 had decreased risk of disease (Table 4&7) (Gilbert et al., 1993, Roche et al., 2009, Saadatian-
Elahi et al., 2016). For example, Gilbert et al. (Gilbert et al., 1993) found cows with a parity 4 or 
greater had reduced neutrophil function in the periparturient period.  
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Our results clearly indicate that peripheral blood monocyte composition relates to the 
overall immune competence of the cow postpartum. Though exact mechanisms which heighten 
susceptibility to postpartum disease cannot not be determined by this model, immune 
dysfunction postpartum seems to become apparent by blood monocyte composition as early as 
42d prepartum. These findings provide new insight on maternal immune status and its 
relationship to postpartum disease. Prepartum monocyte composition could be a potential 
biomarker to identify cows at risk with compromised immune function, and therefore could aid 
in animal selection for immunomodulation therapies. Future research should address the specific 
roles of bovine monocyte subsets in disease and address findings from the model described here.  
The model presented here demonstrates that changes in the numbers of CD14- monocytes 
and CD14+ monocytes in the periphery prepartum predict the development of postpartum 
disease (mastitis, metritis). We found higher counts of circulating CD14- monocytes at 42 and 14 
days prior to calving reduced the probability of acquiring postpartum disease, whereas, an 
increase in CD14+ monocyte counts from 42 to 14 days/at 14d prior to calving increased the 
probability of acquiring postpartum disease. Our findings highlight the need for further 
investigation on the function and regulation of individual monocyte subsets in pregnancy and 
early lactation in order to elucidate their role involved in disease susceptibility. A greater 
understanding of late gestation immune status and its relationship to postpartum disease will 
allow for development of immunomodulators and improvements in dry cow management that 
will reduce the risk of postpartum disease. 
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ADDITIONAL FILES 
Additionalfile1_dataset.dox. Additional file 1. Complete dataset. This file contains a table of 
the complete dataset from all enrolled cows used for descriptive analysis and statistical analysis 
(Materials and methods). 
 
Table 2S. Complete data set used for descriptive and statistical analysis. Abbreviations: 
Disease (0=no disease, 1=disease recorded postpartum), individual cow identification number 
(Cow ID), time point (TP, -42= 42d prior to expected calving date, -14= 14d prior to expected 
calving date), absolute counts of classical monocytes (cM), absolute counts of intermediate 
monocytes (intM), absolute counts of non-classical monocytes (ncM), body condition score 
(BCS, 1= BCS<3, 2= BCS>3), Parity (1= parity=2, 2= parity>2), absolute counts of CD172+ 
CD14+ cells (CD14pos), absolute counts of CD172a+CD14- cells (CD14neg), absolute counts of 
PMN (Neutrophil), vaccine status (Vacc, 0= no BVD prepartum vaccination, 1= yes BVD 
prepartum vaccination).  
Disease CowID TP cM intM ncM BCS Parity CD14+ CD14- PMN Vacc 
1 2 -42 703 133 50 1 1 836 50 2435.3 0 
1 2 -14 854 114 63 1 1 968 63 4212.1 0 
0 7 -42 482 79 43 1 2 561 43 1306.5 1 
0 7 -14 741 167 51 1 2 908 51 2963.6 1 
1 20 -42 448 81 30 1 1 529 30 3050 0 
1 20 -14 788 74 28 1 1 863 28 5282 0 
1 27 -42 581 61 36 2 1 643 36 3135.6 0 
1 27 -14 445 242 81 2 1 688 81 6497 0 
1 30 -42 169 38 44 1 1 207 44 1400 1 
1 30 -14 996 84 64 1 1 1080 64 3670.4 1 
0 32 -42 759 171 53 2 1 929 53 4914 0 
0 32 -14 230 32 18 2 1 262 18 6336 0 
0 35 -42 490 45 47 2 1 535 47 4253.4 0 
0 35 -14 
   
2 1 
   
0 
0 37 -42 419 62 34 2 1 481 34 3019.4 1 
0 37 -14 189 33 38 2 1 222 38 3785.5 1 
0 38 -42 146 127 122 2 1 273 122 1189 1 
0 38 -14 890 142 95 1 1 1032 95 4043.2 1 
1 46 -42 823 135 41 1 1 958 41 3180.8 1 
1 46 -14 912 261 24 1 1 1173 24 2752 1 
0 47 -42 776 171 85 1 1 947 85 4617 0 
0 47 -14 803 140 96 1 1 943 96 3984 0 
1 50 -42 633 45 61 2 1 677 61 3492 0 
1 50 -14 897 174 88 2 1 1071 88 4440 0 
1 618 -42 98 11 9 2 2 109 9 3425 0 
1 618 -14 678 79 29 2 2 757 29 5328 0 
0 716 -42 344 65 33 1 2 409 33 3254.7 0 
0 716 -14 97 12 4 1 2 109 4 5987.8 0 
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0 736 -42       2 2       1 
0 736 -14 669 107 98 2 2 775 98 4089 1 
1 749 -42 134 40 10 2 2 174 10 2652 0 
1 749 -14 1446 149 44 2 2 1596 44 8768 0 
0 802 -42 306 67 59 1 2 373 59 2460 1 
0 802 -14 434 50 65 1 2 483 65 3577 1 
1 810 -42 387 105 6 2 2 492 6 1625.4 0 
1 810 -14 418 126 75 2 2 545 75 2953.2 0 
0 825 -42 379 108 32 2 2 487 32 3031 1 
0 825 -14 148 25 21 2 2 173 21 3359.4 1 
0 833 -42 315 54 23 1 2 369 23 1431 1 
0 833 -14 328 67 35 1 2 395 35 3013.4 1 
1 861 -42 280 175 16 2 2 456 16 1374.7 1 
1 861 -14 749 84 34 2 2 833 34 5700 1 
0 903 -42 449 73 30 1 2 522 30 5056 1 
0 903 -14 162 21 16 1 2 183 16 6363 1 
0 905 -42 103 17 11 2 2 119 11 3572.8 0 
0 905 -14 555 147 93 2 2 701 93 4991.3 0 
1 911 -42 139 25 5 1 2 164 5 896 0 
1 911 -14 465 128 27 1 2 593 27 2556 0 
0 913 -42 394 65 29 1 2 459 29 3120 0 
0 913 -14 256 33 18 1 2 289 18 1665 0 
1 926 -42       1 2       1 
1 926 -14 395 29 47 1 2 424 47 2639.4 1 
1 930 -42 675 143 50 2 1 818 50 3500 1 
1 930 -14 949 133 110 2 1 1082 110 3828.5 1 
 
Additionalfile2_parity+counts.dox. Additional file 2. Cell counts by parity. This file contains 
a table summarizing descriptive analysis of cell count by parity group (Results). 
 
Table 3S. Peripheral blood monocyte and neutrophil cell counts (cells/μl) grouped by parity 
and disease status. Median counts with interquartile range (IQR) presented. 
Healthy 
Parity>2 (n=9) Neutrophils 
(cells/μl) 
CD14- monocytes 
(cells/μl) 
CD14+ monocytes 
(cells/μl) 
Days prepartum Median IQR Median IQR Median IQR 
-42 3075.500 1468 31.08834 12.08982 433.7490 133.34564 
-14 3468.200 2501 27.67735 40.61797 341.9845 414.47448        
       
Parity=2 (n=5) Neutrophils 
(cells/μl) 
CD14- monocytes 
(cells/μl) 
CD14+ monocytes 
(cells/μl) 
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Days prepartum Median IQR Median IQR Median IQR 
-42 3818.200 2661 68.99881 59.69023 705.1991 561.33173 
-14 4013.600 1305 66.50144 67.29404 602.5972 745.55171 
 
Postpartum Disease 
Parity>2 (n=6) Neutrophils 
(cells/μl) 
CD14- monocytes 
(cells/μl) 
CD14+ monocytes 
(cells/μl) 
Days prepartum Median IQR Median IQR Median IQR 
-42 1625.400 1277 8.665826 3.84636 174.1679 291.22023 
-14 5328.000 2747 34.17388 15.10259 757.2828 240.06350        
       
Parity=2 (n=7) Neutrophils 
(cells/μl) 
CD14- monocytes 
(cells/μl) 
CD14+ monocytes 
(cells/μl) 
Days prepartum Median IQR Median IQR Median IQR 
-42 3135.600 1057 43.90255 14.47735 677.4227 307.80345 
-14 4212.100 1612 63.93440 59.29398 1070.528 219.94237 
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ABSTRACT 
Dairy cows have increased risk of intramammary infections with Escherichia coli in the 
non-lactating period of late gestation (known as the ‘dry period). We expand upon an existing 
mathematical model to explore the role of factors unique to the dry period and late gestation 
immunity. We included biological knowledge of the bovine immune response in late gestation 
and known characteristics of the mammary gland in the steady-state portion of the dry period. 
The results indicate that intramammary infection dynamics of the dry period are complex and 
pertain to shifts in immune function in late gestation and changes to the mammary gland during 
involution and stead-state dry period. Only by varying growth rate of E. coli to that in non-
lactating gland secretion, initial number of phagocytes in the gland prior to infection, rate of 
phagocytosis and killing of E. coli by phagocytes, and pro- and anti-inflammatory cytokine 
production reproduced the data for infections caused by persistent E. coli in the dry period. The 
changes to the mammary gland related to the process of involution and within a steady state dry 
period enables persistence of E. coli infections in mammary glands. Knowledge of the 
pathogenesis of persistent infections in the dry period is essential to develop preventive and 
treatment programs for intramammary infections throughout the dry period in dairy cows. 
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1. Introduction  
Mastitis is one of the most prevalent and costly diseases for dairy farms (Burvenich et al., 
2003, Hertl et al., 2014a, Hertl et al., 2014b). The majority of clinical mastitis cases occur within 
the first 60 days post-calving and cause severe losses in milk production that may span the 
remainder of lactation (Barkema et al., 1998, Schukken et al., 2011, Schukken et al., 2012). The 
non-lactating period of late gestation known as the ‘dry period’, primarily around dry-off and 
colostrogenesis, is a known time of heightened susceptibility to new intramammary infections 
(IMI); these IMI often persist until parturition without visible signs of inflammation, and develop 
into clinical mastitis following the onset of lactation (Smith et al., 1985a, Green et al., 2002, 
Green et al., 2005, Burvenich et al., 2007, Quesnell et al., 2012, Pomeroy et al., 2016a). Among 
the mastitis-causing pathogens Escherichia coli is the most common isolate from dry period 
associated with clinical mastitis in the subsequent lactation (Smith et al., 1985, Green et al., 
2002, Green et al., 2005). Quesnell et al. (2012) and Gurjar et al. (2013) found when multiparous 
dairy cows are experimentally challenged in the dry period with E. coli ECC-Z, a strain known to 
cause mild clinical mastitis, the infection persists up until parturition without clinical signs or 
upregulation of pro-inflammatory cytokines (TNFα, IL-1β, IFNγ); following calving, cows 
develop clinical mastitis and upregulate pro-inflammatory cytokines in challenged quarters. 
Sipka et al. (2013) found when mid-lactation multiparous cows are given similar intramammary 
challenges with E. coli ECC-Z, cows developed clinical mastitis and upregulated pro-
inflammatory cytokines within 24hr following challenge. The severity of E. coli mastitis and 
response to infection are thought to be largely dependent on cow factors (Burvenich et al., 2003, 
Schukken et al., 2011). The specific factors associated with late gestation and concurrently the 
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dry period which impact IMI dynamics and allow for persistence of infection without clinical 
signs in the dry period are poorly understood. 
The maternal immune system undergoes regulation to tolerate the growing semi-allogenic 
fetus, and this regulation has been shown to influence susceptibility to infection and immune 
response in mammalian pregnancy (Oliveira and Hansen, 2008, Rosbottom et al., 2008, Pomeroy 
et al., 2015). Highly inflammatory, T helper 1 (Th1) and T helper 17 (Th17)-type responses in 
pregnancy have been shown to be detrimental to the health of the fetus, and facets of these cell-
mediated responses are greatly hindered during late gestation (Rosbottom et al., 2008, Betz, 
2012, Krishnan et al., 2013). Furthermore, during the dry period there is a delay in leukocyte 
recruitment to the mammary gland by approximately a week following the onset of dry-off until 
protective levels are reached; additionally, upon reaching the gland these cells have decreased 
phagocytic function from ingestion of milk fat and cell debris in the early dry period (Burvenich 
et al., 2007). During the mid-dry period the gland remains in steady-state involution and the teat 
ends are sealed, and there is a high concentration of phagocytes, lactoferrin, acute phase proteins, 
and other soluble mediators in the gland and secretion (Todhunter et al., 1990, Stelwagen et al., 
2009, Pezeshki et al., 2010). Although in the mid-dry period conditions are unfavorable for 
bacterial growth and this period has the lowest incidence of new IMI, existing IMI may persist 
(Green et al., 2002, Green et al., 2005, Gurjar et al., 2013). 
Previous work has indicated that the mechanisms which enable E. coli IMI to persist in 
lactation relate to the strain’s ability to invade mammary epithelial cells (Dogan et al., 2006, 
White et al., 2010, Dogan et al., 2012). A mathematical model developed by White et al. (2010) 
elucidating mechanisms which differentiate transient from persistent E. coli IMI in lactation 
adduced that the ability of E. coli to create intracellular reservoirs was a key determinant in 
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whether the IMI would be acute or chronic. It is unclear if similar mechanisms described in the 
model from White et al. (2010) relate to the unique differences in IMI dynamics observed in the 
dry period. Mathematical modeling will provide valuable insight into the potential role of 
maternal immune regulation in late gestation and investigate other key parameters involved in 
IMI dynamics specific to the dry period. 
The original mathematical model was compromised of a series of differential equations 
based on the interaction between the bovine immune system and numbers of extracellular E. coli 
in milk and in intracellular reservoirs within a quarter (White et al., 2010). Specifically, to 
investigate bacterial count and somatic cell count dynamics the model from White et al. (2010) 
included differential equations which described 1. Exponential growth of extracellular bacteria 
(E), 2. Ability of bacteria to move in and out of intracellular compartments to form intracellular 
reservoirs (I), 3. Phagocytosis and killing of extracellular bacteria by neutrophils (PMN) and 
macrophages (M), 4. Pro- and anti-inflammatory cytokine dynamics (C+, C-) which influenced 
the numbers of PMN recruited to the gland, and 5. Milk volume in the gland based on twice daily 
milking which impacted population size of bacterial cells. Biological data from in vivo and in 
vitro bovine and murine models were used to estimate initial conditions and parameter ranges 
including differential cell counts in milk, killing capacity of neutrophils, growth of extracellular 
E. coli, rates of invasion and intracellular survival, and pro- and anti-inflammatory cytokine 
concentrations observed in E. coli mastitis (IL-8, TNFα, IL-10). 
Here we propose to expand the model presented in White et al. (2010) to incorporate 
unique changes associated with the dry period in late gestating dairy cattle. We will alter the 
existing model with stepwise alterations to evaluate the impact of individual changes and 
determine which parameters may be key drivers of E. coli IMI dynamics in the dry period. The 
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sequential steps that we have taken to adjust the model to late gestation dairy cows included the 
following steps: 1. Remove the differential equation and factors related to milking volume, 2. 
Modify the estimates for extracellular E. coli growth to reflect slowed growth in dry cow 
mammary gland secretions which contain increased immune factors and decreased available 
nutrients for the bacteria, 3. Modify the initial number of phagocytes in the gland to reflect 
increased numbers of macrophages and PMN typically observed in the dry period 4. Modify the 
estimates for phagocytosis to reflect the inhibited phagocytosis observed at various stages of the 
dry period, and 5. Modify the estimates and dynamics of cytokine dynamics to reflect maternal 
immune regulation observed in bovine and mammalian late gestation. With this study we aim to 
improve the understanding of IMI dynamics in the dry period, and specifically look at the role of 
maternal immune regulation in enabling persistence of IMI in the dry period. 
2. Materials and Methods  
2.1. The model 
 The original mathematical model created by White et al. (2010) models the interaction 
between the bovine immune system and numbers of E. coli  (E) in milk and in intracellular 
reservoirs within a quarter (1 of the 4 compartments of the bovine mammary gland) in lactating 
animals. The original model assumed that the total number of colony forming units (cfu) of E. 
coli in milk (E) grows exponentially, but these extracellular bacteria are phagocytized and killed 
by macrophages and PMN. Similar to what is observed in human urinary tract infections caused 
by E. coli, White et al. (2010) allowed bacteria to move between milk and an intracellular 
MEC reservoir (I) (Dogan et al., 2006, Olson and Hunstad, 2016). White et al. (2010) modeled 
production of pro-inflammatory cytokines (C+) by phagocytes following E. coli stimulation as 
contact between bacteria and immune cells. The original model accounted for the production of 
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pro-inflammatory cytokines being inhibited by anti-inflammatory cytokines; anti-inflammatory 
cytokine production was dependent on pro-inflammatory cytokine production. Macrophages 
were assumed to remain constant whereas rate of PMN influx was dependent on pro-
inflammatory cytokine production. Milk volume and twice daily milkings were included in the 
original model and depletion of milk volume impacts the extracellular bacterial numbers. Time 
(t) was measured in days. The original model presented in White et al. (2010) was able to model 
differences in IMI dynamics between persistent and transient E. coli IMI in lactating cows based 
upon the rate of invasion, survival, and escape of intracellular reservoir.  
To identify the primary parameters involved in E. coli IMI dynamics observed in the dry 
period we first changed the values of parameters developed for lactating infection dynamics to 
values typical of the dry period and/or late gestation. The original model predicted E. coli strains 
which caused transient IMI had limited ability to form intracellular reservoirs when compared to 
chronic IMI; this related to ability of E. coli to invade MEC, survive in MEC, and remain in 
MEC. 
Eliminating parameters for milk removal by twice daily milkings had little impact on 
infection dynamics. Thus, parameters for milk removal were removed for subsequent 
interrogations of the model; the maximum volume within a quarter was set to a level typical of 
the dry period (V=125ml) (Smith et al., 1966). As described in White et al. (2010), this 
simplified description of inflammatory dynamics leads to the following series of differential 
equations for the concentrations of cytokines (C+ and C—), and the numbers of phagocytes (P) 
and E. coli (E) in milk and intracellular E. coli (I): 
 
𝑑𝐶+
𝑑𝑡
=
𝑔𝑐𝑝
(1 + 𝑖𝑐𝑝𝐶−)
𝐸(𝑀 + 𝑃) − 𝑑𝑐𝐶+ 
  
126 
 
 
 
 
 
 
The equations for the concentrations of phagocytes and cytokines remained deterministic 
and continuous. A stochastic version for the bacterial population section of the model was used 
as follows: 
 
 
 
where ϴ[x] is sampled from a Poisson distribution of mean x. The Poisson distribution was the 
most appropriate for this system because it is a discrete distribution and expresses the probability 
of a number of events (of the type that occur with a known average rate and independently of the 
time since the previous event) occurring in a fixed period of time. Within this model an event is 
defined as a change in the population size due to growth or killing. 
2.2. Biological data 
2.2.1. Extracellular E. coli growth rate (ge) in vitro  
Mammary gland secretions vary in composition depending on stage of lactation and of 
the dry period. The composition of available nutrients and host immune factors impact bacterial 
𝑑𝐶−
𝑑𝑡
= 𝑔𝑐𝑎𝐶+ − 𝑑𝑐𝐶− 
𝑑𝑃
𝑑𝑡
= 𝑔𝑝𝐶+ − 𝑑𝑝𝑃 
𝑑𝐸
𝑑𝑡
= 𝑔𝑐𝐸 − 𝑘𝐸(𝑀 + 𝑃) − 𝑎𝐸 +
𝑏𝐼
𝑉
 
𝑑𝐼
𝑑𝑡
= 𝑎𝐸𝑉 − 𝑏𝐼 − 𝑑𝑖𝐼 
𝐸t+dt = max{ϴ[𝐸t + (𝑔𝑒𝐸t − 𝑘𝐸t(𝑀 + 𝑃) − 𝑎𝐸t + 𝑏𝐼t) ∗ 𝑑𝑡], 0} 
𝐼t+dt = max{ϴ[𝐼t + (𝑎𝐸t − 𝑏𝐼t − 𝑑i𝐼t) ∗ 𝑑𝑡], 0} 
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growth rate (Kornalijnslijper et al., 2003). In lactation, milk secreted from the gland is nutrient 
rich and relatively low in immune factors in contrast to secretions from the dry period which 
have limited nutrients and as increase in immune factors (Smith et al., 1966, Kornalijnslijper et 
al., 2003, Boutinaud et al., 2016). The quantity of secretion, lactose, potassium, casein, α-
lactalbumin, β-lactoglobulin, and citrate in the gland decreases in early stages of drying off 
(Smith et al., 1966, Boutinaud et al., 2016). In contrast, milk somatic cell count, percent total 
protein, percent fat content, and lactoferrin concentrations increase in mammary gland secretions 
as cows progress further into the dry period (Boutinaud et al., 2016). 
The original model predicted a high growth rate for E. coli growth in milk, a nutrient rich 
medium. Experimental work showed both E. coli ECC-Z, a strain isolated from a chronic bovine 
IMI, and E. coli ECA727, a strain isolated from a transient bovine IMI, had reduced range of 
exponential growth when grown in mammary gland secretion from dry cows (DCS) free of 
cellular components; this resulted in a growth rate estimate between 25.62 and 37.17 (Fig. 17). 
The E. coli strains used for growth curves were characterized in Dogan et al. (2006) and (2012). 
Growth curves were setup as described in Todhunter et al. (1990). Briefly, E. coli strains were 
grown in LB broth to log phase then diluted in PBS to approximately 100 CFU/10μL, and 10 μL 
of bacterial suspension was added to 250 μl of pooled DCS and plated in 96-well tissue culture 
plates with duplicate wells for each hourly time point. Plates were incubated at 37°C and 
designated wells were diluted and plated each hour on LB agar plates; plates were incubated at 
37°C for approximately 12-18hr before counting. Todhunter et al. (1990) found majority of E. 
coli isolates had severely reduced growth in pooled dry cow secretion; from this paper exact 
growth rates per isolate cannot be calculated, but it can be estimated <13.4 CFU log10/day, with 
majority of strains not able to overcome the inhibitory effects of DCS and only 9.8% of E. coli 
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isolates able to grow at rates higher than 13.4 10 CFU log10/day. The effect of reducing growth 
rate (ge) in the model is depicted in figure 18 for both transient strains and chronic strains. Based 
on Todhunter et al. (1990) and in vitro data, extracellular E. coli growth rate (ge) was estimated 
to be between 13.4-37.17 CFU log10/day in the dry period.  
   
Figure 17. Growth curves of transient and persistent E. coli isolates in dry cow secretion. 
Dashed lines indicate exponential, non-linear fit to data. Mean growth with standard error 
represented at each hourly time point for transient strain, E. coli ECA-727 (black circle), and 
persistent strain, E. coli ECC-Z (white square). Experiments were run in duplicate. Time in days 
is shown on x-axis. 
 
2.2.2.  Initial SCC in the gland (P+M)  
In lactation, healthy dairy cows have relatively low SCC (<100,000 cells/ml indicates 
healthy quarter); the cut-off for healthy SCC may vary depending upon stage of lactation, 
age/parity, season, stress, etc. (Pilla et al., 2012). The SCC rises drastically from a low SCC 
when a quarter is infected with E. coli during lactation and results in an episode of clinical 
mastitis; transient mastitis-causing strains often result in the greatest influx of PMN (Dopfer et 
al., 1999, Kornalijnslijper et al., 2003, White et al., 2010). The original model is able to 
recapitulate this rise in SCC following infection in transient strains, and in persistent mastitis-
causing strains we see chronically high SCC with no complete clearance of extracellular bacteria. 
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Inchaisri et al. (2000) reported SCC of 5.43 cells log10/ml in milk prior to drying-off; this value 
was comparable to initial PMN values in the original mathematical model for lactating cows. 
During involution phagocytes, predominantly macrophages, are recruited to the gland as a 
normal process of involution (Nickerson, 1989, Inchaisri et al., 2000, Wedlock et al., 2004).  
Todhunter et al. (1990) found SCC rise in uninfected quarters to 7.2 cells log10/ml within a week 
following dry-off, and Inchaisri et al. (2000) found a similar increase in SCC during early stages 
of involution >6.5 cells log10/ml in healthy quarters and maintaining approximately 6.41 cells 
log10/ml in steady-state. The initial value for phagocytes in an uninfected, healthy gland in the 
dry period deviates drastically from that in a lactating animal and was assessed in the in model 
by allowing the initial value of PMN and macrophage to reach 5.40-6.19 cells log10/ml and 5.93-
6.71 cells log10/ml, respectively. To maintain simplicity of the model macrophages (M) and 
PMN (P) were combined into one compartment representing phagocytes for as the original 
model stands the macrophage population is constant and relative small at 5,000 cells/ml).  
2.2.3.  Phagocytic killing (k) of extracellular bacteria (E) 
The capacity of macrophages and PMN to phagocytose and kill bacteria can be 
modulated by factors including cytokines, complement, antibodies, hormones, lipids, etc. and 
thus, are likely to be influenced by changes to the mammary gland secretion composition 
reported in the dry period (Mullan et al., 1985, Subandrio et al., 2000, Denis et al., 2006, Levin 
et al., 2016). Due to lack of bovine data on macrophage and PMN killing rate of E. coli, the 
killing rate was originally estimated from in vitro data from mouse models; this value is likely to 
differ in the dry period. We estimated the ability for mammary gland phagocytes to phagocytose 
and kill E. coli was reduced in the dry period based on multiple in vitro studies which show the 
reduced capacity for PMN and macrophages isolated from mammary gland secretions to kill 
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various mastitis-causing bacteria (Mullan et al., 1985, Bassalik-Chabielska et al., 1988, Fox et 
al., 1988). Fox et al. (1988) reported as cows progressed into the dry period, phagocytes isolated 
from mammary gland secretions had reduced phagocytosis and killing of E. coli. Tjoelker et al. 
(1990) reported approximately an 8-10% decrease in phagocytosis of S. aureus at 2 weeks since 
dry-off. Paape et al. (1992) also report diminished phagocyte function with advancing stage of 
the dry period, with approximately 20% reduction in phagocytosis of S. aureus from 1-2 weeks 
prior to drying off to 15 to 22 days dry. Based on the literature described here, we estimated an 
8-20% reduction in killing rate (k) by phagocytes in the dry period. 
2.2.4.  Cytokine growth rates (gcp, gca)  
The original mathematical model made the following assumptions about cytokines and 
the immune response to IMI: production of pro-inflammatory cytokines is inhibited by the 
presence of anti-inflammatory cytokines, anti-inflammatory cytokines are rate dependent on the 
concentration of pro-inflammatory cytokines, and all pro-inflammatory cytokines or all anti-
inflammatory cytokines share identical profiles and function (White et al., 2010). The original 
model also assumed macrophages present in the milk remain at a constant concentration, 
whereas the concentration of PMN increases at a rate dependent on the concentration of pro-
inflammatory cytokines present in the milk (White et al., 2010). The model relied on in vivo 
experimental infection data from Bannerman et al. (2004) and (2008) as references. 
Experimental E. coli IMI in the dry period with a persistent-mastitis-causing strain from 
Quesnell et al. (2012) and Pomeroy et al. (2016a)  was used as a reference for the modified 
model for IMI in the dry period. Both Quesnell et al. (2012) and Pomeroy et al. (2016a) show 
that there are no detectable increases in pro-inflammatory cytokines in the dry period following 
E. coli challenge, but anti-inflammatory cytokine IL-10 is increased post-challenge. Pomeroy et 
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al. (2015) and (2016b) observed altered cytokine production by bovine monocyte-derived 
dendritic cells (moDC) in response to in vitro stimulation with E. coli ECC-Z in the dry period. 
Specifically, moDC generated from blood monocytes from dry cows had enhanced IL-10 
production compared to early stages of lactation; depending on the stage of lactation or dry 
period compared, there is a 1-2.6 fold-increase in IL-10 production over a 24hr period. This 
range of fold increase was used in conjunction with the original models predicted value for anti-
inflammatory cytokine production rate to investigate the impact of this parameter and estimate 
its value in dry period IMI dynamics. Changes to pro-inflammatory cytokines involved in cases 
of clinical mastitis were more difficult to estimate as not all pro-inflammatory cytokines were 
regulated in similar ways in the bovine moDC model in late pregnancy. For example, IL-12, a 
key Th1 cytokine, appeared to be downregulated in late gestation, with moDC from the first half 
of a 60 day dry period at approximately only 30% of production observed in moDC from early 
lactation (Pomeroy et al., 2015). Unlike IL-12, TNFα production was not found to be 
significantly different in moDC from the dry period compared to early lactation, and IL-1β had 
enhanced production in moDC from the dry period relative to early lactation (Pomeroy et al., 
2016b). The ~30% reduction in the production of Th1-cytokine, IL-12 observed in moDC from 
dry cows was used as the maximum level of reduction in pro-inflammatory cytokine production 
from lactating values in model interrogation (Pomeroy et al., 2015). The upper estimate was the 
original value estimated from the original model of lactating cows. 
2.2.5. Parameter estimation 
The model predictions for the extracellular E. coli counts generated using the differential 
equations from White et al. (2010) were fitted to the data. The parameters were estimated within 
Berkeley-Madonna, by maximizing likelihood assuming a normal distribution of error. The 
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initial values for the parameter estimation are given in Table 9. Parameters values which were 
estimated by the model included rate of phagocytic killing (k), growth rate of E. coli in 
mammary gland secretion (ge), rate of pro- and anti-inflammatory cytokine production (gcp, gca), 
initial number of phagocytes present in the gland (int(P)), and influx rate of PMN to the gland 
(gp). Although the influx rate of PMN to the gland (gp) was not considered in sensitivity analysis, 
and rate of influx in non-lactating glands in the late dry period and lactating glands is unknown, 
this parameter value was shown to be cow-specific in the original model and thus left to be 
estimated with curve fitting (White et al., 2010). 
3. Results 
3.1. Influence of individual parameter values on model output 
To understand how the uncertainty in the output of the original stochastic mathematical 
model can be apportioned to different sources of uncertainty in inputs known to deviate in the 
dry period we first changed one-factor-at-a-time. We found no major differences in dynamics 
e.g. time to clearance or persistence for transient or chronic-mastitis-causing E. coli when twice 
daily milk removal by milking was excluded from the model, respectively therefore, milking was 
excluded for subsequent deviations of the model. The discretized stochastic model was run 1000 
times, and mean ±SD were calculated and are depicted in Figures 18-21 for one-factor-at-a-time 
sensitivity analysis.  
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Figure 18. One-factor-at-a-time sensitivity analysis: varying growth rate of extracellular E. 
coli (ge). Model outputs for extracellular E. coli (A), and intracellular E. coli reservoirs (B) for 
both persistent and transient E. coli strains when ge parameter value is varied while other 
parameter values are fixed. Solid lines represent model output mean of 1000 actualizations of the 
model; dotted lines represent +/- standard deviation. Time in days is shown on x-axis. 
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The value of maximum E. coli bacteria numbers and the time at which this peak occurs is 
sensitive to the growth rate of extracellular bacteria (ge) for both transient and chronic E. coli 
strains (Fig. 18). As the growth rate of extracellular E. coli (ge) is reduced to estimated rates of E. 
coli growth in dry cow secretion (ge= 13.4, ge=25.6) the peak in extracellular bacteria and 
intracellular bacteria declines and the time at which maximum counts occurs is delayed. Decline 
in extracellular E. coli coincides with a decline in SCC, pro- and anti-inflammatory cytokine 
production (not shown). Changes to growth rate yields similar changes for both transient and 
chronic-mastitis causing E. coli strains. However, even at the lowest growth rate (ge=13.4) we do 
not see bacterial numbers as low as observed in vivo. This parameter influences the model output 
but reduced ge alone cannot explain differences in dynamics between lactating and dry period 
according to our mathematical model.  
 Figure 19. One-factor-at-a-time sensitivity analysis: varying rate of killing of extracellular 
E. coli by phagocytes (k).Model outputs for extracellular E. coli (A), and intracellular E. coli 
reservoirs (B) for both persistent and transient E. coli strains when k parameter value is varied 
while other parameter values are fixed. Solid lines represent model output mean of 1000 
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actualizations of the model; dotted lines represent +/- standard deviation. Time in days is shown 
on x-axis. 
 
The value of maximum E. coli bacteria numbers and the time at which this peak occurs is 
not highly sensitive to the killing rate of extracellular bacteria by phagocytes (k) for both 
transient and chronic E. coli strains (Fig. 19). There was only a minute increase in E. coli 
bacteria numbers with reduced killing rates, but time to peak bacterial counts was not effected 
nor was overall shape of model output. Sole changes to this parameter minimally influences the 
model output but may be involved in IMI dynamics in the dry period as an interaction with other 
dry period-altered model inputs.  
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Figure 20. One-factor-at-a-time sensitivity analysis: varying rate of pro- and anti-
inflammatory cytokine production by phagocytes (gcp, gca). Model outputs for extracellular E. 
coli (A), intracellular E. coli reservoirs (B), PMN numbers (C), and pro- and anti- inflammatory 
cytokine production (D) for both persistent and transient E. coli strains when gcp and gca 
parameter values are varied while other parameter values are fixed. Solid lines represent model 
output mean of 1000 actualizations of the model; dotted lines represent +/- standard deviation. 
Time in days is shown on x-axis. 
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 The value of maximum E. coli bacteria numbers is sensitive to the growth rate of pro- and 
anti-inflammatory cytokine production (gcp, gca) in model outputs for both transient and chronic 
E. coli strains (Fig. 20). As the rate of anti-inflammatory cytokine production is increased to 
estimated rates in late gestation cows the peak extracellular bacteria and intracellular bacteria 
numbers increases, however, the time at which maximum counts occurs was not affected. 
Increases to rate of pro-inflammatory cytokine production also increased E. coli bacteria 
numbers, and when both input values for pro- and anti-inflammatory cytokines were altered to 
late gestation-estimated levels the effect on E. coli bacteria numbers was additive. The impact of 
cytokine production rate values on other outputs is minimal, and only related to changes in anti-
inflammatory cytokine production (Fig. 20). These model inputs influence the model output but 
cannot recapitulate the cytokine profiles in the dry period or bacterial counts 
Figure 21. One-factor-at-a-time sensitivity analysis: varying initial number of phagocytes 
in the gland (int(P)). Model outputs for extracellular E. coli (A), intracellular E. coli reservoirs 
(B), and PMN numbers (C) for both persistent and transient E. coli strains when int(P) value is 
varied while other parameter values are fixed. Solid lines represent model output mean of 1000 
actualizations of the model; dotted lines represent +/- standard deviation. Time in days is shown 
on x-axis. 
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The peak E. coli bacteria numbers, persistency of bacteria in the gland, and overall shape 
of extracellular and intracellular E. coli bacteria count outputs were highly sensitive to the initial 
number of phagocytes in the mammary gland. Of the model inputs tested in the one-factor-at-a-
time sensitivity analysis using estimated dry period values, initial number of phagocytes in the 
gland showed the greatest source of uncertainty. As the initial number of phagocytes in the gland 
was increased in the model input, there was a dramatic decrease in peak extracellular E. coli 
bacteria numbers, and a delay in time for extracellular E. coli bacteria numbers to reach peak 
values. There exists a threshold between 6.00 CFU log10/ml and 6.39 CFU log10/ml initial number 
of phagocytes at which above this threshold the intracellular E. coli bacteria numbers do not 
decline nor reach 0; this is observed even in transient strains which have minimal capacity to 
invade and survive in MEC according to the original model. There also exists a threshold 
between 6.39 CFU log10/ml and 6.54 CFU log10/ml initial number of phagocytes at which 
extracellular bacteria no longer experience an initial rise and peak within the first few days of the 
infection, but rather decline. 
3.2. Curve fitting to in vivo data of experimental E. coli IMI in the dry period 
In vivo data on bacteria counts at quarter level following experimental E. coli IMI from 
Pomeroy et al. (2016a) (n=3) were used to estimate input parameter values hypothesized to 
deviate in the dry period. The model reproduced the data with the estimated parameter in Table 
9. Values for parameters for phagocytic killing rate (k), extracellular E. coli growth rate (ge), pro- 
and anti-inflammatory cytokine production (gcp, gca) following curve fitting to in vivo data of 
extracellular E. coli counts in mammary gland secretion were estimated (Table 9).  
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Figure 22. Curve fitting to in vivo data. Model predictions for extracellular E. coli (A), 
intracellular E. coli reservoirs (B), PMN numbers (C), and cytokine production (D) for persistent 
E. coli strain intramammary infection using data from in vivo experimental infection from 
Pomeroy et al. 2016 on extracellular E. coli (A). Raw data is indicated in (A) as solid dots; 
excluding raw data shown in (A), the remaining curves in (A-D) represent a single realization of 
the stochastic model. Pro-inflammatory cytokine production is represented by solid line, and 
anti-inflammatory cytokine production is represented by dashed line. Time in days is shown on 
x-axis. 
 
 The original model predicted lactating cows had peaks in pro-inflammatory cytokine 
levels between 13 to 22 h after infection. When model is fit to data from experimental infection 
in the dry period the peak in pro-inflammatory cytokine levels occurs later ranging from 26 to 
50h after infection, varying by cow (Fig. 22). The peak in anti-inflammatory cytokine levels was 
predicted to occur approximately 1 to 2h following the peak in pro-inflammatory cytokines 
which is a more rapid onset than with model predictions in lactating cows. Though peaks in 
cytokine production were predicted by the model, the peak levels for both pro- and anti-
  
140 
 
inflammatory cytokine production (units/mL) were reduced by approximately 2 logs compared 
to model predictions for lactating cows in (White et al., 2010). The rate of production of pro-
inflammatory cytokine production was estimated to be reduced by approximately 30% 
comparable to reduced production of IL-12 from in vitro cultured bovine moDC following UV-
killed E. coli ECC-Z stimulation from dry period compared to those from lactation (Table 9) 
(Pomeroy et al., 2015). The anti-inflammatory production rate was estimated to be increased but 
only by approximately 6 to 27% compared to the value predicted for lactating animals which is 
within range from values found from in vitro cultured bovine moDC following UV-killed E. coli 
ECC-Z stimulation from dry period compared to those from lactation (Table 9) (White et al., 
2010, Pomeroy et al., 2016b) 
The model is able to predict a small peak in extracellular E. coli with a peak in 
intracellular bacteria following peak in extracellular E. coli population, and the intracellular 
reservoir persists at levels between 1.5 to 3.5E+06 CFU while extracellular bacteria remain at 
below approximately 200 CFU following peak counts (Fig. 22). The curve fitting estimated 
growth rate to be reduced and this was consistent between model predictions based on different 
cow data. The model is unable to show complete elimination of extracellular bacteria as seen in 
in vivo IMI data. Changes to the E. coli behavior under non-lactating mammary gland conditions 
may occur and impact the rate of invasion of MEC, rate of exiting intracellular reservoir to 
extracellular compartment, and/or death rate of intracellular E. coli; we were unable to model 
here due to lack of existing data (Kalita et al., 2014).   
The model predicted higher numbers of phagocytes initially present in the non-lactating 
gland prior to infection (Table 9). The rate of killing of extracellular E. coli by phagocytes 
estimated from in vivo dry period E. coli IMI was reduced by 13.1-18.5% from the rate estimated 
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for lactating cows (White et al., 2010) (Table 9). Recruitment of PMN to the gland (gp) varied 
more by individual cow and were within range of those from lactating cows, but were 
comparatively high to majority of values estimated for lactating cows; despite higher estimates 
for rate of PMN infux to the gland, the peak number of phagocytes in the gland was only 
between 0.1 to 0.4 log10 cells/mL increase from the initial number present in the gland. 
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4. Discussion 
The dry period is a time of increased susceptibility to new IMI, of which, coliforms 
bacteria have been shown to be a common cause of these IMI (Green et al., 2002). E. coli IMI do 
not elicit severe clinical mastitis in the dry period, but rather IMI acquired in the dry period 
persist until calving, and often cause clinical mastitis in early lactation (Quesnell et al., 2012, 
Gurjar et al., 2013, Pomeroy et al., 2016a). The bovine mammary gland experiences drastic 
changes during involution and steady-state of the dry period. The dry period also overlaps with 
immunological changes occurring in late gestation apart of healthy pregnancy. These major 
physiological and immunological changes to the gland are likely to impact E. coli IMI dynamics, 
however the specific factors responsible for allowing infection to establish and persistent into the 
subsequent lactation are unknown. The objective of this work was to interrogate the 
mathematical model for lactating cows developed by White et al. (2010) to elucidate the role of 
factors known to change in the dry period in IMI dynamics. 
The model suggests lower growth rate of extracellular bacteria does reduce total bacterial 
counts in the mammary as expected and consequently reduces the cytokine response and 
recruitment to the gland, but change to this variable alone was not sufficient to recapitulate the 
IMI dynamics observed in vivo. Reduced growth rates, even those less than half the rate from the 
original model for lactating cows, still have a dramatic, rapid rise in SCC, pro- and anti-
inflammatory cytokines, and extracellular E. coli CFU/ml ranges between 5-6 CFU log10/ml 
which is 1-3 CFU log10/ml higher than previously document in in vivo experimental challenge 
models (Quesnell et al., 2012, Pomeroy et al., 2016a).  
During involution, phagocytes are recruited to the mammary gland, and the number of 
phagocytes remains high in the steady-state of the dry period (Nickerson, 1989, Inchaisri et al., 
  
144 
 
2000, Wedlock et al., 2004). Increasing the initial number of phagocytes in the gland prior to E. 
coli challenge had a drastic effect on the model output and IMI dynamics. Increasing the number 
of phagocytes resulted in reduced numbers of E. coli bacteria, with extracellular bacteria 
numbers reaching 0 during the course of infection, but in conjunction this also often resulted in 
enhanced bacterial persistency in the gland through the formation of intracellular reservoirs, and 
reduced inflammatory response. Pathogen load is known to influence the severity of clinical 
signs of mastitis (Burvenich et al., 2003). Burvenich et al. (2003) found that the concentration of 
environmental E. coli in the mammary gland was the primary determinant in the severity of the 
clinical signs in early lactation cows. This immediate reduction in extracellular E. coli numbers 
by increased phagocytes likely played a role in reducing immune response though reduction in 
antigen load. Previous experimental work in lactating cows demonstrated increased clinical 
mastitis severity with deficiencies in both neutrophil function and concentrations, further 
suggesting our model is biologically relevant. Furthermore, in this model, the influx rate of PMN 
to the gland (gp) was allowed to vary by cow in data fitting, according to the model influx rate 
was relatively high compared to many of the lactating animal values from White et al. (2010) 
(Table 9). The role of phagocyte composition, number, and rate of influx to the mammary gland 
in dry, late gestation cows needs further investigation in vivo to support model findings. 
When fit to in vivo data from an experimental IMI with chronic-mastitis-causing E. coli 
ECC-Z, the model estimated increased initial numbers of phagocytes which reflected 
biologically relevant values documented in the literature, however, if other immune parameters 
were fixed at lactating values (k, Ca, Cp) the peak E. coli numbers were underestimated. The 
model fit was improved with these other immune parameters were estimated concurrently, and 
the model predictions showed reduced in inflammatory responses and killing capacity in 
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conjunction with increased initial phagocyte numbers and reduced bacterial growth. This 
suggests there is an interaction between changes specific to dry period and changes associated 
with maternal immune regulation in late gestation (Todhunter et al., 1990, Collier et al., 2012, 
Pomeroy et al., 2015, Pomeroy et al., 2016b). Though peaks in both pro- and anti-inflammatory 
cytokines were predicted by the model for dry cows, it is possible that with approximately 2 log 
reduction in units, these peaks may have been missed due to low sensitivity of protein 
measurements by ELISA in in vivo E. coli experimental IMI in the dry period observed by 
Quesnell et al. (2012). Furthermore, this drastic reduction in peak production of pro-
inflammatory cytokines is hypothesized to directly relate to lack of clinical signs following IMI 
in the dry period. 
Another intriguing finding was the ability of transient strains to persist when initial 
numbers of phagocytes in the gland were high despite minimal capacity to invade and survive in 
MEC. This poses a question on the involvement in cell-mediated responses in persistent E. coli 
IMI. White et al. (2010) found the model output for E. coli bacteria numbers and persistency was 
highly sensitive to survival of bacteria in the intracellular compartment, but there was no input in 
the model for Th1-type, cell-mediated responses such as killing of infected MEC by the NK cells 
and antigen-specific cytotoxic T-cells. These Th1-type responses and formation of antigen-
specific responses are hypothesized to be hindered in bovine late gestation, and it is likely the 
reduced ability of host immune cells to generate Th1-type responses and kill infected MEC 
contributes to IMI persistency in late gestation. In mammalian pregnancy, the maternal immune 
system is regulated to protect the semi-allogenic fetus. Furthermore, the current mathematical 
model has an oversimplified equation is used to describe all pro-inflammatory cytokines despite 
the known, unique roles of individual cytokines in immune response. We lack in vitro and in vivo 
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data to properly model cell-mediated immune response, and future work should investigate cell-
mediated responses in the mammary gland during the dry period and lactation. 
Intramammary infection dynamics are complex and involve multiple factors which our 
model is not able to describe such as cell-mediated responses/killing of infected MEC, antigen 
specific responses, role of individual cytokines/chemokines in response, functional differences 
amongst phagocytes i.e. neutrophils vs. macrophages. Further the available data for parameter 
estimation only relates to chronic-mastitis-causing strains. It may also be possible that E. coli 
strains may respond to the limited nutrients and other soluble factors in the non-lactating gland 
environment which cause changes to invasion of MEC, rate of exiting these intracellular 
compartments, and/or survival within MEC (Blomfield, 2001, Kalita et al., 2014). The 
modifications to the original model developed by White et al. (2010) presented here suggest dry 
period IMI dynamics and persistency relate to interactions between maternal immune regulation 
in late gestation and changes to the mammary gland during involution and steady-state of the dry 
period. Future experimental work should enhance our understanding of the relationship between 
maternal immune regulation mechanisms in late gestation and immune response in the mammary 
gland. Future work should also investigate changes to mammary tissue-resident immune cell 
populations and cell-mediated responses in IMI in the dry period with E. coli strains varying in 
ability to form intracellular reservoirs.  
5. Conclusions 
The key findings from this study indicate that E. coli IMI infection dynamics relate to 
both factors associated with involution and steady-state period in the non-lactating mammary 
gland and changes to immune function in late gestation. Specifically, reduced E. coli growth rate 
in non-lactating mammary gland secretion, phagocytic function, and pro-inflammatory cytokine 
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production, increased anti-inflammatory cytokine production and number of phagocytes in the 
gland all influence the IMI dynamics in the dry period according to the model predictions. This 
study has limited in vivo data to confirm these model predictions and can only be used to guide 
future in vivo and in vitro work pertaining to IMI dynamics in the dry period. Future in vivo work 
should investigate the role of late gestation factors vs. factors related to changes to the mammary 
gland during involution and steady state dry period and other hypotheses generated from this 
model interrogation. More data should also be collected for to improve precision of parameter 
value estimation to improve the accuracy of the model and biological relevance. 
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ABSTRACT 
The objective of this study was to evaluate the efficacy of intramammary immunization 
with UV-killed E. coli ECC-Z on prevention of intramammary colonization after a challenge 
with a dose of the homologous E. coli ECC-Z live bacteria. 
A total of 10 cows were included in a study to evaluate the efficacy of intramammary 
immunization.  All 10 cows received then an intramammary immunization of 100 CFU of UV-
killed E. coli ECC-Z bacteria into one hind quarter at the time of dry off.  Approximately 2 weeks 
before the anticipated calving date both hind quarters of all cows were challenged with 100 CFU 
of live E. coli ECC-Z bacteria. Five of the cows were vaccinated parenterally with a commercial 
J5 bacterin, and 5 cows served as no parenteral vaccination controls. The cows were then 
followed over time and infection risk, clinical scores, somatic cell count and milk production 
were observed over time. 
The results of these 10 cows showed partial protection of intramammary immunization 
on the outcome of a subsequent homologous intramammary challenge. Immunization resulted in 
a lower probability of infection, a lower bacteria count, lower somatic cell counts and milk 
conductivity, a lower clinical mastitis score and increased milk production compared to 
unimmunized control quarters. Once the analysis was corrected for immunization, parenteral J5 
vaccination had no significant impact on any of the measured parameters. These results provide 
the first evidence that intramammary immunization may improve the outcome of an 
intramammary E. coli infection in late gestation and onset of mastitis immediately following 
parturition. Unlike systemic vaccination, which generally does not reduce the intramammary 
infection risk, the intramammary immunization did show a five-times reduced odds of an 
established intramammary infection after challenge. Cytokine profiles indicated a local return of 
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pro-inflammatory response after challenge as the data showed a more pronounced increase in in 
IFN-γ with a subsequent negative feedback due to a spike in the level of IL-10 in immunized 
quarters relative to non-immunized quarters. 
Although these results are preliminary and obtained on only 10 cows, the results provide 
insight into the biological benefits of triggering mucosal immunity in the mammary gland.  
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1. Introduction 
 Clinical mastitis is one of the most common, and costly challenges to the dairy industry 
(Grohn et al, 2004). Approximately 40% of clinical mastitis cases are attributed to gram-
negative, mostly coliform, bacterial infection (Barkema et al. 1998, Grohn et al. 2004, Oliveira 
et al. 2013). Bovine coliform mastitis is generally considered to be caused by opportunistic 
infections (Bradley and Green, 2001),  although evidence for a host-adapted sub-population is 
growing (Bradley and Green, 2001, Dogan et al. 2006, Shpigel et al. 2008, Lippolis et al. 2014). 
The incidence of clinical mastitis peaks on most farms immediately following parturition 
(Barkema et al., 1998), although several observational and experimental challenge studies 
indicate the presence of the mastitis-causing bacteria isolated from the dry gland before 
parturition without clear inflammatory indicators of mastitis (Green et al., 2007, Quesnell et al. 
2012). The late gestation challenge study using E. coli ECC-Z by Quesnell and co-workers 
(2012) showed that cows in late gestation respond to challenge with an IL-10 dominated 
response and a minimal response of pro-inflammatory cytokines such as IFN-γ and IL-1β. This 
suggested shift towards a predominantly anti-inflammatory, highly regulated response during 
the dry period likely reflects an adaptation in maternal immune signaling during late gestation to 
protect the semi-allogenic fetus (Quesnell et al. 2012, Pomeroy et al. 2015).  
 Dairy cows may be vaccinated parentally against coliform mastitis using a core J5 
bacterin that has been repeatedly reported to/ reduce clinical severity of response to these 
infections (Hogan et al. 1992; Hogan et al. 1995; Wilson 2008). However, the data of these 
vaccination studies have not shown a reduction in incidence of clinical coliform cases. Local 
immune responses are important for protection against pathogens which predominately infect 
and cause disease at mucosal sites. Mucosal vaccines have shown to be effective both in the 
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case of viral (i.e. oral polio vaccine, intranasal infectious bovine rhinotracheitis (IBR) vaccine, 
oral rabies vaccine) and bacterial (i.e. oral cholera vaccine, oral E. coli vaccine, S. aureus imm 
vaccine) pathogens (Pavot et al. 2012, Vilte et al. 2012, Gogoi-Tiwari et al. 2015). Hogan et al. 
(1997) and Smith et al. (1999) studied the effect of a systemic vaccination in combination with 
an intramammary E. coli J5 bacterin immunization schedule on responses of antibody titers.  
The results showed that intramammary immunization enhanced IgG titers in serum in the dry 
period and in lactation and in whey in early lactation compared to subcutaneous immunizations 
(Hogan et al. 1997, Smith et al. 1999).  However, the immunization schedule had minimal 
effect on systemic and local signs of clinical mastitis following challenge. The authors 
concluded that the reason for this lack of protection was due to the 4 hour boiling of the bacteria 
in the creation of the bacterin-vaccine (Smith et al. 1999).   
More recent studies have used so called ‘ghost’ bacteria as vaccine organisms. These 
‘ghost’ organisms are killed bacteria where the internal structures of the bacteria are destroyed 
but the bacterin have the same cell surface composition as their living counterparts (Mayr et al. 
2005). Such ghost organisms display all surface components in a natural non-denatured form, 
even highly sensitive and fragile structures like pili are well protected. It has been shown that 
ghost organisms are able to induce a strong mucosal immune response (Jalava et al. 2003). The 
potency, safety and relatively low production cost of bacterial ghosts also offer a significant 
technical advantage (Mayr et al. 2005, Yuli and Kiyono 2003, Lubitz et al. 2009).  
 Therefore, the objective of this study was to evaluate the efficacy of intramammary 
immunization with UV-killed E. coli ECC-Z on prevention of intramammary colonization after a 
challenge with a dose of the homologous E. coli ECC-Z bacterium prepartum, a period of 
heightened susceptibility to intramammary infection. The E. coli ECC-Z strain used for this 
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study has been used in previous challenge trials in both the dry period and lactation, is well-
characterized, and known to cause mild, clinical mastitis (Dogan et al. 2006, Quesnell et al. 
2012, Sipka et al. 2013, Lippolis et al. 2014).  The impact of immunization on clinical signs, 
milk production, somatic cell counts and cytokine profiles was also evaluated. 
2. Materials and methods 
2.1. Cows 
Ten adult Holstein cows were selected from the Cornell University Teaching and 
Research Dairy herd (T&R). Selection was based on the following criteria: cows had 
completed at least 1 previous lactation, and they were expected to have an approximate 45-48 
days dry period. Also, cows with any signs of detectable illness including but not limited to 
clinical mastitis at time of dry-off or with any of the last six monthly individual cow’s SCC 
before dry-off greater than 250,000 cells/mL were excluded. Cows were culture negative at 
time of enrollment, and culture negative prior to challenge with E. coli ECC-Z as determined 
by bacteriology described within the section, ‘Mammary gland secretion and blood sample 
collection’. Finally, cows with any major traumatic injury to the teat ends were excluded. 
2.2. Housing 
Cows in both groups were housed, fed, and managed identically throughout the dry 
period and postpartum. Three weeks prior to the anticipated calving date, cows were 
transferred from free stalls to the Cornell University Large Animal Research and Training 
Unit (LARTU) facility. Here the cows were housed in individual maternity pens and had 
unlimited access to water and feed. Cows remained in the study throughout the non-lactating 
period, calving and first 7 days of the ensuing lactation. No adverse reactions to the vaccine 
prior to the intramammary E. coli challenge were observed in any of the cows. The study 
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protocol was approved by the Cornell University committee on Animal Use and Care 
(IACUC protocol 2006-0158). 
2.3. Parenteral vaccination and intramammary immunization 
The selected cows were paired by expected calving date so they were approximately the 
same and then were randomized to receive parenteral J5 vaccine or serve as control.  The J5 
vaccine (Escherichia coli Bacterin, J5 strain; Zoetis, Kalamazoo, MI) was administered by the 
investigators (5mL) subcutaneously on the upper part of the rib cage just posterior to the scapula. 
The cows in the control group were unvaccinated controls. Vaccinated cows were immunized 15 
days prior to dry-off followed by a second dose at dry-off and a third dose 15 days post dry-off. 
Cows in both the groups were dried off by abrupt cessation of milking and all four quarters were 
left untreated with also no internal teat sealant.  
In addition to the systemic vaccination, all cows received an intramammary 
immunization of the equivalent approximately 100 CFU of UV irradiated E. coli ECC-Z at the 
time of dry-off in one of the two hind quarters. The production of the UV-killed E. coli is 
described here in brief. The E. coli ECC-Z bacterial strain was grown in Luria Bertani (LB) broth 
until a concentration of approximately 10E6 bacteria per mL of broth was obtained. 
Approximately 1 liter of broth was then irradiated. The UV irradiation device is composed of a 
stainless steel outer unit containing three inner chambers of quartz tubes connected in sequence. 
The bacterial broth was pumped through a thin layer between the outer steel unit and inner quartz 
tubes. Eight germicidal low pressure mercury lamps were used as the source of UV light 
exposure. Every 50 milliseconds, two UVX-25 UV light sensors monitored the desirable amount 
of UV energy required for consistent radiation. The resulting UV radiated bacterial solution was 
checked for bacterial growth. No live bacteria were recovered. The sterility of the UV irradiated 
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broth was checked before each intramammary application. Throughout this manuscript, the 
intramammary application of these ghost bacteria will be referred to as immunization rather than 
vaccination.  
2.4. Intramammary bacterial challenge 
Escherichia coli strain ECC-Z (Dogan et al. 2006), a strain originally isolated from a cow 
with mild persistent clinical mastitis (Lippolis et al. 2014), was used as the intramammary 
challenge strain. The challenge inoculum was prepared by inoculating a frozen stock culture of 
the ECC-Z strain into LB broth. The LB broth was incubated for 18h at 37°C. A total of 100µL 
of this culture was inoculated into fresh LB broth and incubated for approximately 2.5h at 37°C. 
The log phase LB broth culture was used for inoculation. A 1:10 dilution of the log phase culture 
was made in phosphate buffer saline (PBS) and adjusted to 100 colony forming units (CFU) of 
inoculation dose. The CFU per mL of the challenge bacteria was determined by plating 100µL in 
duplicate on LB agar plates. Two hind quarters of each control or parenterally vaccinated cow 
was challenged by infusion of approximately 100 CFU of E.coli ECC-Z strain suspended in PBS. 
The cows were challenged approximately 10 days before the expected calving date, a third 
quarter received a similar infusion of vehicle (PBS) only, while the fourth quarter remained 
unchallenged.  
2.5. Mammary gland secretion and blood sample collection  
Milk or dry cow secretion samples were collected at the time of vaccinations, at the time 
of intramammary immunization and daily thereafter for seven days, from one week before to the 
day of challenge on a daily basis, at the time of challenge and every 12 hours thereafter until 72h 
after challenge, and from the day of calving until 7d thereafter at every milking (12h apart). 
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Previous work demonstrates that frequency of sampling in the dry period, when using aseptic 
technique as done here, is not associated with clinical mastitis (Green et al. 2002). 
Milk, dry cow secretions (hereafter referred as dry cow mammary gland secretions, DCS) were 
aseptically collected in sterile vials for microbiological culture and cytokine analysis.  All four 
quarters were sampled individually. For cytokine analyses, milk samples were centrifuged at 
20,000×g and 4°C for 30 min. The fat layer was removed and milk whey was collected and 
stored in aliquots at −20°C until ELISA analyses. For microbiological culture, samples were 
transported immediately on ice to the microbiology laboratory for culture according to the 
protocols recommended by the National Mastitis Council and described in detail by Hogan et al. 
1992). Briefly, 100µL of milk or DCS were plated on Columbia Sheep Blood agar (Oxoid) and 
MacConkey’s agar plate. Plates were incubated for 24 – 48h at 37°C and were examined daily 
for bacterial growth. As previously described in Gurjar et al. 2013, representative individual 
colonies were isolated and stored at −70°C for molecular strain typing by random amplification 
of polymorphic DNA (RAPD) analysis to identify challenge strain E. coli ECC-Z. In brief, 
individual isolates from bacterial culture plates were grown in LB broth at 37°C for 12 h. The 
DNA was isolated from samples using a QIAquick DNeasy isolation kit (Qiagen Inc., Valencia, 
CA). The RAPD primers designed specifically for RAPD typing of gram-negative bacteria were 
as follows: forward 5′-AGTAAGTGACTGGGGTGAGCG-3′ and reverse 5′-
TACATTCGAGGACCCCTAAGTG-3′. These primers have previously been shown to provide 
discernment between mastitis E. coli bacterial strains (Dogan et al., 2006). The PCR products 
were evaluated using gel electrophoresis in a 1.5% agarose gel at 60 V for 1.5 h. Bacteria counts 
were obtained through three serial 10-fold dilutions. Where necessary additional dilutions were 
performed for peak CFU counts which occurred roughly around C+18h. The results of the 
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bacteriological analysis were expressed as log10 CFU per mL of milk. An aliquot of each milk 
sample was sent to Dairy One® (Ithaca, NY) for SCC determination using a fossomatic cell 
count analyzer. Data were counted as SCC per mL of milk and expressed as a linear score. In the 
post calving period, the animals were milked with a quartermilker and four Lactocorders®, each 
connected to a single quarter. This enabled determining the milk production and conductivity 
from individual quarters with the aid of the Lactocorder® device.  
2.6. Clinical observation for local and system signs 
Systemic and local symptoms of inflammation were assessed throughout the trial period 
as described earlier by Petzl et al. (2012). All time periods indicated above for collection of 
blood and milk or DCS samples were also used for recording clinical signs. Rectal temperature, 
appetite and general attitude were evaluated. The systemic signs were scored on a three point 
scale, 1 = no signs to 3 = severe systemic signs. The udder was palpated for soreness, swelling, 
and hardness. The udder was scored on a 1 to 4 scale with 1 being normal and 4 being the gland 
swollen, warm, sore, firm, and with a red discoloration. The milk appearance, consistency and 
color were scored daily in the post calving period at every 12 hour interval. The milk appearance 
was scored on a 4 point scale with 1 being normal white homogenous milk and 4 being dark 
yellowish milk with clots as observed on the Lactocorder® filter. The three scores, cow, udder 
and milk score, where then added to an overall clinical score. Cows with overall clinical score of 
3 or less were recorded as having no clinical mastitis, those with scores between 4 and 7 as 
having mild to moderate mastitis and those with scores of > 8 as having severe mastitis. 
2.7. Cytokine analysis 
Ninety-six well sample plates (Thermo-Fisher, Pittsburg, PA) were coated with a primary 
capture antibody for IFN-γ  (1µg/mL, CLONE, Serotec, Inc., Raleigh, NC), IL-10 (5µg/mL, 
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CLONE, Serotec, Inc., Raleigh, NC) in a 0.05M carbonate coating buffer, pH 9.6. Plates were 
allowed to incubate overnight at 4°C. All plates, washes, and blocking reagents were allowed to 
equilibrate to room temperature. Plates were washed 3 times with wash buffer (50mM tris-
buffered saline (TBS) w/ 0.05% tween-20, pH 8.0) and blocked with 1:10 Seablock:TBS (Pierce, 
Rockford, IL) for one hour. Subsequently, plates were washed again 3 times with wash buffer. 
Recombinant proteins for cytokine IFN-γ were diluted to appropriate concentrations and 
included as a standard curve for each assay. Due to unavailability of recombinant bovine IL-10 at 
the time this study was conducted, we could not run standards for IL-10 with this assay; IL-10 
was therefore expressed as measured optical density (OD) values. For each assay 100μl of 
standards and samples were incubated at room temperature for at 2 hours. Plates were washed 3 
times with wash buffer. Biotin-labeled secondary antibodies: IFN-γ (5µg/mL, CLONE Serotec, 
Inc., Raleigh, NC), IL-10 (5µg/mL, CLONE, Serotec, Inc., Raleigh, NC) diluted in blocking 
buffer were added to the wells (100μL/well). Plates were incubated for 1 hour at room 
temperature in the dark. Plates were washed 3 times in wash buffer, and following washing steps 
streptavidin:HRP complex diluted 1:1000 in blocking buffer was added to wells (100μL/well), 
and incubated in the dark for 1 hour at room temperature. Plates were washed 3 times in wash 
buffer and 100μl/well TMB was added to each well. Plates were incubated for 10 – 25 minutes at 
room temperature in the dark and 100μL/well of 2M H2SO4 was added to wells. The 
concentrations of IFN-γ in the whey samples were calculated by extrapolating from the 
respective standard curves, and the values expressed as biological units of activity per milliliter. 
A background correction reading at 565nm was subtracted from the 450nm absorbance readings. 
2.8. Data analysis 
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Data were entered into spreadsheets and double checked for entry errors. All data was 
analyzed using the SAS v 9.4 statistical analysis program (SAS Institute Inc., Cary, NC). Initially 
data was graphed and evaluated for outliers and unlikely observations. Outliers were studied in 
detail and re-analyzed to confirm where necessary. Differences in linear score of SCC,  milk 
production, conductivity, clinical score, log10(bacteria count) were analyzed using linear mixed 
models (SAS, PROC MIXED), adjusting for repeated measures within animals and using 
Bonferroni for post hoc tests. The general format of the model was: 
Y = α + β1 * time point + β2 * immunization + β3 * vaccination + β4 * immunization*vaccination 
+ Cow (random) + Re. 
Where Y is the outcome variable, α is the intercept, βi are regression coefficients, time 
point is a categorical variable for each time-point of measurement, immunization is a dummy 
variable (1=yes, 0= no), vaccination is a dummy variable (1=yes, 0= no), 
immunization*vaccination is the interaction term, Cow is a random cow effect and Re is a 
complex error term, where R is the within cow correlation and e is an identically, independently 
normally distributed error term. A very similar model was used for the IMI outcome variable, but 
this was analyzed in a logistic regression term where logit(probability of IMI) was the outcome 
variable. A somewhat more complex model was used for cytokine profile analysis. The model 
used for analysis was: 
Y = α + β1 * time point + β2 * immunization + β3 * vaccination + β4 * immunization*vaccination 
+ β5 * prechallenge average + β6 * postchallenge + β7 * immunization*postchallenge + Cow 
(random) + Re. 
Where all terms are the same as previous and prechallenge average is the average 
cytokine level of the three samples taken immediately before challenge (C-4d, C-7d, C), 
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postchallenge is an indicator variable taking on the value of 1 for the time points C+12h to C+7d 
and all time points in between, the final interaction reflects the impact of immunization on the 
cytokine profile in the time periods immediately after challenge. Differences were considered 
statistically significant when the probability of a type I error is < 0.05.  
3. Results 
3.1. Clinical data 
No major clinical disease issues were encountered with the 10 cows that were enrolled 
into the trial. All cows went through the trial, eventually recovered from challenge infection and 
were all returned to the teaching and research dairy facility. Clinical scoring of cows and milk of 
the cows was done at every milking. After challenge with E. coli ECC-Z, clinical abnormalities 
were observed in almost all cows, but none of the cows became systemically sick due to clinical 
mastitis. The result of the regression analysis [results not shown] of the clinical score indicated 
that the quarters that were immunized had a lower score by an average of .09 score points and 
this reduction was borderline significant with a p-value of .07. All challenged quarters, 
immunized and non-immunized, showed a significantly increased score that had increased with 
an average of .15 compared to non-challenged control quarters (P<.01). The least square means 
obtained from the regression model are shown in Figure 23. The clinical score in the challenged 
but non-immunized control quarters started out higher immediately after calving and then 
became approximately identical to the immunized quarters after three days. Body temperature of 
the cows throughout the trial was on average 38.6oC (SD .52), with no significant differences 
observed between the vaccinated and control cows, at 38.6oC (SD .57) and 38.5oC (SD .45) 
respectively. 
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Figure 23. Least square means of the clinical score in unimmunized control quarters and 
quarters that were immunized. Time points refer to time (hours ‘h’, days ‘d’) relative to 
parturition ‘P’. Error bars represent the SE of the LSM estimates. 
 
3.2. Intramammary infection 
The effect of immunization on bacteria counts is shown in table 10. Intramammary 
infection was defined as a sample being culture positive for E. coli ECC-Z as determined by 
RAPD of isolates. In table 10 the 10 logarithm of bacteria counts were used as the outcome 
variable for linear mixed model regression. Of the challenged, unimmunized control quarters, 10 
out of 10 quarters were at least once positive for E. coli ECC-Z, one out of these 10 quarters was 
only positive at the very first post-challenge sampling. Of the challenged, immunized quarters, 7 
out of 10 quarters were at least once positive, 5 out of these 7 quarters were only positive at the 
very first post-challenge sampling. The results indicate that the log10 bacteria counts are 
significantly lower in the immunized quarters relative to the control quarters. The average drop 
in bacteria counts was .33 log units and this was highly significant (P<.0001). Parenteral 
vaccination did not contribute to a further reduction in bacteria counts once the effect of 
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intramammary immunization was accounted for (P=.13). The least square means of the linear 
mixed model regression are shown in figure 24a. A very clear distinction between immunized 
and control quarters is evident. There is also a clear bi-modality in the graphs, where bacteria 
counts are dropping at 5 days after challenge before calving, but then increase again as soon as 
the cow has calved. The logistic mixed model regression results on the probability of a new IMI 
is also shown in table 10. Again, immunized quarters had a significantly lower probability of 
being infected. The odds ratio of being infected can be estimated as .2 ( = e-1.63 ), or control 
quarters are 5 times more likely of being infected compared to immunized quarters. In figure 
24b, the probability of a quarter being culture positive is calculated and plotted over time. 
Immunized quarters had a higher probability of becoming culture negative immediately after 
challenge (P<.05). The immunized quarters also had a lower probability of being infected post-
calving.  
 
Table 10.  Impact of immunization on bacterial counts and probability of IMI in the 
challenged quarters. Bacterial counts were 10Log transformed and analyzed in a linear model, 
probability of IMI was binary and analyzed used a logistic regression model. 
 
    Bacterial counts   Probability of IMI 
Effect   Estimate 
Standard 
Error Pr > |t|   Estimate 
Standard 
Error Pr > |Z| 
                  
Intercept   -0.30 0.26 0.28   -2.36 0.47 <.0001 
Time point   n/a n/a 0.00   3.06 0.99 0.00 
Vaccine Yes 0.41 0.27 0.13   0.99 0.73 0.17 
Immunization Yes -0.33 0.08 <.0001   -1.63 0.60 0.01 
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Figure 24. (a) Least squares means of mixed model regression on log10 bacteria counts and 
(b) probability of having an IMI in the immunized and unimmunized control quarters. 
Time points refer to time relative to challenge (C) or parturition (P). 
 
3.3. Milk production, SCC and conductivity 
Quarter milk production was measured using the lactocorder device. Milk production 
regression results indicated that the immunized quarters had an increased quarter milk production 
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of .58 kg/milk per day (P<.01). Parenteral vaccination did not have a significant impact on milk 
production once immunization was accounted for (P=.40). The least square means resulting from 
the final regression model are shown in figure 25. Milk production started out approximately 
equal between the unimmunized, challenged control quarters and immunized, challenged 
quarters but in the days after calving milk production in immunized quarters increased relative to 
unimmunized quarters for the duration of the trial. In table 11, the linear mixed model regression 
of the linear score of the somatic cells counts at quarter level are shown. Immunized quarters had 
a significantly lower linear score by .40 linear score units. Challenge increased the linear score. 
The least square means of this model are shown in figure 26a. In table 11, the linear mixed 
model regression results of milk conductivity are shown. The average conductivity in 
immunized, challenged quarters was significantly lower compared to unimmunized, challenged 
quarters. Least square means from the regression model on milk conductivity are shown in figure 
26b. 
 
Table 11. Linear mixed model results of linear score and electrical conductivity in 
immunized and control quarters. Both models used were linear regression models. 
      Linear score     Conductivity 
Effect   Estimate 
Standard 
Error Pr > |t|   Estimate 
Standard 
Error Pr > |t| 
                  
Intercept   2.45 0.23 <.0001   4.34 0.27 <.0001 
Time point   n/a n/a <.0001   n/a n/a <.0001 
Challenge   0.18 0.07 0.01   0.92 0.10 <.0001 
Vaccine   0.40 0.29 0.17   0.23 0.31 0.46 
Immunization   -0.40 0.08 <.0001   -1.43 0.12 <.0001 
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Figure 25. Least squares means of quarter milk production in immunized and 
unimmunized control quarters. Time points refer to time relative to parturition (P). 
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Figure 26. Least squares means of (a) linear score and (b) electrical conductivity in 
immunized and unimmunized control quarters. Time points refer to time relative to 
parturition (P). Error bars represent the SE of the LSM estimates. 
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Cytokine profiles for IFN-γ and IL-10 are shown in figure 27a and 27b respectively. For 
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cytokine immediately before challenge (pre-challenge average: the average of d-7, d-4 and d0). 
Results of the linear models are shown in Table 12. The key variable to evaluate in this table is 
the interaction between immunization and post-challenge. In the case of IFN-γ this interaction 
has a parameter value of 1.68, indicating that immediately after challenge the IFN-γ level in 
immunized quarters increased by 1.68 units compared to the control quarters. In the case of IL-
10, the opposite was shown. In immunized quarters, IL-10 levels dropped by 0.74 units in 
immunized quarters immediately after challenge compared to control quarters. 
These two effects are shown in detail in figure 27. Interferon-γ levels increased 
significantly post-challenge but only in the immunized quarters, non-immunized quarters showed 
no increase due to challenge (Fig. 27a). This increase in IFN-γ levels after challenge was of 
relative short duration and the levels were back to the level of non-immunized quarters at 
approximately 4 days post challenge. After calving, IFN-γ levels decreased again and went back 
to the levels of the period before dry-off and during vaccination. Figure 27b shows the levels of 
IL-10 in immunized and control quarters. There was again a slight, but in this case non-
significant, increase in IL-10 immediately before challenge. The level of IL-10 was significantly 
lower after challenge in quarters that were immunized compared to the control quarters. 
Immediately after calving IL-10 levels in immunized quarters spiked and then returned to pre-
challenge levels. After calving no difference in IL-10 levels were observed between immunized 
and control quarters. 
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Table 12. Linear mixed model for IFN-γ and IL-10; both models used were linear mixed 
models. 
The t- and Z-critical values to determine if coefficients are significantly different from 0 are 
based on a 2-tailed test with an alpha of 0.05 
 
 
  
   IFN-γ  IL-10 
Effect   Estimate 
Standard 
Error Pr > |t|  Estimate 
Standard 
Error  Pr > |t| 
                 
Intercept   -0.57 0.53 0.31  0.03 0.36 0.95 
Time point   n/a n/a 0.90  n/a n/a 0.006 
Immunization 0.06 0.17 0.70  -0.09 0.17 0.59 
Vaccine   -0.66 0.67 0.33  0.29 0.20 0.15 
Prechallenge average 0.57 0.10 <.0001  0.15 0.09 0.14 
Postchallenge 2.51 0.29 <0.001  0.01 0.28 0.98 
Immunization*postchallenge 1.68 0.39 <0.001  -0.74 0.32 0.02 
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Figure 27. Least squares means of (a) IFN-γ cytokine values and (b) IL-10 in unimmunized 
control and immunized quarters. Time points refer to time relative to challenge (C) or 
parturition (P). Time of peripheral vaccination (V) is indicated. Error bars represent the SE of the 
LSM estimates. 
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4. Discussion 
The results of the intramammary immunization study in 10 cows showed a partially 
protective effect of intramammary immunization at dry-off on the outcome of a subsequent 
intramammary challenge in the late dry period. Immunization resulted in a fivefold lower 
probability of infection (odds ratio of .2), and a lower bacterial load. These results provide the 
first strong evidence that intramammary immunization with UV-killed E. coli bacterin in dairy 
cows may improve the outcome of an intramammary infections acquired in the dry period. The 
results of intramammary immunization appear to be more protective compared to systemic 
vaccination, which most often does not reduce the intramammary infection risk (Hogan et al. 
1992, Wilson et al. 2008). The precise mechanism that would lead to this protection against 
infection is not known, but it may be hypothesized that immunization with UV-killed E. coli is 
protective. This is in line with a series of studies on protective effects of mucosal immunization 
with oral administration of E. coli ghost bacteria in defense against experimental infection in 
mice (Mayr et al. 2005, 2012). In a recent study on intramammary immunization of mice against 
a subsequent S. aureus challenge, it was also shown that intramammary immunization 
significantly reduced bacterial load after challenge when compared to subcutaneous vaccination 
or a non-treated control group (Gogoi-Tiwari et al. 2015, 2016). The authors suggested that the 
enhanced generation of antigen-specific humoral and cell-mediated immunity observed 
following intramammary immunization lead the superior protection against S. aureus challenge 
(Gogoi-Tiwari et al. 2015). 
The second important finding was that intramammary immunization resulted in lower 
SCC and milk conductivity, a somewhat lower clinical mastitis score, and increased milk 
production compared to challenged, unimmunized quarters. Part of this effect may be attributed 
to the much lower risk of infection and lower bacteria counts in quarters that did get infected. 
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However, even in infected quarters, the severity of signs was numerically, but not statistically, 
lower in immunized quarters (data not shown). Reduction in clinical severity caused by IMI 
present in early lactation by UV-killed bacterin intramammary immunization in at dry-off needs 
further investigation in order to differentiate between cases in which there was full protection vs. 
partial protection. 
Another valuable finding in this study was the difference in cytokine profile observed 
between immunized and challenged versus unimmunized and challenged quarters. The 
unimmunized control quarters responded as shown before by Quesnell and co-workers (2012); 
these quarters showed no significant increase in pro-inflammatory cytokine production following 
challenge, in this case IFN-γ, and increased concentration of IL-10 after challenge relative to 
immunized, challenged quarters. In contrast, the immunized quarters showed a modified pro-
inflammatory response with a moderate increase in IFN-γ and a decrease in IL-10 concentrations 
following challenge. This study indicates the suggested maternal immune regulation of pro-
inflammatory, Th1-type responses described in late gestation may be modified in the mammary 
gland with intramammary immunization (Rosbottom et al. 2008, Quesnell et al. 2012, Maeda et al., 
2013; Paibomesai et al., 2013; Pomeroy et al. 2015). This may suggest that mucosal immunity in 
the mammary gland is more flexible during this period of maternal immune regulation. Previous 
studies on mucosal immunization against E. coli using ghost bacteria have also shown in 
addition to improved humoral immunity enhanced antigen-specific IFN-γ response following 
challenge with target antigen (Mayr et al. 2005, 2012). Additionally, non-specific priming of 
innate immune cell populations at mucosal sites such as monocytes and macrophages which 
induce epigenetic changes to generate what is known as “trained immunity’’ has been well-
documented in other species and these effects have been shown to improve the efficacy of 
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immunization and the protection against secondary, non-target infections (Benn et al. 2013, Arts 
et al. 2015). Since antigen-specific immunity was not determined by either antibody titers or in 
vitro recall responses, it cannot be determined from this study which cell types were affected by 
the immunization and whether the enhanced protection from E. coli IMI was due to the 
generation of primed tissue-resident innate immune cells and/or antigen-specific lymphocytes by 
intramammary immunization. The mechanisms involved can only be speculated at this point 
based on current understanding in immunomodulation and immune programming.  
The mechanism of action of such a local immunization of the mucosa in the mammary 
gland is not fully understood.  Although few studies have been published on intramammary 
immunization, already in 1985, Colditz and Watson (1985) reported on intramammary 
immunization of sheep to prevent IMI with S. aureus bacteria. Glands locally immunized with 
killed Brucella abortus provided a greater neutrophil response to staphylococcal infection.  
Secretions of these immunized glands contained elevated concentrations of mononuclear cells. 
The authors concluded that humoral and cellular characteristics of the locally immunized 
mammary gland influences the kinetics of the neutrophil influx during staphylococcal infection 
(Colditz and Watson, 1985). The studies on intramammary immunization in dairy cows by Smith 
et al. (1999) did not show any protective effect of the immunization i.e. there was no difference 
in clinical signs, bacterial load, or cell influx observed between immunized and control quarters, 
despite the enhanced antibody response in the mammary secretum. The authors hypothesized 
that the extensive boiling of the organisms prior to use as a vaccine may have resulted in low 
antigenic properties of this solution. It has been suggested that ghost bacteria alone are able to 
stimulate both the innate and adaptive immune system (Lubitz et al. 2009). The use of ghost 
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bacteria may have been a key difference between the earlier studies of Smith et al. (1999) and the 
current studies using intramammary application of ghost bacteria such as UV-killed bacterin. 
Although these results are preliminary and obtained on only 10 cows, the results certainly 
appear to provide insight into the biological benefits of triggering mucosal immunity in the 
mammary gland. The current study uses 10 adult cows, and showed a significant impact on 
bacterial infection risk after challenge. Still, this first study with 10 cows will need to be repeated 
to be able to provide more solid evidence that intramammary immunization with UV-killed 
bacterin is indeed efficacious in reducing intramammary infections. The use of a homologous 
challenge provides the best possible scenario to show efficacious protection of intramammary 
immunization. Obviously, such homologous challenge is not a very realistic scenario for 
commercial dairy farms. Further experimental work with heterologous organisms will be 
necessary to show a broad spectrum of efficacy (Schukken et al. 2011). Ultimately, such 
intramammary immunization with UV-killed bacterin will need to be effective under field 
conditions. Not only is it essential to show further efficacy in repeated studies with heterologous 
challenge, it is also necessary to obtain a better mechanistic understanding of the immune 
response that is stimulated using this novel vaccination approach (Bharathan et al. 2011). Finally, 
it will be essential to develop an application system that under all management circumstances 
will be both effective and safe. Application of UV-killed bacterin into the mammary gland 
certainly also provides a risk for contamination at the time of heightened susceptibility to 
infection. Therefore, further investigations into the mechanisms and clinical efficacy of 
intramammary immunization are warranted based on the promising observations in the study 
reported here.  
5. Conclusions 
  
177 
 
 Intramammary immunization at the time of dry-off with UV killed E. coli bacterin 
without addition of adjuvant proved to be partially effective in preventing subsequent 
intramammary infection after a homologous live E. coli challenge. Immunization also resulted 
after calving in a lower linear score, lower electrical conductivity and a higher milk production. 
The small size of the study warrants careful conclusions and further studies on intramammary 
immunization, to show it efficacy with heterologous challenge and eventually its efficacy and 
safety under field conditions. 
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CHAPTER 8: DISCUSSION 
1. Introduction 
Cows have an increased susceptibility to E. coli IMI during the early and late stages of 
the dry period (Smith et al., 1985a, Green et al., 2002). Intramammary infections acquired in the 
dry period often persist until calving and cause clinical mastitis in the subsequent lactation 
(Green et al., 2002, Pyorala, 2008). Clinical signs of mastitis typically do no accompany 
infection within the dry period, not even IMI caused by E. coli which typically elicit highly 
inflammatory responses during lactation (Quesnell et al., 2012, Sipka et al., 2013, Pomeroy et al., 
2016a). Available perinatal vaccines targeted at E. coli mastitis, the predominant isolate found in 
IMI acquired in the dry period, are currently only labeled to reduce clinical severity of the 
disease. The work presented here sought to identify and characterize key parameters involved in 
the heightened risk to E. coli IMI in the dry period and subsequent postpartum mastitis. The 
major findings from the studies show: 1) the dam’s immune system has a dynamic regulation of 
peripheral blood monocyte composition and moDC function by stage of lactation and pregnancy 
(chapters 2&3); 2) cows have reduced populations of inflammatory monocytes, antigen 
presentation, and Th1-type cytokine production and enhanced anti-inflammatory cytokine 
production in late gestation (chapters 2-4); 3) moDC function can be regulated by pregnancy-
associated hormones 17β-estradiol and progesterone (chapter 4); 4) deviations in prepartum 
peripheral blood monocyte composition can increase the risk of postpartum infectious disease 
(chapter 5); and 5) the persistence and unique dynamics of IMI in the dry period appears to be an 
interaction between hindered maternal immune function in pregnancy and the drastic changes to 
the gland related to involution/steady-state of the dry period (chapter 6). However despite the 
changes to immune function in late gestation, the mammary gland is still able to generate 
protective immunity in the dry period to eliminate E. coli IMI effectively and reduce clinical 
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severity following UV-killed E. coli intramammary immunization (chapter 7). The collective 
work from this dissertation suggests the relationship between maternal immune regulation and 
immune response in the non-lactating mammary gland is complex. Our understanding of both 
maternal immune regulation in dairy cattle and the mucosal immunity in the non-lactating 
mammary gland are still limited, but this work may guide future work in this area and provide 
insight for the design of vaccines, biotherapeutics, and immunomodulators and identify when 
such interventions would be beneficial. 
2. Maternal immune regulation of myeloid cells in bovine late gestation 
A primary objective of this dissertation was to characterize changes in immune function 
in late gestation in order to elucidate the underlying mechanisms in E. coli IMI dynamics in the 
dry period. The maternal immune system is regulated during pregnancy in order to tolerate the 
developing semi-allogenic fetus, but these changes also impact the ability to respond to invading 
pathogens (Betz, 2012, Krishnan et al., 2013, Zenclussen, 2013, Schumacher et al., 2014, Fair, 
2015). Maternal-fetal tolerance involves multiple mechanisms to prevent highly inflammatory, 
cell-mediated responses against fetal antigens however, these mechanisms are not well-
characterized in dairy cattle. Oliveira and Hansen (2008), Oliveira et al. (2010), and Mansouri-
Attia et al. (2012) described the pivotal role of monocytes (Mo), macrophages (Mφ), and 
dendritic cells (DC) in early bovine pregnancy, and they observed an increase in these 
mononuclear phagocytic cells in the endometrium in early stages of pregnancy that were 
maintained at high numbers into late gestation; these cells played a role in regulating the 
cytokine environment. The cross-sectional study presented in chapter 2 and longitudinal study 
presented in chapter 3 both showed that late gestation, non-lactating cows have unique profile of 
myeloid cell composition and function likely to promote tolerance though reduced antigen 
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presentation, enhanced anti-inflammatory responses, and reduction in certain inflammatory 
responses. Maternal immunity varies by stage of pregnancy based on unique roles the immune 
system plays in pregnancy recognition, placentation, maintenance, and labor. The results from 
the longitudinal study presented in chapter 3 provide evidence that cattle, similar to humans and 
rodents, experience dynamic shifts in the maternal immune system as pregnancy progresses until 
calving. Specifically, the work presented here indicates late gestation, concurrent to the dry 
period, contains the most dramatic changes to monocyte composition and moDC function. 
2.1. Monocyte composition in late gestation and postpartum infectious disease 
Cows maintained higher proportions of cM and lower proportions of intM in the 
peripheral blood from mid-gestation up until calving, after which the cM decreased and intM 
increased in the postpartum period as cows progressed further into lactation (chapter 3). A nadir 
in the proportion of ncM was observed approximately 2 weeks prior to calving (chapter 3). 
Analogous to human monocytes, three bovine monocyte subsets are classified by expression of 
CD14 and CD16, however, only certain functional characteristics overlap between human and 
bovine monocyte subsets primarily between cM and intM (Hussen et al., 2013, Hussen et al., 
2014, Ziegler-Heitbrock, 2014, Corripio-Miyar et al., 2015, Thomas et al., 2015, Hussen et al., 
2016). Classical monocytes arise from the bone marrow and are thought to mature into ncM via 
intM (Sunderkotter et al., 2004, Ziegler-Heitbrock et al., 2010). Bovine intM generate 
comparatively greater pro-inflammatory responses to LPS and neutrophil degranulation products 
than cM and ncM (Hussen et al. 2013; Corripio-Miyar et al. 2015; Hussen et al. 2016). Limiting 
the population size of the more mature, more inflammatory intM subset that expresses high 
levels of MHC II relative to cM may be one mechanism of maintaining fetal tolerance in bovine 
pregnancy and reduce highly inflammatory responses (Hussen et al., 2013, Hussen et al., 2014, 
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Hussen et al., 2016). The absolute count of monocyte population in the blood peaked 
immediately following calving, but declined as cows progressed in lactation (chapter 3). This 
dramatic increase in monocyte numbers observed postpartum may potentially relate to the 
damaging, prolonged, highly inflammatory responses that most often accompany E. coli IMI in 
the postpartum period (Ziegler-Heitbrock, 2007). 
Unlike the findings presented here on monocyte composition in bovine pregnancy, 
healthy human pregnancy has been characterized by increases in intM and decreases in cM in the 
blood, and an overall rise in monocyte numbers with a steady increase in monocyte activation as 
pregnancy progresses (Luppi et al., 2002, Faas and de Vos, 2016). Cattle and humans differ in 
placentation, humans require a substantial increase in uterine NK cells and inflammatory 
monocytes to the reproductive tract in the early vascular remodeling and maintenance of such an 
invasive placenta whereas this need may not be as prominent in non-invasive cotyledon 
placentation in cattle (Smith et al., 2009, Lash et al., 2010, Peter, 2013). Again, these differences 
reiterate the need to characterize bovine pregnancy immunology as these production animals 
have distinct differences from humans and other mammalian species. 
Findings from the longitudinal study also show that approximately 2 weeks prior to 
calving cows experience a nadir in ncM proportions (chapter 3). As the function of ncM is not 
well-defined in bovine species it is difficult to say their exact role in pregnancy, but these 
changes may relate to preparation for labor. Bovine ncM have also been shown to have different 
function from their human counterparts, making extrapolations from human pregnancy difficult. 
These cells are thought to have patrolling function, and more anti-inflammatory properties. 
Hussen et al. (2013), (2014), and (2016) found ncM to show little to no response to neutrophil 
degranulation products, LPS, and CCL5. Thus, it is also not easy to decipher their role in bovine 
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E. coli IMI and mastitis with the available peer-reviewed literature. Further research needs to be 
conducted on ncM function to interpret the importance of this nadir 2 weeks prepartum with 
regards to maternal immune regulation, labor, and implications for immune response to IMI and 
other infectious postpartum diseases. 
Monocytes play multiple roles in shaping the immune response from polarization and 
expansion of primary and memory lymphocytes to activation, recruitment of other myeloid cells, 
and can exert microbicidal effects (Geissmann et al., 2008, Xiong and Pamer, 2015). Monocytes 
may also differentiate into Mφ or DC of varying phenotypes with in the tissue depending upon 
the initial monocyte subset and signals received from other tissue-resident cells and soluble 
factors present in the tissue (Tacke and Randolph, 2006, Geissmann et al., 2008, Dominguez and 
Ardavin, 2010). The fate of circulating monocyte subsets upon reaching the mammary gland is 
not entirely known in dairy cattle. Hussen et al. (2014) showed that CCL5 induced selective 
migration of bovine cM and differentiation of these cells towards LPS-hypo responsive Mφ in 
vitro reiterating functional differences in these subsets, and also suggesting in vivo migration to 
and differentiation in tissue may vary between subsets; this may relate the increased cM in blood 
to the lack of inflammatory following E. coli intramammary challenge observed in the dry 
period. Oliveira et al. (2010) found a subpopulation of endometrial Mφ that differentiated via the 
M2 activation pathway during pregnancy and based on similarity in gene expression between 
endometrial and blood CD14+ cells, suggested that the immense infiltration of CD14+ cells in the 
pregnant endometrium is a result of the recruitment from blood monocytes. As dry cows also 
experience a substantial increase in Mφ and other phagocytes in the mammary gland during 
involution, this is likely comparable to the findings on endometrial Mφ. This monocyte 
composition in the blood likely shapes the monocyte and macrophage differentiation in the tissue 
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to give rise to more M2-like macrophages with reduced antigen presentation. Given the 
importance of late gestation and E. coli IMI in the dry period, these changes noted in blood cells 
presented here in conjunction with previous work on bovine monocyte subset differentiation and 
endometrial Mφ, future work needs to address these hypotheses in an in vivo model analyzing 
cells in the mammary gland. 
In human and rat pregnancy, deviations from maternal immune regulation of monocyte 
and Mφ composition and function lead to complications and increased risk of preeclampsia. 
Although healthy human and rat pregnancy is accompanied with increased monocyte activation, 
there is a limit, beyond which an inflammatory disorder may develop or other complications may 
arise (Tang et al., 2015a, Faas and de Vos, 2016). Findings from the prospective study presented 
in chapter 5 show deviations from maternal immune regulation of monocyte composition 
prepartum poses as a risk for postpartum infectious diseases including metritis and mastitis. In 
the case of mastitis, these deviations may potentially exacerbate inflammation in the postpartum 
period without effective clearance of the pathogen to IMI acquire in the dry or postpartum. It is 
also possible these prepartum immune dysfunctions may increase risk of acquire IMI in the dry 
period. Galvao et al. (2012) showed blood monocytes from cows which developed metritis had 
lower IL-10 and TNFα gene expression following in vitro E. coli stimulation; the monocyte 
subset composition from these animals were unknown. Without functional analysis of these 
monocytes in pre- and postpartum periods it is not possible to determine if these animals’ 
monocytes were functionally comparable, nor can the role of peripheral blood monocyte 
composition in postpartum disease be determined. Nonetheless, these findings do indicate 
individual monocyte subsets are regulated in healthy pregnancy, and deviations in their 
regulation in late gestation, specifically the balance between CD14+ and CD14- subsets, increase 
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risk for incidence of infectious disease following parturition. This places precedence on future 
research to investigate the various roles of bovine monocyte subsets play in both pregnancy and 
disease. In addition, future work should elucidate factors which may cause monocyte 
composition and maternal immune regulation to deviate and increase risk of disease.  
2.2. Regulation of moDC response to E. coli  in late gestation and the dry period 
Dendritic cells are potent antigen presenting cells which play a critical role in maternal 
immune tolerance (Blois et al., 2007, Gomez-Lopez et al., 2014). Dendritic cells have a unique 
ability to induce both antigen-specific immunity and tolerance through their prominent role in 
naïve T cell activation (Hivroz et al., 2012). In addition to initiation of antigen-specific 
responses, DC are also involved in initiating and directing innate immunity, this includes 
crosstalk with NK cells to induce NK cell activation, IFNγ production, and cytotoxic function 
(Zanoni et al., 2007, Sipka et al., 2016). In mammalian pregnancy, DC are regulated to hinder 
development of cell-mediated, inflammatory responses against fetal antigens and cells by 
promoting the generation of Treg cells, inhibiting NK cell cytotoxicity, and hindering generation 
of Th1 and Th17-type responses (Saito et al., 2005, Lin et al., 2007, Leno-Duran et al., 2014). 
Tolerance generated by DC play a crucial role in preventing pregnancy complications such as 
preeclampsia and preterm birth in humans and rodents (Negishi et al., 2012, Hsu and Nanan, 
2014, Wang et al., 2014, Prins et al., 2015). Studies presented here indicate there are comparable 
dynamic changes occurring in gestating dairy cows which had not been described previously 
(chapters 2&3). 
In both the cross-sectional study and longitudinal study presented in chapters 2 and 3, 
respectively moDC were found to have impaired maturation in response to E. coli stimulation in 
late gestation within the early dry period. Phenotypic changes following E. coli stimulation 
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suggest moDC in late gestation are least mature and likely have a reduced ability to activate 
naïve T helper cells due to hindered CD80 and MHC II upregulation when compared to moDC 
from early lactation (chapters 2&3). Monocyte-derived DC from the dry period have reduced IL-
12 production, increased IL-10 production, increased IL-1β production with no major changes to 
TNFα production; these profiles vary throughout pregnancy and lactation, but greatest changes 
from the studies presented here were observed in the first week of dry-off. These results support 
a the initial hypotheses that DC have reduced ability to generate antigen-specific, Th1-type 
responses with greatest regulation of these responses in late gestation compared to other stages of 
pregnancy and lactation. The peak production in pro-inflammatory cytokine, IL-1β observed in 
the first week of the dry period concurrent to late gestation, and the unhindered TNFα production 
throughout pregnancy in bovine moDC are comparable to the selective, tightly regulated increase 
in specific inflammatory cytokines observed in human pregnancy; bovine pregnancy is not a 
general state of suppressed inflammatory responses (Rusterholz et al., 2007). The dynamic 
changes to phenotypic maturation and cytokine production following E. coli stimulation 
throughout pregnancy likely reflect the complex and differing needs and unique factors present 
at each stage of pregnancy and lactation. For example, IL-1β, among other cytokines may relate 
to the recruitment of phagocytes to the mammary gland during involution and/or cervical 
ripening and preparation for labor in late stages of pregnancy and may be balanced with 
heightened IL-10 production to mitigate risk of preterm birth (Peltier, 2003, Wedlock et al., 
2004, van Engelen et al., 2009, Dubicke et al., 2010, Nagamatsu and Schust, 2010).  
The observations made in the study presented in chapter 4 show moDC have impaired 
maturation in response to E. coli stimulation following in vitro treatments of late gestation levels 
of progesterone and estradiol. Comparable to other mammalian species, findings presented here 
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indicate high levels of estradiol and progesterone in circulation observed in late gestation dairy 
cows regulate moDC and likely other myeloid immune cells which express progesterone and 
estradiol receptors (chapter 4) (Hunter et al., 1970, Echternkamp and Hansel, 1973, Pioli et al., 
2006, Segerer et al., 2009, Lasarte et al., 2013, Schumacher et al., 2014). Specifically, estradiol 
and progesterone hindered CD80 and MHC II expression, and enhanced IL-10 production in 
moDC from lactating, non-pregnant cows following in vitro E. coli stimulation (chapter 4). 
These changes induced by progesterone and estradiol in DC populations are comparable to what 
has been described other mammalian species (Bachy et al., 2008, Butts et al., 2008, Hughes et 
al., 2008, Della Bella et al., 2011, Papenfuss et al., 2011, Xu et al., 2011, Cordeau et al., 2012, 
Lasarte et al., 2013). However, these estradiol and progesterone treatments did not recapitulate 
the enhanced CD14 expression observed in both the cross sectional and longitudinal study, and 
the effects on the production of other cytokines is unknown. As described in murine and human 
pregnancy, there are numerous pregnancy-associated factors that extend beyond progesterone 
and estradiol which regulate myeloid cells including fetal-derived factors, pregnancy-associated 
glycoproteins, human chorionic gonadotropin, etc. (Segerer et al., 2009, Della Bella et al., 2011, 
Warning et al., 2011, Schumacher et al., 2013, Schumacher et al., 2014). Regulation by 
pregnancy-associated factors likely differs between the periphery and tissue due to interactions 
between various cell populations, and unique composition and level of pregnancy-associated at 
various sites in the body. Future work needs to further investigate other pregnancy-associated 
factors and factors specific to the dry period, and their interactions to understand how moDC 
phenotype and function are regulated dynamically throughout pregnancy. The effects on the 
production of other cytokines such as IL-12 and IL-1β, and on other functional traits are 
unknown, and the mechanism by which these hormones regulate bovine moDC have yet to be 
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determined. Furthermore, the pregnancy-associated factors which regulate monocyte 
composition described earlier also remain unknown, but these items should addressed in future 
research.  
Metabolism and metabolic factors such as adipocytokines, glucose levels, ketone bodies, 
and vitamin D3 vary by stage of lactation and pregnancy; these factors have all be shown to 
influence immune function across mammalian species (Valsamakis et al., 2010, Contreras and 
Sordillo, 2011, Rulle et al., 2012, Kabara et al., 2014). These metabolic factors are known to 
influence the effects of other immunomodulatory factors for example, inhibition of mTOR, a 
pathway which integrates growth factors, energy status, oxygen and amino acid signals to 
regulate multiple cell growth processes, can inhibit the anti-inflammatory, immunosuppressive 
effects of glucocorticoids on immune cell function (Weichhart et al., 2011). The onset lactation 
following parturition comes with high energy demands and metabolic changes that are known to 
influence immune function in dairy cows (Contreras and Sordillo, 2011, Zarrin et al., 2014, 
Sundrum, 2015). In addition to steroid hormones such as progesterone and estradiol, 
differentiation of monocytes into DC and DC maturation is regulated by lipid metabolism, 
ketone bodies, glucose metabolism and the mTOR pathway, and vitamin D3 and specifically 
play a large role in generation of tolerogenic DC in non-bovine, mammalian species (Ferreira et 
al., 2015, Kelly and O'Neill, 2015, Pearce and Everts, 2015, Youm et al., 2015, Sim et al., 2016, 
Sukhbaatar et al., 2016). Recently, Eger et al. (2016) found bovine monocytes had limited ability 
to take up glucose following parturition compared to monocytes from the prepartum period due 
to downregulation of glucose transporter expression as a function of lactose production. Eger et 
al. (2016) suggested changes to monocyte glucose metabolism might relate to their impaired 
macrophage differentiation; this work supports the likely a role of metabolism in the 
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differentiation and maturation of bovine monocytes into moDC. Perkins et al. (2001) found that 
diet-induced negative energy balance caused an increase in MHC II expression on blood 
leukocytes in steers further supporting potential metabolic induced changes in moDC over stages 
of pregnancy and lactation. Myeloid cells are dependent on glycolysis to generate more pro-
inflammatory responses like IL-1β production suggesting changes decreases in glucose following 
parturition may be one factor related to cytokine profiles from moDC observed at various stages 
of pregnancy and lactation (Orlinska and Newton, 1993, Freemerman et al., 2014). Furthermore, 
β-hydroxybutyrate (BHB) negatively regulates human monocyte IL-1β production, and given 
levels of BHB in serum are high postpartum in early lactation but low in the dry period this 
emphasizes the connection between metabolic state of a non-lactating period and immune 
regulation in conjunction with effects by pregnancy-associated steroid hormones (Bernier-Dodier 
et al., 2011, Youm et al., 2015). Cessation of lactation also causes a reduction in hormones 
related to milk production such as prolactin, which has been shown to enhance inflammatory 
responses of various PBMC (Brand et al., 2004, Boutet et al., 2007). Given the unique energy 
demands of a dairy cow, the effects of metabolic and lactation-related factors on bovine moDC 
and myeloid cell populations as they relate to changes throughout lactation and the dry period 
need to be addressed in future work. These metabolic changes associated with the energy 
demands of the growing fetus and the transition from lactation to the dry period likely relate to 
the unique in moDC differentiation and maturation in the early dry period in addition to effects 
of estradiol and progesterone. The interaction of these metabolic changes from non-lactating to 
lactating stages, such as mTOR inhibition or activation, with other immunomodulatory 
pregnancy-associated factors and/or metabolic factors are not well-characterized in cattle.  
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The mechanisms by which these pregnancy-associated factors regulate immune cells is 
not well-described in dairy cattle. In non-bovine species, pregnancy is known to involve 
epigenetic regulation and improper epigenetic regulation may lead to pregnancy complications 
like preeclampsia (Chen and Wang, 2013, Brooks et al., 2016). Paibomesai et al. (2013) found 
that both parturition and dexamethasone treatment were able to regulate the DNA methylation 
patterns of IL-4 and IFNγ promoters of CD4+ T cells in dairy cattle related to an increase of 
IFN-γ production following parturition and an increase in IL-4 production prior to calving. It is 
known that environmental factors which induce differential epigenetic regulation of immune cell 
populations creating lasting, heritable impacts on immune response to disease (Jirtle and Skinner, 
2007). Epigenetic mechanisms including DNA methylation, histone modification, and 
microRNA can be induced by endocrine factors, endocrine-disruptors, and metabolites and 
nutritional status including estrogen, phytoestrogens, and Acetyl-CoA respectively through the 
regulation of epigenetic-modifying gene expression (Zhang and Ho, 2011, Etchegaray and 
Mostoslavsky, 2016). Epigenetic regulation of maternal immune cells by pregnancy-associated 
factors is another area of research worth investigating to assist in the development of novel 
immunomodulators by identifying targets and improve understanding of mechanisms generating 
maternal immune tolerance and altered immunity in the dry period.  
3. Drawing relationships between late gestation immune regulation and E. coli IMI 
dynamics in the dry period 
The work presented in chapters 2-5 investigated changes in blood myeloid cell 
populations in pregnancy. These changes in blood cells may relate to the unique IMI dynamics 
observed in the dry period, but these in vitro studies cannot account for the specific changes 
which occur during involution and steady-state of the dry period within the mammary gland. 
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Findings from the mathematical modeling of IMI dynamics in the dry period presented in chapter 
6 recapitulate both the persistency of IMI in the dry period and the reduction in cytokine 
response which likely relates to the lack clinical signs observed with IMI occurring in the dry 
period. The E. coli IMI dynamics are more complex than initially hypothesized, and the 
involvement of unique physiological and immune changes to the mammary gland with the 
cessation of lactation is likely to play a larger role than initially thought. The model findings 
suggest the persistency and limited pro-inflammatory response is related to effects from 
physiological and immunological changes in the dry period and late gestation maternal immune 
regulation which overlaps with the dry period. The non-lactating mammary gland has an 
increased numbers of phagocytes with reduced phagocytic abilities, and secretions from the 
gland are unfavorable for bacterial growth i.e. reduced nutrients, increased soluble immune 
factors, etc. relative to milk (Todhunter et al., 1990, Inchaisri et al., 2000, Boutinaud et al., 
2016). The role of maternal immune regulation i.e. suppression of Th1-type immunity and highly 
inflammatory responses appears to contribute to dampened cytokine responses, and may relate to 
inability to kill infected host cells however this cannot be confirmed with the mathematical 
model or experimental work (chapters 2-6). The in vivo work presented in chapter 7 shows the 
mammary gland is able to clear extracellular bacteria yet the IMI persists post-calving which 
suggests the formation of intracellular reservoirs is crucial (Dogan et al., 2006, White et al., 
2010). Future work should investigate changes to mammary tissue-resident immune cell 
populations and cell-mediated responses in IMI in the dry period with different E. coli strains 
that vary in their ability to form intracellular reservoirs. Furthermore, future work should 
differentiate between dry period and late gestation factors involved in the unique IMI dynamics 
observed in late gestation, dry cows. 
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4. Targeting mucosal immunity in the dry period for E. coli IMI 
The long term goal of the work presented here is to provide necessary insight to progress 
preventive medicine for postpartum E. coli mastitis through the development and/or optimization 
of immunomodulators and vaccination in the dry period. The work presented in chapter 7 
indicate that it is possible to elicit protective Th1-type immunity against E. coli IMI occurring in 
the dry period with an intramammary immunization of a homologous strain at the start of dry off.   
Local immunization resulted in enhanced IFNγ production and reduced IL-10 production 
following live E. coli challenge approximately 10-12d prior to calving; this coincided with 
reduced bacterial numbers and probability of being infected, and effectively reduced cases of 
clinical mastitis and clinical severity postpartum relative to unimmunized, challenged quarters 
(chapter 7) (Pomeroy et al., 2016a). This further suggests the late gestation maternal immune 
regulation observed in previous work in chapters 1- and in peer-reviewed literature functions 
differently from immune cells in the blood and/or can be manipulated locally in the mammary 
gland to produce Th1-type responses (Rosbottom et al., 2008, Maeda et al., 2013, Pomeroy et al., 
2015, Pomeroy et al., 2016b). The lack of crossover of protective immunity between 
unimmunized and immunized quarters within a cow further emphasizes the quarters act as 
individual compartments which is relevant when designing a locally administered 
immunomodulator or vaccine.  
The presence of DC and other myeloid cell populations in the bovine mammary gland has 
been confirmed in previous work, and work presented here emphasizes the need to continue 
research on the function of myeloid cell populations resident in mammary tissue to elucidate the 
relevancy of the moDC in vitro model in local immune response to IMI in the dry period 
(chapters 2-4). It is not possible to decipher the mechanisms that were involved in generating 
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protective immunity from the work presented in chapter 7, and it is unknown if the protective 
immunity related to non-specific trained immunity of innate cells, and/or the generation of a 
local antigen-specific lymphocyte cell population from effective activation of DC (van der Meer 
et al., 2015, Jensen et al., 2016). Future work should also include measurements of antigen-
specific antibody production and T cell via recall responses by cells within an immunized 
quarter. In addition to measurements on antigen-specific immunity, future work should also 
investigate the formation of trained immunity for example, by analyzing epigenetic changes to 
local immune cell populations and/or by investigating the effect of an intramammary 
immunization on a non-homologous E. coli challenge. 
Findings from the mathematical modeling study presented in chapter 6 indicated local 
changes to the mammary gland during involution and cessation of milk production were 
important parameters in shaping IMI dynamics. Like the mathematical model, the results from 
dry period intramammary immunization reiterate the need to investigate pregnancy-associated 
changes to tissue resident DC to understand the role of maternal immune regulation in 
intramammary immunization and IMI infection dynamics in the dry period. Although 
mechanisms cannot be deduced here, targeting mucosal immunity in late gestation with 
intramammary immunization appears to be more effective than systemic vaccination in 
generating protective responses. Furthermore the lack of crossover of protective immunity from 
an immunized quarter to a neighboring unimmunized quarter within a cow emphasizes 
localization and lack of migration of these trained and/or antigen specific cells. Thus, route of 
administration and should be considered when developing immunomodulators and vaccinations 
to prevent IMI. 
5. Conclusions and future directions 
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Pregnancy occurs regularly and frequently in dairy cattle, and the impact of pregnancy 
immune regulation should not be ignored when considering disease management and the 
development of vaccines, immunomodulators, and therapeutics. Findings in this dissertation, 
items from current literature, and hypotheses and ideas developed from these two sources are 
summarized in figure 28 of the general discussion. Mechanisms pertinent to fetal tolerance may 
compromise immune response to certain invading pathogens and effective response to 
vaccination. In order to develop successful preventative medicine and treatment for E. coli IMI 
that aim to manipulate and boost the host immune response, target pathways must be identified, 
and timing and route of administration of immunomodulators and vaccines must be selected to 
optimize efficacy without compromising safety or milk and meat withholding time. Species 
differences including placentation and unique energy demands of a production animal render 
human and rodent models of pregnancy suboptimal for understanding maternal immune 
regulation in dairy cattle. Work presented here indicates that dairy cattle undergo dynamic 
maternal immune regulation of mononuclear phagocytic cells which are likely to contribute to 
the unique E. coli IMI dynamics in the dry period in conjunction with physiological and 
immunological changes specific to cessation of lactation. Future work should expand upon the 
role of maternal regulation in later stages of pregnancy with regards to tolerance of the fetus and 
relationship with response to vaccination and invading pathogens. The unique changes to 
immune function within the mammary gland in the dry period and interplay with maternal 
immune regulation must also be addressed in future work. Expediting the development of safe 
and effective immunomodulators and vaccines for late gestation dairy cows impinges on 
mechanisms of maternal-fetal immune tolerance involved in a healthy, uncomplicated pregnancy 
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and negative effects on pregnancy and calf health when there are deviations in the maternal 
immune system. 
Figure 28. Summary of dissertation findings with relevant literature. Aspects of immune 
function of dry cows, late gestation and dry period factors which may regulate these changes, 
and the proposed relationship with E. coli IMI, postpartum mastitis risk, and ability to enhance 
immunity via immunomodulators and vaccination. 
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